0001193125-12-234493.txt : 20120515 0001193125-12-234493.hdr.sgml : 20120515 20120515160401 ACCESSION NUMBER: 0001193125-12-234493 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20120331 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cereplast Inc CENTRAL INDEX KEY: 0001324759 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-34689 FILM NUMBER: 12844552 BUSINESS ADDRESS: STREET 1: 300 N. CONTINENTAL STREET 2: SUITE 100 CITY: EL SEGUNDO STATE: CA ZIP: 90245 BUSINESS PHONE: 310-615-1900 MAIL ADDRESS: STREET 1: 300 N. CONTINENTAL STREET 2: SUITE 100 CITY: EL SEGUNDO STATE: CA ZIP: 90245 10-Q 1 d352018d10q.htm FORM 10-Q Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

Commission File Number 001-34689

 

 

CEREPLAST, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Nevada   91-2154289

(State or Other Jurisdiction of

Incorporation or Organization)

 

(I.R.S. Employer

Identification No.)

300 N. Continental Boulevard, Suite 100

El Segundo, California

  90245
(Address of Principal Executive Office)   (Zip Code)

(310) 615-1900

(Registrant’s Telephone Number, Including Area Code)

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 or Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   ¨
Non-accelerated filer   ¨    Smaller reporting company   x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

The number of shares of common stock outstanding as of May 10, 2012 is 20,027,204.

 

 

 


Table of Contents

CEREPLAST, INC.

FORM 10-Q

TABLE OF CONTENTS

 

     Page  
PART I—FINANCIAL INFORMATION   

Item 1. FINANCIAL STATEMENTS

     3   

CONSOLIDATED BALANCE SHEETS AT MARCH 31, 2012 AND DECEMBER 31, 2011

     3   

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME FOR THE THREE MONTHS ENDED MARCH 31, 2012 AND 2011

     4   

CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE THREE MONTHS ENDED MARCH 31, 2012 AND 2011

     5   

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

     6   

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

     16   

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     22   

Item 4. CONTROLS AND PROCEDURES

     22   
PART II—OTHER INFORMATION   

Item 1. LEGAL PROCEEDINGS

     22   

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

     23   

Item 3. DEFAULTS UPON SENIOR SECURITIES

     23   

Item 4. MINE SAFETY DISCLOSURES

     23   

Item 5. OTHER INFORMATION

     23   

Item 6. EXHIBITS

     23   

SIGNATURES

     24   

Exhibit 31.1

  

Exhibit 31.2

  

Exhibit 32.1

  

Exhibit 32.2

  

EX-101 INSTANCE DOCUMENT

  

EX-101 SCHEMA DOCUMENT

  

EX-101 CALCULATION LINKBASE DOCUMENT

  

EX-101 LABELS LINKBASE DOCUMENT

  

EX-101 PRESENTATION LINKBASE DOCUMENT

  

EX-101 DEFINITION LINKBASE DOCUMENT

  

Unless otherwise indicated or unless the context requires otherwise, all references in this report to “we,” “us,” “our,” “Cereplast” or the “Company” shall refer to Cereplast, Inc.

 

2


Table of Contents

PART I – FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

CEREPLAST, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except shares data)

 

     March 31, 2012     December 31, 2011  
     (Unaudited)     

ASSETS

    

Current Assets

    

Cash

   $ 1,059      $ 3,940   

Accounts Receivable, Net

     14,787        14,744   

Inventory, Net

     4,285        4,406   

Prepaid Expenses and Other Current Assets

     828        966   
  

 

 

   

 

 

 

Total Current Assets

     20,959        24,056   
  

 

 

   

 

 

 

Property and Equipment

    

Property and Equipment

     13,928        13,752   

Accumulated Depreciation and Amortization

     (3,315     (3,151
  

 

 

   

 

 

 

Property and Equipment, Net

     10,613        10,601   
  

 

 

   

 

 

 

Other Assets

    

Restricted Cash

     43        43   

Deferred Loan Costs

     1,182        1,321   

Intangible Assets, Net

     211        183   

Deposits

     47        47   
  

 

 

   

 

 

 

Total Other Assets

     1,483        1,594   
  

 

 

   

 

 

 

Total Assets

   $ 33,055      $ 36,251   
  

 

 

   

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current Liabilities

    

Accounts Payable

   $ 1,496      $ 1,813   

Accrued Expenses

     2,472        2,760   

Capital Leases, Current Portion

     75        73   

Loan Payable, Current Portion

     1,897        1,855   
  

 

 

   

 

 

 

Total Current Liabilities

     5,940        6,501   
  

 

 

   

 

 

 

Long-Term Liabilities

    

Loan Payable

     6,955        7,307   

Convertible Subordinated Notes

     12,500        12,500   

Capital Leases, Long-Term

     226        245   
  

 

 

   

 

 

 

Total Long-Term Liabilities

     19,681        20,052   
  

 

 

   

 

 

 

Total Liabilities

     25,621        26,553   
  

 

 

   

 

 

 

Shareholders’ Equity

    

Preferred Stock, $0.001 par value; 5,000,000 shares authorized and none outstanding

     —          —     

Common Stock, $0.001 par value; 495,000,000 shares authorized; 19,027,204 and 18,933,139 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively

     19        19   

Additional Paid in Capital

     66,644        66,524   

Accumulated Deficit

     (59,321     (56,935

Accumulated Other Comprehensive Income

     88        86   
  

 

 

   

 

 

 
     7,430        9,694   

Noncontrolling Interests

     4        4   
  

 

 

   

 

 

 

Total Equity

     7,434        9,698   
  

 

 

   

 

 

 

Total Liabilities and Shareholders’ Equity

   $ 33,055      $ 36,251   
  

 

 

   

 

 

 

See accompanying notes to unaudited consolidated financial statements.

 

3


Table of Contents

CEREPLAST, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME

(unaudited, in thousands, except per share data)

 

     Three Months Ended  
     March 31, 2012     March 31, 2011  

Gross Product Sales

   $ 114      $ 7,285   

Sales Discounts, Returns and Allowances

     (11     (45
  

 

 

   

 

 

 

Net Sales

     103        7,240   

Cost of Goods Sold

     638        6,538   
  

 

 

   

 

 

 

Gross Profit (Loss)

     (535     702   

Operating Expenses:

    

Research and Development

     129        250   

Selling, General and Administrative

     1,216        2,043   
  

 

 

   

 

 

 

Total Operating Expenses

     1,345        2,293   
  

 

 

   

 

 

 

Operating Loss

     (1,880     (1,591

Interest and Other Income

     18        —     

Interest Expense

     (524     (159
  

 

 

   

 

 

 

Loss Before Provision for Income Taxes

     (2,386     (1,750

Provision for Income Taxes

     —          —     
  

 

 

   

 

 

 

Net Loss

     (2,386     (1,750

Gain (Loss) on Foreign Currency Translation

     2        (47
  

 

 

   

 

 

 

Total Comprehensive Loss

   $ (2,384   $ (1,797
  

 

 

   

 

 

 

Net Loss Per Share—Basic and Diluted

   $ (0.13   $ (0.12
  

 

 

   

 

 

 

Weighted Average Common Shares Outstanding—Basic and Diluted

     18,948,644        14,873,018   
  

 

 

   

 

 

 

See accompanying notes to unaudited consolidated financial statements.

 

4


Table of Contents

CEREPLAST, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited, in thousands, except shares data)

 

     Three Months Ended  
     March 31, 2012     March 31, 2011  

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net Loss

   $ (2,386   $ (1,750

Adjustment to Reconcile Net Loss to Net Cash Used in Operating Activities

    

Depreciation and Amortization

     176        216   

Allowance for Doubtful Accounts

     —          42   

Common Stock Issued for Services, Salaries and Wages

     121        584   

Amortization of Loan Discount

     19        19   

Impairment of Intangible Assets

     —          64   

Changes in Operating Assets and Liabilities

    

Accounts Receivable

     (43     (6,417

Deferred Loan Costs

     138        28   

Inventory

     121        (403

Deposits

     —          (10

Prepaid Expenses

     147        (76

Accounts Payable

     (315     (1,337

Accrued Expenses

     (289     97   
  

 

 

   

 

 

 

NET CASH USED IN OPERATING ACTIVITIES

     (2,311     (8,943
  

 

 

   

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Purchase of Property and Equipment, and Intangibles

     (115     (89

Proceeds from Sale of Equipment

     15        —     
  

 

 

   

 

 

 

NET CASH USED IN INVESTING ACTIVITIES

     (100     (89
  

 

 

   

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Payments on Capital Leases

     (18     (1

Payments made on Notes Payable

     (454     —     

Proceeds from Loan Payable, Net of Loan Costs

     —          2,502   

Proceeds from Issuance of Common Stock and Subscriptions, Net of Issuance Costs

     —          11,372   
  

 

 

   

 

 

 

NET CASH (USED) PROVIDED BY FINANCING ACTIVITIES

     (472     13,873   
  

 

 

   

 

 

 

FOREIGN CURRENCY TRANSLATION

     2        (47
  

 

 

   

 

 

 

NET INCREASE (DECREASE) IN CASH

     (2,881     4,794   

CASH, BEGINNING OF PERIOD

     3,940        2,391   
  

 

 

   

 

 

 

CASH, END OF PERIOD

   $ 1,059      $ 7,185   
  

 

 

   

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

    

Cash Paid During the Year For:

    

Interest

   $ 151      $ 119   

Income Taxes

   $ —        $ —     

SUPPLEMENTAL DISCLOSURE OF NON-CASH TRANSACTIONS

    

During the three months ended March 31, 2012, the Company issued 84,478 shares valued at $88 to employees for service rendered during the period and 9,587 shares valued at $10 for a settlement agreement. The Company also recognized $23 of expense related to vesting of employee stock options for the same period. During the three months ended March 31, 2011, the Company issued 83,877 shares valued at $414 for services to directors and employees for services rendered during the period, 12,000 shares valued at $59 for prepaid services and 4,062 shares valued at $20 for a settelment agreement. The Company also recognized $112 of expense related to vesting of employee stock options for the same period.

See accompanying notes to unaudited consolidated financial statements.

 

5


Table of Contents

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2012

(Unaudited)

1. ORGANIZATION AND LINE OF BUSINESS

Organization

We were incorporated on September 29, 2001 in the State of Nevada under the name Biocorp North America Inc. On March 18, 2005, we filed an amendment to our certificate of incorporation to change our name to Cereplast, Inc.

Line of Business

Cereplast, Inc. (“we” or “Cereplast”) has developed and is commercializing proprietary bio-based resins through two complementary product families: Cereplast Compostables® resins which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables™ resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Our resins can be converted into finished products using conventional manufacturing equipment without significant additional capital investment by downstream converters.

The demand for non-petroleum based, clean and renewable sources for materials, such as bioplastics, and the demand for compostable/biodegradable products are being driven globally by a variety of factors, including fossil fuel price volatility, energy security and environmental concerns. These factors have led to increased spending on clean and renewable products by corporations and individuals as well as legislative initiatives at national, state and local level.

We are a full-service resin solution provider uniquely positioned to capitalize on the rapidly increasing demand for sustainable and environmentally friendly alternatives to traditional plastic products.

We primarily conduct our operations through two product families:

 

   

Cereplast Compostables® resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. We offer 13 commercial grades of Compostable resins in this product line. These resins are compatible with existing manufacturing processes and equipment making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Compostable line in November 2006.

 

   

Cereplast Sustainables™ resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications. We offer six commercial grades of Sustainable resins in this product line. These resins are compatible with existing manufacturing processes and equipment, making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Sustainable line in late 2007 under the name “Cereplast Hybrid Resins®.”

 

   

Cereplast Hybrid Resins® products replace up to 55% of the petroleum content in conventional plastics with bio-based materials such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. The Cereplast Hybrid Resins® line provides a viable alternative for brand owners and converters looking to partially replace petroleum-based resins in durable goods applications. Hybrid resins address this need in a wide range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. We commercially introduced our first grade of Hybrid resin, Hybrid 150, at the end of 2007. We currently offer four commercial grades in this product line.

 

6


Table of Contents
   

Cereplast Algae Plastic® resins. In October of 2009 we announced that we have been developing a new technology to transform algae into bioplastics and intend to launch a new resin family containing algae-based materials that will complement our existing line of resins. The first commercial product with Cereplast Algae Plastic® resin is now being produced and sold as part of our Sustainables resin family. We believe that it is important to enhance research on non-food crops as we expect a surge in demand in bioplastics in future years, thus potentially creating pressure on food crops. Algae are the first non-food crop project that we have introduced and our R&D department is contemplating the development of additional non-food crop based materials in future years.

Our patent portfolio is currently comprised of six patents in the United States (“U.S.”), one Mexican patent, and eight pending patent applications in the U.S. and abroad. Our trademark portfolio is currently comprised of approximately 45 registered marks and 21 pending applications in the U.S. and abroad.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Consolidation

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The unaudited consolidated financial statements include the financial condition and results of operations of our wholly-owned subsidiary, Cereplast International, S.A., a Luxembourg company organized during the year ended December 31, 2008, for the purpose of conducting sales operations in Europe. Intercompany balances and transactions have been eliminated in consolidation. The results of operations for interim periods are not necessarily indicative of the results that may be expected for a full year. These financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance and the fair value of stock options. Actual results could differ from those estimates.

Cash

We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. At various times throughout the year, the Company may have exceeded federally insured limits. At March 31, 2012 and December 31, 2011, balances in our cash accounts exceeded federally insured limits of $0.25 million by approximately, $0.7 million and $4.0 million, respectively. We have not experienced any losses in such accounts and we do not believe we are exposed to any significant credit risk on cash and cash equivalents.

Concentration of Credit Risk

We had unrestricted cash totaling $1.1 million and $3.9 million at March 31, 2012 and December 31, 2011, respectively. The unrestricted cash and cash equivalents are held for working capital purposes. We do not enter into investments for trading or speculative purposes. Some of the securities in which we invest, however, may be subject to market risk. This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate. To minimize this risk, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, debt securities and certificates of deposit. Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates. We actively monitor changes in interest rates.

 

7


Table of Contents

Concentration of credit risk with respect to accounts receivable is limited to certain European customers to whom we make substantial sales. As of March 31, 2012 we had one large European customer that accounted for $7.6 million, or 36% of our accounts receivable balance, which is past due. We have another large European customer with $6.1 million, or 29% of our receivable balance. Agreed upon payment terms for both of these customers are 90 days from receipt of goods. These customers have acknowledged to us their agreement with the amounts owing and no amounts recognized in revenue or recorded in accounts receivable from these customers are in dispute. To reduce risk, we routinely assess the financial strength of our most significant customers, using standard credit risk evaluation methods with reference to publicly available and customer supplied information, and monitor the amounts owed to us, taking appropriate action when necessary. As a result of the recent deterioration in the general economic conditions in Europe and the slow payment by some of our European customers, we have established an allowance for doubtful accounts of $5.4 million to reflect management’s assessment of credit risk associated with these customer balances. We are working with all customers to mitigate credit risk and ensure collection of all outstanding amounts.

Other Concentration

During the three months ended months ended March 31, 2012, we did not have any significant suppliers that accounted for greater than 10% of total cost of goods sold. During the same period in the prior year, we had three significant suppliers that accounted for 34.5%, 17.2%, and 15.0% of total cost of goods sold. No other suppliers accounted for more than 10% of cost of goods sold during these periods.

Liquidity and Capital Resources

We have incurred a net loss of $2.4 million for the three months ended March 31, 2012, and $14.0 million for the year ended December 31, 2011, and have an accumulated deficit of $59.3 million as of March 31, 2012. Based on our operating plan, our existing working capital will not be sufficient to meet the cash requirements to fund our planned operating expenses, capital expenditures and working capital requirements through December 31, 2012 without additional sources of cash.

Our plan to address the shortfall of working capital is to generate additional financing through a combination of sale of our equity securities, refinancing existing credit facilities, incremental product sales and collection of outstanding receivables. We are confident that we will be able to deliver on our plans, however, there are no assurances that we will be able to obtain any sources of financing on acceptable terms, or at all.

If we cannot obtain sufficient additional financing in the short-term, we may be forced to curtail or cease operations or file for bankruptcy. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be forced to take such actions.

Restricted Cash

We had restricted cash in the amount of approximately $43,000 on March 31, 2012 and December 31, 2011. The restricted cash amount consists of a “Certificate of Deposit” which supports a “Letter of Credit” for a leased facility.

Fair Value of Financial Instruments

The carrying amounts of our financial instruments as of March 31, 2012, which include cash, accounts receivable, unbilled receivable, accounts payable, accrued expenses, loans payable and convertible subordinated notes approximate their fair values due to the short-term nature of these instruments.

 

8


Table of Contents

Accounts Receivable

We maintain an allowance for doubtful accounts for estimated losses that may arise if any of our customers are unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. Quantitative factors include customer’s past due balance, prior payment history, recent sales activity and days sales outstanding. Qualitative factors include macroeconomic environment, current product demand, estimated inventory levels and customer’s financial position. In certain cases, we may have access to repossess unsold products held at customer locations as recourse for payment defaults. The fair market value of these products are considered as potential recovery in estimating net losses from uncollectible accounts. We record an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $5.4 million as of March 31, 2012 and December 31, 2011.

Inventories

Inventories are stated at the lower of cost (first-in, first-out basis) or market, and consist primarily of raw materials used in the manufacturing of bioplastic resins, finished bioplastic resins and finished goods. Inventories are reviewed for excess and obsolescence and a reserve is established accordingly. As of March 31, 2012 and December 31, 2011, inventories consisted of the following (in thousands):

 

     March 31, 2012     December 31, 2011  
     (Unaudited)        

Raw Materials

   $ 2,399      $ 2,565   

Bioplastic Resins

     1,918        1,959   

Finished Goods

     41        42   

Packaging Materials

     78        69   

WIP

     60        —     

Obsolescence Reserve

     (211     (229
  

 

 

   

 

 

 

Inventories, net

   $ 4,285      $ 4,406   
  

 

 

   

 

 

 

Property and Equipment

Property and equipment are stated at cost, and depreciation is computed on the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are between five and seven years. Repairs and maintenance expenditures are charged to expense as incurred. Property and Equipment consist of the following (in thousands):

 

     March 31, 2012     December 31, 2011  
     (Unaudited)        

Equipment

   $ 5,749      $ 5,434   

Building

     5,906        5,906   

Land

     32        32   

Construction In Progress

     1,630        1,743   

Auto

     11        37   

Furniture and Fixtures

     327        327   

Leasehold Improvements

     273        273   
  

 

 

   

 

 

 
     13,928        13,752   

Accumulated Depreciation

     (3,315     (3,151
  

 

 

   

 

 

 

Property and Equipment, Net

   $ 10,613      $ 10,601   
  

 

 

   

 

 

 

 

9


Table of Contents

Intangible Assets

Intangible assets are stated at cost and consist primarily of patents and trademarks. Amortization is computed on the straight-line method over the estimated life of these assets, estimated to be between five and fifteen years. Intangible assets consist of the following (in thousands):

 

     March 31, 2012     December 31, 2011  
     (Unaudited)        

Intangible Assets

   $ 252      $ 222   

Accumulated Amortization

     (41     (39
  

 

 

   

 

 

 

Intangible Assets, Net

   $ 211      $ 183   
  

 

 

   

 

 

 

Deferred Income Taxes

Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.

The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

Interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statement of income.

Revenue Recognition

We recognize revenue at the time of shipment of products, when the following fundamental criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the price to the customer is fixed or determinable; and (iv) collection of the sales price is probable.

Certain of our product sales are made to distributors under agreements with generally the same terms of sale and credit as all other customer agreements. Revenue from product sales to our customers, including our customers who are distributors, is recognized upon shipment provided the above noted fundamental criteria of revenue recognition are met. The sale of products to our customers who are distributors is not contingent upon the distributor selling the product to the end-user, and our current agreements with distributors do not have any rights of return.

Impairment of Long-Lived Assets

We review long-lived assets for possible impairment by evaluating whether the carrying amount of assets exceed its recoverable amount. Our judgment regarding the existence of impairment is based on legal factors, market conditions and operational performance of our assets. Future adverse changes in legal environment, market conditions or poor operating results could result in losses or an inability to recover the carrying value of the long-lived assets, thereby possibly requiring an impairment charge in the future.

 

10


Table of Contents

Comparative Figures

Certain of the prior year figures have been reclassified to conform to the presentation adopted in the current year.

3. CAPITAL STOCK

Capital Stock Issued

During the three months ended March 31, 2012, we issued shares of common stock as follows:

 

   

We issued 84,478 shares of restricted common stock valued at approximately $88,000 to various employees for services rendered during the period.

 

   

We issued 9,587 shares of common stock valued at approximately $10,000 pursuant to a settlement agreement.

Valuation Assumptions for Stock Options

During the year ended December 31, 2011, we granted options to our employees to purchase an aggregate of 300,000 shares of our common stock, with estimated total grant-date fair values of $0.7 million. We estimate that stock-based compensation for awards not expected to be exercised is $0.2 million. During the three months ended March 31, 2012, we recorded stock-based compensation related to stock options of $23,000. The grant date fair value was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends and the following assumptions:

 

     January 14, 2011

Average risk-free interest rate

   2.29%

Average expected life (in years)

   6.0

Volatility

   41.9%

 

   

Expected Volatility: The fair values of stock based payments were valued using a volatility factor based on our historical stock prices.

 

   

Expected Term: We elected to use the “simplified method” as discussed in SAB No. 107 to develop the estimate of the expected term.

 

   

Expected Dividend: We have not paid any dividends and do not anticipate paying dividends in the foreseeable future.

 

   

Risk-Free Interest Rate: We base the risk-free interest rate used on the implied yield currently available on U.S. Treasury zero-coupon issues with remaining term equivalent to the expected term of the options.

Stock Option Activity

Under the 2004 Employee Stock Option Plan adopted by our board of directors (the “Plan”), our board of directors may issue incentive and non-qualified stock options to our employees. Options granted under the Plan generally expire at the end of five or ten years and vest in accordance with a vesting schedule determined by our board of directors, usually over three years from the grant date. As of March 31, 2012, we have 34,375 shares available for future grants under the Plan. We settle stock option exercises with newly issued shares of our common stock (in thousands except, per share data):

 

11


Table of Contents
     2012      2011  
     Shares      Weighted
Average
Exercise Price
     Shares      Weighted
Average
Exercise Price
 

Outstanding—January 1

     373       $ 8.65         73       $ 22.40   

Granted at fair value

     —           —           300         5.31   

Exercised

     —           —           —           —     

Cancelled/forfeited

     —           —           —           —     
  

 

 

       

 

 

    

Outstanding—March 31

     373         8.65         373         8.65   
  

 

 

       

 

 

    

Options exercisable at March 31

     193       $ 11.77         133       $ 14.69   
  

 

 

       

 

 

    

The following table summarizes information about stock options as of March 31, 2012, (in thousands, except per share data):

 

     Options Outstanding      Options Exercisable  

Range of Exercise Prices

   Shares      Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contract
Life
     Aggregate
Intrinsic
Value
     Shares      Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contract
Life
     Aggregate
Intrinsic
Value
 

$0.0—$5.31

     300       $ 5.31         8.91       $ —           120       $ 5.31         8.91       $ —     

$5.32—$22.40

     73       $ 22.40         2.67       $ —           73       $ 22.40         2.67       $ —     

The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing stock price of $0.62 at March 31, 2012 which would have been received by the option holders had all option holders exercised their options as of that date.

4. LOANS PAYABLE

Venture Loan Payable

On December 21, 2010, we entered into a Venture Loan and Security Agreement (the “Loan Agreement”) with Compass Horizon Funding Company, LLC (the “Lender”). The Loan Agreement provides for a total loan commitment of $5.0 million comprising of Loan A and Loan B, each in the amount of $2.5 million. Loan A was funded at closing on December 21, 2010 and matures 39 months after the date of advance. Loan B was funded on February 17, 2011 and also matures 39 months after the date of advance. We are obligated to pay interest per annum equal to the greater of (a) 12% or (b) 12% plus the difference between (i) the one month LIBOR Rate, on the date which is five business days before the funding of such loan and (ii) .30%. We are required to make interest only payments for the first nine months of each loan and equal payments of principal over the final thirty months of each loan. Any payments received after five days of written notice from the Lender will be assessed a 4% late payment fee. We granted a security interest to the Lender in all of our property.

In connection with loan, we issued a seven year warrant to the Lender to purchase 140,000 shares of common stock of the Company at an exercise price of $4.40. The relative fair value of the warrants was $0.2 million and will be recorded as interest expense over the term of the loan. We estimated the fair value of the warrants using the Black-Scholes option pricing model using the following assumptions:

 

12


Table of Contents

Assumptions:

   December 22, 2010  

Expected Life

     7 years   

Expected volatility

     39.9

Dividends

     None   

Risk-free interest rate

     2.74

Also in connection with the Loan Agreement, we incurred $0.4 million of debt issue costs which were deferred and are being amortized to interest expense over the term of the loan.

Convertible Subordinated Notes

On May 24, 2011, we issued $12.5 million in aggregate principal amount of 7% Senior Subordinated Convertible Notes due June 1, 2016 (the “Notes”). The Notes were issued pursuant to an indenture (the “Indenture”), entered into between us and Wells Fargo Bank, National Association, as trustee, on May 24, 2011. In connection with the issuance of the Notes, we entered into a Waiver to our Venture Loan and Security Agreement with Horizon, dated May 18, 2011 pursuant to which Horizon provided its consent to the offering of the Notes and waived any restrictions in the Loan Agreement.

The Notes are senior subordinated unsecured obligations which will rank subordinate in right to payment to all of our existing and future senior secured indebtedness and bear interest at a rate of 7% per annum payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2011. The Notes mature on June 1, 2016, with an early repurchase date of June 15, 2014 at the option of the purchaser. The Notes are convertible into shares of our common stock in accordance with the terms of the Notes and the Indenture, at the initial conversion rate of 172.4138 shares of our common stock per $1,000 principal amount of Notes, equivalent to a conversion price of approximately $5.80 per share, subject to adjustment. If the Notes are converted into shares of our common stock prior to June 2, 2014, an interest make-whole payment will be due based on the conversion date up until June 2, 2014. Upon a non-stock change in control, additional shares of our common stock may need to be issued upon conversion, with a maximum additional shares of 25.606 per $1,000 in principal amount of Notes being issuable thereunder, for a total maximum of 198.0198 shares per $1,000 Note. Certain customary anti-dilution provisions included in the Indenture and/or the Notes could adjust the conversion rate. At March 31, 2012, the Notes are convertible into 2,155,173 shares of our common stock.

The conversion feature within the Notes is not considered to be a beneficial conversion feature within the meaning of Accounting Standards Codification (“ASC”) 470, Debt, and therefore all of the gross proceeds from the Notes have been classified as long term debt. In connection with the issue of the Notes, we incurred approximately $1.3 million of debt issue costs which were deferred and are being amortized to interest expense over the term to the early repurchase date of June 15, 2014.

Also in connection with the issuance of the Notes, we entered into a Securities Purchase Agreement dated May 18, 2011 pursuant to which we agreed to prepare and file a registration statement with the Securities and Exchange Commission (the “SEC”) registering the resale of the Notes and the shares of common stock underlying the Notes. The registration statement was declared effective on August 10, 2011.

Mortgage Payable

Effective October 24, 2011, Cereplast Italia S.p.A (“Cereplast Italia”), our wholly owned subsidiary, completed its acquisition of an industrial plant and the real estate on which the industrial plant is located in Cannara, Italy. The Deed of Sale between Cereplast Italia and Societa Regionale Per Lo Sviluppo Economico Dell’Umbria — Sviluppumbria S.p.A, provided for an aggregate purchase price of approximately $6.4 million. In connection with the acquisition, Cereplast Italia entered into the following financing transactions:

 

13


Table of Contents
   

Mortgage loan with Banca Monte Dei Paschi Di Sienna S.p.A for the principal of $4.5 million. The loan bears interest of Euribor (6-month) plus 5.7%. The loan is for a term of 15 years with interest only payments for the first two years, payable January 1 and July 1 each year and principal and interest payments thereafter according to an amortization schedule. 20% of the principal is guaranteed for 10 years by Gepafin, a local government agency; $0.5 million of the principal is guaranteed by Eurofidi through December 31, 2016.

 

   

Credit facility with Intesa Sanpaolo for up $0.7 million. The facility is for a term of eight months with a floating interest rate based on Euribor (3 month), currently 5.85%. Interest is deferred for the first two months of the term. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.

 

   

Credit facility with Unicredit Bank for up to $0.8 million. The facility is for a term of 18 months with a floating interest rate based on Euribor (3 month), currently 5.93%. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.

5. LEASES

We currently operate out of El Segundo, CA, Seymour, IN, and Bönen, Germany. The leases underlying these three facilities are summarized below:

 

   

California Facility — The El Segundo facility consists of approximately 5,475 square feet of corporate office space. The lease commenced on March 1, 2010 and has a term of five years. The lease was subsequently amended on April 1, 2011 to add additional office space. The lease term relating to the additional office space expires on May 31, 2013. Our current monthly rent is $13,389, with 3% annual escalation.

 

   

Indiana Facility — The Seymour facility consists of approximately 105,000 square feet used as a manufacturing and distribution facility for our products. The lease commenced in January 2008, with a ten year term expiring in January 2018. Our current monthly rent is $25,000.

 

   

Bönen Facility— The Bönen facility consists of approximately 1,000 square feet of corporate office space. The facility is subject to a lease with monthly rents of approximately $2,000 expiring in December 2018.

6. MAJOR CUSTOMERS AND FOREIGN SALES

The following customers accounted for 10% or more of net revenue in the periods presented:

 

     Three Months Ended
March 31,
 
     2012     2011  

Customer A

     —          64.8

Customer B

     —          17.0

Customer C

     —          10.2

Customer D

     34.2     —     

Customer E

     24.2     —     

 

14


Table of Contents

Our net sales were made up of sales to customers in the following geographic regions (in thousands):

 

     Three Months Ended March 31,  
     2012     2011  

North America

   $ 84         81.7   $ 238         3.3

International

          

Germany

     3         3.1     4,687         64.7

Italy

     6         6.2     1,533         21.2

Other

     10         9.0     782         10.8
  

 

 

    

 

 

   

 

 

    

 

 

 

Net sales

   $ 103         100.0   $ 7,240         100.0
  

 

 

    

 

 

   

 

 

    

 

 

 

7. INCOME TAX

We are subject to U.S. and California income tax. Subject to limited statutory exceptions, we are no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for years before 2006. We are not presently liable for any income taxes nor are we undergoing any tax examinations by the Internal Revenue Service. No Deferred Tax Assets or Deferred Tax Liabilities are included in our balance sheets at March 31, 2012 or December 31, 2010.

Our policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

8. COMMON STOCK WARRANTS

In connection with the registered direct offering of 3,125,000 Units effective November 2011, we issued warrants to purchase 2,343,750 of our common stock. The per share exercise price of the warrants is $2.20. The warrants are exercisable at any time on or after the date that is 180 days after the initial issuance on the date of closing and will expire on a date that is five years from the date of closing.

In connection with the issue of 2,596,500 shares of common stock to accredited investors pursuant to the Securities Purchase Agreement entered into on January 26, 2011, we issued warrants to purchase 649,128 shares of the Company’s common stock. The warrants have an exercise price of $6.35 per share and are exercisable for a period of five years commencing August 1, 2011.

A summary of warrant activity for the period ending March 31 is as follows (in thousands except per share data):

 

     2012      2011  
     Number of
Warrants
     Weighted
Average
Exercise Price
     Number of
Warrants
     Weighted
Average
Exercise Price
 

Outstanding—January 1,

     4,219       $ 5.09         1,273       $ 4.44   

Issued

     —           —           649         6.35   

Exercised

     —           —           —           —     
  

 

 

       

 

 

    

Outstanding—March 31

     4,219         5.09         1,922         5.08   
  

 

 

       

 

 

    

Warrants exercisable at end of period

     4,219       $ 5.09         1,922       $ 5.08   
  

 

 

       

 

 

    

9. SUBSEQUENT EVENTS

On April 30, 2012, we entered into a Subscription Agreement for the sale of 1,000,000 shares of our common stock at a price of $.50 per share (the “Shares”) in a registered direct offering. The net offering proceeds from the sale of the Shares will be used for general corporate purposes. The closing of the sale and issuance of the Shares was completed on May 7, 2012.

On May 1, 2012, we received notice from NASDAQ that our securities do not meet NASDAQ’s Listing Rule 5550(a)(2) minimum bid price requirement. Under the Listing Rules we have a period of 180 days to regain compliance.

 

15


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

CAUTIONARY STATEMENTS

This Form 10-Q may contain forward-looking statements, as that term is used in federal securities laws, about our financial condition, results of operations and business. These statements include, among others, statements concerning the potential benefits that we may experience from our business activities and certain transactions we contemplate or have completed; and statements of our expectations, beliefs, future plans and strategies, anticipated developments and other matters that are not historical facts. These statements may be made expressly in this Form 10-Q. You can find many of these statements by looking for words such as believes, expects, anticipates, estimates, “opines, or similar expressions used in this Form 10-Q. These forward-looking statements are subject to numerous assumptions, risks and uncertainties that may cause our actual results to be materially different from any future results expressed or implied by us in those statements. The most important facts that could prevent us from achieving our stated goals include, but are not limited to, the following:

 

   

inability to raise sufficient additional capital to finance operations;

 

   

potential fluctuation in quarterly results;

 

   

worsening economic conditions affecting the economic health of our clients;

 

   

uncertain global economic conditions

 

   

failure to earn profits;

 

   

inadequate capital to expand our business, inability to raise additional capital or financing to implement our business plans;

 

   

decline in demand for our products and services;

 

   

inability to source raw materials in sufficient quantities to support growth in customer demand;

 

   

rapid and significant changes in markets and other factors, including national, state and local legislation, that encourage use of bioplastics;

 

   

failure to commercialize new grades of resin being pursued in our technical / market development “pipeline;”

 

   

competitor actions that curtail our market share, negatively affect pricing or limit sales growth;

 

   

litigation with or legal claims and allegations by outside parties;

 

   

insufficient revenues to cover operating costs;

There can be no assurance that we will be profitable. We may not be able to successfully manage or market our products, attract or retain qualified executives and technology personnel or obtain additional customers for our products. Our products may become obsolete, government regulation may hinder our business, additional dilution in outstanding stock ownership may be incurred due to the issuance of more shares, warrants and stock options, or the exercise of outstanding warrants and stock options, and other risks inherent in our business.

 

16


Table of Contents

Because forward-looking statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by the forward-looking statements. We caution you not to place undue reliance on these statements, which speak only as of the date of this Form 10-Q. The cautionary statements contained or referred to in this section should be considered in connection with any subsequent written or oral forward-looking statements that our company or persons acting on our behalf may issue. We do not undertake any obligation to review or confirm analysts’ expectations or estimates or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date of this Form 10-Q, or to reflect the occurrence of unanticipated events.

OVERVIEW

General

We have developed and are commercializing proprietary bio-based resins through two complementary product families: (1) Cereplast Compostables® resins, which are compostable and bio-based, ecologically sound substitutes for traditional petroleum-based non-compostable plastics, and (2) Cereplast Sustainables™ resins, which replace up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Our resins aim to be competitively priced compared to fully petroleum-based plastic resins and can be converted into finished products using conventional manufacturing equipment without significant additional capital investment by downstream converters.

The demand for non-petroleum based, clean and renewable sources for materials, such as bioplastics, and the demand for compostable/biodegradable products, is each being driven globally by a variety of factors, including environmental concerns, new stringent regulations on compostable material, fossil fuel price volatility and energy security. These factors have led to increased spending on clean and sustainable products by corporations and individuals as well as legislative initiatives at the local and state level.

We are a full-service resin solution provider uniquely positioned to capitalize on the rapidly increasing demand for sustainable and environmentally friendly alternatives to traditional plastic products.

We primarily conduct our operations through two product families:

 

   

Cereplast Compostables® resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. We offer 13 commercial grades of Compostable resins in this product line. These resins are compatible with existing manufacturing processes and equipment making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Compostable line in November 2006.

 

   

Cereplast Sustainables™ resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications. We offer six commercial grades of Sustainable resins in this product line. These resins are compatible with existing manufacturing processes and equipment, making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Sustainable line in late 2007 under the name “Cereplast Hybrid Resins®.”

 

   

Cereplast Hybrid Resins® products replace up to 55% of the petroleum content in conventional plastics with bio-based materials such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. The Cereplast Hybrid Resins® line provides a viable alternative for brand owners and converters looking to partially replace petroleum-based resins in durable goods applications. Hybrid resins address this need in a wide range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. We commercially introduced our first grade of Hybrid resin, Hybrid 150, at the end of 2007. We currently offer four commercial grades in this product line.

 

   

Cereplast Algae Plastic® resins. In October of 2009 we announced that we have been developing a new technology to transform algae into bioplastics and intend to launch a new resin family containing algae-based materials that will complement our existing line of resins. The first commercial product with Cereplast Algae Plastic® resin is now being produced and sold as part of our Sustainables resin family. We believe that it is important to enhance research on non-food crops as we expect a surge in demand in bioplastics in future years, thus potentially creating pressure on food crops. Algae are the first non-food crop project that we have introduced and our R&D department is contemplating the development of additional non-food crop based materials in future years.

 

17


Table of Contents

Our patent portfolio is currently comprised of six patents in the United States (“U.S.”), one Mexican patent, and eight pending patent applications in the U.S. and abroad. Our trademark portfolio is currently comprised of approximately 45 registered marks and 21 pending applications in the U.S. and abroad.

Trends and Uncertainties that May Impact Future Results of Operations

Global Market and Economic Conditions. Recent global market and economic conditions have been unprecedented and challenging with tighter credit conditions and slower growth. These conditions, combined with volatile oil prices, declining business and consumer confidence and increased unemployment have contributed to continued volatility of unprecedented levels.

As a result of these market conditions, the cost and availability of credit has been, and may continue to be, adversely affected by illiquid credit markets and wider credit spreads. Concern about the stability of the markets generally, and the strength of counterparties specifically, has led many lenders and institutional investors to reduce, and in some cases, cease to provide funding to borrowers and to developing companies, such as ours. Continued turbulence in the U.S. and international markets and economies may adversely affect our liquidity and financial condition and the liquidity and financial condition of our customers. If these market conditions continue, they may limit our ability, and the ability of our customers, to timely replace maturing liabilities and access the capital markets to meet liquidity needs, resulting in an adverse effect on our financial condition and results of operations.

Sales. We record sales at the time that we ship our products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable and collection of the related receivable is reasonably assured. We record sales net of sales discounts and allowances. Beginning in 2011, we provided price incentives to several customers that entered into significant supply contract for their initial purchase commitments to assist in commercial launch activities. In the future, we may offer these incentives on a selective basis as we continue to grow our customer base. The amount of these incentives in future periods will be a function of the growth of our customer base and the particular commercialization.

Operating Expenses. Operating expenses consist principally of salaries (both cash and non-cash equity-based compensation), professional fees (including legal, accounting, patent-related, government compliance), marketing, sales commissions, rent and research and development. Salaries include all cash and non-cash compensation and related costs for all principal selling, general and administrative functions. During recent periods we have made grants of equity awards, including shares of restricted stock and stock options, to attract directors and members of senior management, which have resulted in non-cash compensation expense for the periods reported. We expect that non-cash compensation expense attributed to equity-based awards may increase in future periods as the result of future equity-based incentive compensation awards granted to attract and retain talented employees as we continue to grow our business. In addition, we expect to experience increases in our research and development expenses as we continue to develop new products and formulations, as well as increases in marketing and promotional expenses as we seek to increase our customer base.

 

18


Table of Contents

CRITICAL ACCOUNTING POLICIES AND USE OF ESTIMATES

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We monitor our estimates on an ongoing basis for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are recorded in the period in which they become known. We base our estimates on historical experience and other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate.

Revenue Recognition

We recognize revenue at the time of shipment of products, when the following fundamental criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the price to the customer is fixed or determinable; and (iv) collection of the sales price is probable.

Certain of our product sales are made to distributors under agreements with generally the same terms of sale and credit as all other customer agreements. Revenue from product sales to our customers, including our customers who are distributors, is recognized upon shipment provided the above noted fundamental criteria of revenue recognition are met. The sale of products to our customers who are distributors is not contingent upon the distributor selling the product to the end-user, and our current agreements with distributors do not have any rights of return.

Stock-Based Compensation

Compensation cost for all stock-based awards is measured at fair value on the date of grant and recognized over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes valuation model. Such value is recognized as expense over the service period, net of estimated forfeitures, using the straight-line method. Adjustments to this expense are made periodically to recognize actual rates of forfeiture which vary significantly from estimates.

Accounts Receivable

We maintain an allowance for doubtful accounts for estimated losses that may arise if any of our customers are unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. Quantitative factors include customer’s past due balance, prior payment history, recent sales activity and days sales outstanding. Qualitative factors include macroeconomic environment, current product demand, estimated inventory levels and customer’s financial position. In certain cases, we may have access to repossess unsold products held at customer locations as recourse for payment defaults. The fair market value of these products are considered as potential recovery in estimating net losses from uncollectible accounts. We record an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote.

Inventories

Inventories are stated at the lower of cost (first-in, first-out basis) or market, and consist primarily of raw materials used in the manufacturing of bioplastic resins, finished bioplastic resins and finished goods. Inventories are reviewed for excess and obsolescence and a reserve is established accordingly.

Intangibles

Intangibles are stated at cost and consist primarily of patents and trademarks. Amortization is computed on the straight-line method over the estimated life of these assets, estimated to be between five and fifteen years.

 

19


Table of Contents

Property and Equipment

Property and equipment are stated at cost, and depreciation is computed on the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are between three and seven years. Repairs and maintenance expenditures are charged to expense as incurred. Assets under construction are not depreciated until placed into service.

Deferred Income Taxes

Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.

The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED MARCH 31, 2012 COMPARED TO THE THREE MONTHS ENDED MARCH 31, 2011

Sales

Net sales for the three months ended March 31, 2012 were approximately $0.1 million, compared to $7.2 million in the same period in 2011. The decrease in sales was due to transitioning significant resources and efforts toward recovery of past due accounts receivables from customers and minimizing any additional exposure to our accounts receivable credit risk. Our current period sales were primarily prepaid shipments of sample materials and nominal shipments to established existing customers with low risk credit limits.

Cost of Sales

Cost of sales is comprised of both fixed and variable costs, including materials and supplies, labor, facilities and other overhead costs associated with our product revenues. Cost of sales for the three months ended March 31, 2012 were approximately $0.6 million, compared to $6.5 million for the same period in 2011. The decline in cost of sales is due to our lower variable manufacturing costs from our reduced sales volumes and reduction in manufacturing overhead through reduced supplies and headcount.

Gross Profit (Loss)

Gross profit (loss) for the three months ended March 31, 2011 was approximately ($0.5) million, compared to $0.7 million for the same period in 2011. Our decline in gross profit was attributable to our decline in sales as stated above.

Research and Development Expenses

Research and development expenses for the three months ended March 31, 2012 were $0.1 million, compared to approximately $0.2 million for the same period in 2011. Our decrease in research and development expenses was primarily attributable to lower outside services costs related to our current projects.

 

20


Table of Contents

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 31, 2012 were $1.2 million, compared to $2.0 million for the same period in 2011. Our decrease in sales, general and administrative expenses was primarily due to reduced headcount and variable sales and marketing expenses due to lower sales volume in the current year.

Other Income and Expense, Net

Other income and expense, net for the three months ended March 31, 2012 was $0.5 million, as compared to $0.2 million in the same period in 2011. The increase was primarily related to additional interest expense related to the issuance of our convertible debentures in May 2011.

Net Loss

Net loss for the three months ended March 31, 2012 was $2.4 million, as compared to $1.8 million in the same period in 2011. As discussed above, our results were unfavorably impacted by our decrease in net sales.

LIQUIDITY AND CAPITAL RESOURCES

We require working capital to fund our operations, including payments to finance our research and development and expand sales and marketing, to purchase equipment, service indebtedness, satisfy lease obligations and execute on our business plan and growth strategy.

We had net unrestricted cash of $1.1 million at March 31, 2012 as compared to $3.9 million at December 31, 2011. The decrease in unrestricted cash is primarily due to cash used in operations.

Cash used in operating activities during the three months ended March 31, 2012 was $2.3 million, compared to $8.9 million during the same period in the 2011. The decrease in cash used in operations was primarily a result of an increase in working capital of $12.3 million in 2011, driven by an increase in accounts receivable and reduction in accounts payable.

Cash used in investing activities during the three months ended March 31, 2012 was $0.1 million compared to cash used in investing activities of approximately $0.1 million during the same period in 2011.

Cash used in financing activities during the three months ended March 31, 2011 was $0.5 million compared to $13.9 million provided by financing activities during the same period in 2011. The decrease is attributable to $13.9 million of debt and equity financing that occurred in the prior year only.

We have incurred a net loss of $2.4 million for the three months ended March 31, 2012, and $14.0 million for the year ended December 31, 2011, and have an accumulated deficit of $59.3 million as of March 31, 2012. Based on our operating plan, our existing working capital will not be sufficient to meet the cash requirements to fund our planned operating expenses, capital expenditures and working capital requirements through December 31, 2012 without additional sources of cash.

Our plan to address the shortfall of working capital is to generate additional financing through a combination of refinancing of existing credit facilities, incremental product sales and collection of outstanding receivables. We are confident that we will be able to deliver on our plans, however, there can be no assurances that we will be able to obtain any sources of financing on acceptable terms, or at all.

If we cannot obtain sufficient additional financing in the short-term, we may be forced to curtail or cease operations or file for bankruptcy. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be forced to take such actions.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any relationships with unconsolidated entities or financial partnerships such as entities often referred to as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance-sheet arrangements or for other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

 

21


Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to a number of market risks in the ordinary course of business. These risks, which include interest rate risk, foreign currency exchange risk and commodity price risk, arise in the normal course of business rather than from trading. We have examined our exposures to these risks and concluded that none of our exposures in these areas is material to fair values, cash flows or earnings. We regularly review these risks to determine if we should enter into active strategies, such as hedging, to help manage the risks. At the present time, we do not have any hedging programs in place and we are not trading in any financial or derivative instruments.

We currently do not have any material debt, so we do not have interest rate risk from a liability perspective. We do have a significant amount of cash and short-term investments with maturities less than three months. This cash portfolio exposes us to interest rate risk as short-term investment rates can be volatile. Given the short-term maturity structure of our investment portfolio, and the high-grade investment quality of our portfolio, we believe that we are not subject to principal fluctuations and the effective interest rate of our portfolio tracks closely to various short-term money market interest rate benchmarks.

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, we conducted an evaluation, under the supervision and with the participation of our chief executive officer and chief financial officer of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) of the Exchange Act). Based upon this evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is: (i) recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms, and (ii) accumulated and communicated to our management, including our chief executive officer and chief financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting, as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act, during the fiscal quarter ended March 31, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

From time to time, we may become involved in various lawsuits and legal proceedings that arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in matters that may harm our business may arise from time to time. We are currently not aware of nor have any knowledge of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

 

22


Table of Contents

ITEM 1A. RISK FACTORS

There are no material changes from the risk factors previously disclosed in the Registrant’s Form 10-K filed on April 16, 2012.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

We issued the following unregistered securities during the three months ended March 31, 2012:

 

   

On March 16, 2012, we issued 84,478 shares of common stock valued at approximately $88,000 to various employees for services rendered.

 

   

On March 16, 2012, we issued 9,587 shares of common stock valued at approximately $10,000 pursuant to a settlement agreement

All of the offerings and sales above were deemed to be exempt under rule 506 of Regulation D and/or Section 4(2) of the Securities Act, No advertising or general solicitation was employed in offering the securities. The offerings and sales were made to a limited number of persons, all of whom were accredited investors, our business associates or our executive officers, and transfers of the securities were restricted by us in accordance with the requirements of the Securities Act. In addition to representations by the above-referenced persons, we have made independent determinations that all of the above-referenced persons were accredited or sophisticated investors, were capable of analyzing the merits and risks of their investment, and understood the speculative nature of their investment. Furthermore, all of the above-referenced persons were provided with access to our SEC filings.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

None

ITEM 6. EXHIBITS

 

Exhibit

Number

  

Description

31.1    Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2    Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1    Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. ***
32.2    Certification of the Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002***
101    XBRL (Extensible Business Reporting Language) The following materials from Cereplast Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, formatted in Extensive Business Reporting Language (XBRL), (i) consolidated balance sheets, (ii) consolidated statements of operations and other comprehensive loss, (iii) consolidated statement of cash flows, and (iv) the notes to the consolidated financial statements.

 

*** In accordance with Item 601(b)(32)(ii) of Regulation S-K, this exhibit shall not be deemed “filed” for the purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

23


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: May 15, 2012       CEREPLAST, INC.
    By:   /s/ Frederic Scheer
     

Frederic Scheer

Chairman and Chief Executive Officer

(Principal Executive Officer)

 

24

EX-31.1 2 d352018dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Frederic Scheer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Cereplast, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: May 15, 2012   By:   /s/ Frederic Scheer
    Frederic Scheer
    Chairman and Chief Executive Officer
    (Principal Executive Officer )
EX-31.2 3 d352018dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Michael Okada, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Cereplast, Inc. (the “Registrant”);

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: May 15, 2012   By:   /s/ Michael Okada
         Michael Okada
         Vice President, Chief Accounting Officer and
         Interim Chief Financial Officer
         (Principal Financial Officer)
EX-32.1 4 d352018dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Cereplast, Inc. (the “Company”) on Form 10-Q for the three months ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Frederic Scheer, Chief Executive Officer and Principal Executive Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 15, 2012   By:   /s/ Frederic Scheer
   

Frederic Scheer

Chairman and Chief Executive Officer

(Principal Executive Officer)

EX-32.2 5 d352018dex322.htm EX-32.2 EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Cereplast, Inc. (the “Company”) on Form 10-Q for the three months ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Okada, Vice President & Chief Accounting Officer and Principal Financial Officer, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: May 15, 2012   By:   /s/ Michael Okada
   

Michael Okada

Vice President, Chief Accounting Officer

and Interim Chief Financial Officer

(Principal Financial Officer)

EX-101.INS 6 cerp-20120331.xml XBRL INSTANCE DOCUMENT 0001324759 2012-03-31 0001324759 2011-12-31 0001324759 2012-01-01 2012-03-31 0001324759 2012-05-10 0001324759 2011-01-01 2011-03-31 0001324759 2010-12-31 0001324759 2011-03-31 0001324759 cerp:DirectorAndEmployeeServicesMember 2012-01-01 2012-03-31 0001324759 cerp:SettlementAgreementMember 2011-01-01 2011-03-31 0001324759 cerp:DirectorAndEmployeeServicesMember 2011-01-01 2011-03-31 0001324759 cerp:SettlementAgreementMember 2012-01-01 2012-03-31 0001324759 cerp:PrepaidServicesMember 2011-01-01 2011-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares 47000 1594000 1483000 36251000 33055000 1813000 1496000 2760000 2472000 73000 75000 1855000 1897000 6501000 5940000 7307000 6955000 12500000 12500000 245000 226000 20052000 19681000 26553000 25621000 19000 19000 66524000 66644000 -56935000 -59321000 86000 88000 9694000 7430000 4000 4000 9698000 7434000 36251000 33055000 0.001 0.001 5000000 5000000 0 0001324759 Cereplast Inc 10-Q 2012-03-31 false --12-31 Yes Smaller Reporting Company 2012 Q1 20027204 <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">ORGANIZATION AND LINE OF BUSINESS</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Organization</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We were incorporated on September&#160;29, 2001 in the State of Nevada under the name Biocorp North America Inc. &#160;On March&#160;18, 2005, we filed an amendment to our certificate of incorporation to change our name to Cereplast,&#160;Inc.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Line of Business</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Cereplast,&#160;Inc. (&#8220;we&#8221; or &#8220;Cereplast&#8221;) has developed and is commercializing proprietary bio-based resins through two complementary product families: Cereplast Compostables&#174; resins which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables&#8482; resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Our resins can be converted into finished products using conventional manufacturing equipment without significant additional capital investment by downstream converters.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The demand for non-petroleum based, clean and renewable sources for materials, such as bioplastics, and the demand for compostable/biodegradable products are being driven globally by a variety of factors, including fossil fuel price volatility, energy security and environmental concerns. These factors have led to increased spending on clean and renewable products by corporations and individuals as well as legislative initiatives at national, state and local level.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We are a full-service resin solution provider uniquely positioned to capitalize on the rapidly increasing demand for sustainable and environmentally friendly alternatives to traditional plastic products.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We primarily conduct our operations through two product families:</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.75in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">Cereplast Compostables&#174; resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. We offer 13 commercial grades of Compostable resins in this product line. These resins are compatible with existing manufacturing processes and equipment making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Compostable line in November&#160;2006.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.75in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.75in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">Cereplast Sustainables&#8482; resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications. We offer six commercial grades of Sustainable resins in this product line. These resins are compatible with existing manufacturing processes and equipment, making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Sustainable line in late 2007 under the name &#8220;Cereplast Hybrid Resins&#174;.&#8221;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.75in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 1in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">Cereplast Hybrid Resins&#174; products replace up to 55% of the petroleum content in conventional plastics with bio-based materials such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. The Cereplast Hybrid Resins&#174; line provides a viable alternative for brand owners and converters looking to partially replace petroleum-based resins in durable goods applications. Hybrid resins address this need in a wide range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. We commercially introduced our first grade of Hybrid resin, Hybrid 150, at the end of 2007. We currently offer four commercial grades in this product line.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 1in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">Cereplast Algae Plastic&#174; resins. In October&#160;of 2009 we announced that we have been developing a new technology to transform algae into bioplastics and intend to launch a new resin family containing algae-based materials that will complement our existing line of resins. The first commercial product with Cereplast Algae Plastic&#174; resin is now being produced and sold as part of our Sustainables resin family. We believe that it is important to enhance research on non-food crops as we expect a surge in demand in bioplastics in future years, thus potentially creating pressure on food crops. Algae are the first non-food crop project that we have introduced and our R&amp;D department is contemplating the development of additional non-food crop based materials in future years.</font></p> <p style="TEXT-INDENT: -18.35pt; MARGIN: 0in 0in 0pt 79.55pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Our patent portfolio is currently comprised of six patents in the United States (&#8220;U.S.&#8221;), one Mexican patent, and eight pending patent applications in the U.S. and abroad. Our trademark portfolio is currently comprised of approximately 45 registered marks and 21 pending applications in the U.S. and abroad.</font></p></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">2.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Basis of Presentation and Consolidation</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;).&#160; The unaudited consolidated financial statements include the financial condition and results of operations of our wholly-owned subsidiary, Cereplast International, S.A., a Luxembourg company organized during the year ended December&#160;31, 2008, for the purpose of conducting sales operations in Europe.&#160; Intercompany balances and transactions have been eliminated in consolidation.&#160; The results of operations for interim periods are not necessarily indicative of the results that may be expected for a full year.&#160; These financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2011.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Use of Estimates</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements.&#160; Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance and the fair value of stock options.&#160; Actual results could differ from those estimates.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Cash</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. At various times throughout the year, the Company may have exceeded federally insured limits.&#160; At March&#160;31, 2012 and December&#160;31, 2011, balances in our cash accounts exceeded federally insured limits of $0.25 million by approximately, $0.7 million and $4.0 million, respectively.&#160; We have not experienced any losses in such accounts and we do not believe we are exposed to any significant credit risk on cash and cash equivalents.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Concentration of Credit Risk</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We had unrestricted cash totaling $1.1 million and $3.9 million at March&#160;31, 2012 and December&#160;31, 2011, respectively.&#160; The unrestricted cash and cash equivalents are held for working capital purposes.&#160;&#160; We do not enter into investments for trading or speculative purposes.&#160; Some of the securities in which we invest, however, may be subject to market risk.&#160; This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate.&#160; To minimize this risk, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, debt securities and certificates of deposit.&#160; Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates.&#160; We actively monitor changes in interest rates.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Concentration of credit risk with respect to accounts receivable is limited to certain European customers to whom we make substantial sales. As of March&#160;31, 2012 we had one large European customer that accounted for $7.6 million, or 36% of our accounts receivable balance, which is past due. We have another large European customer with $6.1 million, or 29% of our receivable balance. Agreed upon payment terms for both of these customers are 90 days from receipt of goods. These customers have acknowledged to us their agreement with the amounts owing and no amounts recognized in revenue or recorded in accounts receivable from these customers are in dispute. To reduce risk, we routinely assess the financial strength of our most significant customers, using standard credit risk evaluation methods with reference to publicly available and customer supplied information, and monitor the amounts owed to us, taking appropriate action when necessary. As a result of the recent deterioration in the general economic conditions in Europe and the slow payment by some of our European customers, we have established an allowance for doubtful accounts of $5.4 million to reflect management&#8217;s assessment of credit risk associated with these customer balances. We are working with all customers to mitigate credit risk and ensure collection of all outstanding amounts.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Other Concentration</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">During the three months ended months ended March&#160;31, 2012, we did not have any significant suppliers that accounted for greater than 10% of total cost of goods sold.&#160; During the same period in the prior year, we had three significant suppliers that accounted for 34.5%, 17.2%, and 15.0% of total cost of goods sold.&#160; No other suppliers accounted for more than 10% of cost of goods sold during these periods.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Liquidity and Capital Resources</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We have incurred a net loss of $2.4 million for the three months ended March&#160;31, 2012, and $14.0 million for the year ended December&#160;31, 2011, and have an accumulated deficit of $59.3 million as of March&#160;31, 2012. Based on our operating plan, our existing working capital will not be sufficient to meet the cash requirements to fund our planned operating expenses, capital expenditures and working capital requirements through December&#160;31, 2012 without additional sources of cash.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Our plan to address the shortfall of working capital is to generate additional financing through a combination of sale of our equity securities, refinancing existing credit facilities, incremental product sales and collection of outstanding receivables. We are confident that we will be able to deliver on our plans, however, there are no assurances that we will be able to obtain any sources of financing on acceptable terms, or at all.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">If we cannot obtain sufficient additional financing in the short-term, we may be forced to curtail or cease operations or file for bankruptcy. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be forced to take such actions.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Restricted Cash</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We had restricted cash in the amount of approximately $43,000 on March&#160;31, 2012 and December&#160;31, 2011. The restricted cash amount consists of a &#8220;Certificate of Deposit&#8221; which supports a &#8220;Letter of Credit&#8221; for a leased facility.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Fair Value of Financial Instruments</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The carrying amounts of our financial instruments as of March&#160;31, 2012, which include cash, accounts receivable, unbilled receivable, accounts payable, accrued expenses, loans payable and convertible subordinated notes approximate their fair values due to the short-term nature of these instruments.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Accounts Receivable</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We maintain an allowance for doubtful accounts for estimated losses that may arise if any of our customers are unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. Quantitative factors include customer&#8217;s past due balance, prior payment history, recent sales activity and days sales outstanding. Qualitative factors include macroeconomic environment, current product demand, estimated inventory levels and customer&#8217;s financial position. In certain cases, we may have access to repossess unsold products held at customer locations as recourse for payment defaults. The fair market value of these products are considered as potential recovery in estimating net losses from uncollectible accounts. We record an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $5.4 million as of March&#160;31, 2012 and December&#160;31, 2011.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Inventories</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Inventories are stated at the lower of cost (first-in, first-out basis) or market, and consist primarily of raw materials used in the manufacturing of bioplastic resins, finished bioplastic resins and finished goods. Inventories are reviewed for excess and obsolescence and a reserve is established accordingly. As of March&#160;31, 2012 and December&#160;31, 2011, inventories consisted of the following (<i>in thousands</i>):</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">March&#160;31,&#160;2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">December&#160;31,&#160;2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">(Unaudited)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Raw Materials</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">2,399</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">2,565</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Bioplastic Resins</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1,918</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1,959</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Finished Goods</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">41</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">42</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Packaging Materials</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">78</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">69</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">WIP</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">60</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Obsolescence Reserve</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">(211</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">(229</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">)</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Inventories, net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">4,285</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">4,406</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Property and Equipment</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Property and equipment are stated at cost, and depreciation is computed on the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are between five and seven years. Repairs and maintenance expenditures are charged to expense as incurred. Property and Equipment consist of the following (<i>in thousands</i>):</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">March&#160;31,&#160;2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">December&#160;31,&#160;2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">(Unaudited)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Equipment</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5,749</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5,434</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Building</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5,906</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5,906</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Land</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">32</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">32</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Construction In Progress</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1,630</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1,743</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Auto</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">11</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">37</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Furniture and Fixtures</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">327</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">327</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Leasehold Improvements</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">273</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">273</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">13,928</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">13,752</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Accumulated Depreciation</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">(3,315</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">(3,151</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">)</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Property and Equipment, Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">10,613</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">10,601</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Intangible Assets</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Intangible assets are stated at cost and consist primarily of patents and trademarks.&#160; Amortization is computed on the straight-line method over the estimated life of these assets, estimated to be between five and fifteen years.&#160; Intangible assets consist of the following (<i>in thousands</i>):</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">March&#160;31,&#160;2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">December&#160;31,&#160;2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">(Unaudited)</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Intangible Assets</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$252</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$222</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Accumulated Amortization</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">(41</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">)</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">(39</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">)</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Intangible Assets, Net</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$211</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$183</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Deferred Income Taxes</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences.&#160; Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.&#160; Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.&#160; Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.&#160; Tax positions taken are not offset or aggregated with other positions.&#160; Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.&#160; The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statement of income.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Revenue Recognition</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We recognize revenue at the time of shipment of products, when the following fundamental criteria are met: (i)&#160;persuasive evidence of an arrangement exists; (ii)&#160;delivery has occurred; (iii)&#160;the price to the customer is fixed or determinable; and (iv)&#160;collection of the sales price is probable.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Certain of our product sales are made to distributors under agreements with generally the same terms of sale and credit as all other customer agreements. Revenue from product sales to our customers, including our customers who are distributors, is recognized upon shipment provided the above noted fundamental criteria of revenue recognition are met. The sale of products to our customers who are distributors is not contingent upon the distributor selling the product to the end-user, and our current agreements with distributors do not have any rights of return.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Impairment of Long-Lived Assets</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We review long-lived assets for possible impairment by evaluating whether the carrying amount of assets exceed its recoverable amount. Our judgment regarding the existence of impairment is based on legal factors, market conditions and operational performance of our assets. Future adverse changes in legal environment, market conditions or poor operating results could result in losses or an inability to recover the carrying value of the long-lived assets, thereby possibly requiring an impairment charge in the future.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Comparative Figures</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Certain of the prior year figures have been reclassified to conform to the presentation adopted in the current year.</font></p></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">3.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">CAPITAL STOCK</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Capital Stock Issued</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">During the three months ended March&#160;31, 2012, we issued shares of common stock as follows:</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">We issued 84,478 shares of restricted common stock valued at approximately $88,000 to various employees for services rendered during the period.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">We issued 9,587 shares of common stock valued at approximately $10,000 pursuant to a settlement agreement.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Valuation Assumptions for Stock Options</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">During the year ended December&#160;31, 2011, we granted options to our employees to purchase an aggregate of 300,000 shares of our common stock, with estimated total grant-date fair values of $0.7 million. We estimate that stock-based compensation for awards not expected to be exercised is $0.2 million. During the three months ended March&#160;31, 2012, we recorded stock-based compensation related to stock options of $23,000. The grant date fair value was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends and the following assumptions:</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="84%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">January&#160;14,&#160;2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="84%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Average risk-free interest rate </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">2.29</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="84%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Average expected life (in years) </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">6.0</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="84%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Volatility </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">41.9</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt" size="2">Expected Volatility:</font></i><font style="FONT-SIZE: 10pt" size="2"> The fair values of stock based payments were valued using a volatility factor based on our historical stock prices.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt" size="2">Expected Term:</font></i><font style="FONT-SIZE: 10pt" size="2"> We elected to use the &#8220;simplified method&#8221; as discussed in SAB No.&#160;107 to develop the estimate of the expected term.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt" size="2">Expected Dividend:</font></i><font style="FONT-SIZE: 10pt" size="2"> We have not paid any dividends and do not anticipate paying dividends in the foreseeable future.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt" size="2">Risk-Free Interest Rate:&#160; </font></i><font style="FONT-SIZE: 10pt" size="2">We base the risk-free interest rate used on the implied yield currently available on U.S. Treasury zero-coupon issues with remaining term equivalent to the expected term of the options.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Stock Option Activity</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Under the 2004 Employee Stock Option Plan adopted by our board of directors (the &#8220;Plan&#8221;), our board of directors may issue incentive and non-qualified stock options to our employees. Options granted under the Plan generally expire at the end of five or ten years and vest in accordance with a vesting schedule determined by our board of directors, usually over three years from the grant date. As of March&#160;31, 2012, we have 34,375 shares available for future grants under the Plan. We settle stock option exercises with newly issued shares of our common stock (<i>in thousands except, per share data):</i></font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="41%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="41%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Shares</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Weighted<br /> Average<br /> Exercise&#160;Price</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Shares</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Weighted<br /> Average<br /> Exercise&#160;Price</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Outstanding&#8212;January&#160;1</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">373</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">8.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">73</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">22.40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Granted at fair value</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">300</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Exercised</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Cancelled/forfeited</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Outstanding&#8212;March&#160;31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">373</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">8.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">373</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">8.65</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Options exercisable at March&#160;31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">193</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">11.77</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">133</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">14.69</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The following table summarizes information about stock options as of March&#160;31, 2012, (<i>in thousands, except per share data):</i></font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 19%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="19%" colspan="2"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="38%" colspan="9"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Options&#160;Outstanding</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 38%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="38%" colspan="9"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Options&#160;Exercisable</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 19%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="19%" colspan="2"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Range&#160;of&#160;Exercise&#160;Prices</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="8%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Shares</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="8%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Weighted<br /> Average<br /> Exercise<br /> Price</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="8%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Weighted<br /> Average<br /> Remaining<br /> Contract<br /> Life</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="8%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Aggregate<br /> Intrinsic<br /> Value</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="8%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Shares</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="8%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Weighted<br /> Average<br /> Exercise<br /> Price</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="8%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Weighted<br /> Average<br /> Remaining<br /> Contract<br /> Life</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="8%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Aggregate<br /> Intrinsic<br /> Value</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">0.0 - $5.31 </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">300</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">8.91</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">120</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.31</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">8.91</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 17.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="17%"> <p style="TEXT-ALIGN: right; TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.32 - $22.40 </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">73</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">22.40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">2.67</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">73</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">22.40</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 8%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="8%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">2.67</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 6.7%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="6%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing stock price of $0.62 at March&#160;31, 2012 which would have been received by the option holders had all option holders exercised their options as of that date.</font></p></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">4.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">LOANS PAYABLE</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Venture Loan Payable</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">On December&#160;21, 2010, we entered into a Venture Loan and Security Agreement (the &#8220;Loan Agreement&#8221;) with Compass Horizon Funding Company, LLC (the &#8220;Lender&#8221;). The Loan Agreement provides for a total loan commitment of $5.0&#160;million comprising of Loan A and Loan B, each in the amount of $2.5 million. Loan A was funded at closing on December&#160;21, 2010 and matures 39&#160;months after the date of advance.&#160; Loan B was funded on February&#160;17, 2011 and also matures 39 months after the date of advance. We are obligated to pay interest per annum equal to the greater of (a)&#160;12% or (b)&#160;12% plus the difference between (i)&#160;the one month LIBOR Rate, on the date which is five business days before the funding of such loan and (ii)&#160;.30%. We are required to make interest only payments for the first nine months of each loan and equal payments of principal over the final thirty months of each loan.&#160; Any payments received after five days of written notice from the Lender will be assessed a 4% late payment fee.&#160; We granted a security interest to the Lender in all of our property.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">In connection with loan, we issued a seven year warrant to the Lender to purchase 140,000 shares of common stock of the Company at an exercise price of $4.40. The relative fair value of the warrants was $0.2&#160;million and will be recorded as interest expense over the term of the loan. We estimated the fair value of the warrants using the Black-Scholes option pricing model using the following assumptions:</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="84%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Assumptions:</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">December&#160;22,&#160;2010</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="84%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Expected Life</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">7 years</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="84%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Expected volatility</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">39.9</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="84%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Dividends</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">None</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 84.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="84%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Risk-free interest rate</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">2.74</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Also in connection with the Loan Agreement, we incurred $0.4&#160;million of debt issue costs which were deferred and are being amortized to interest expense over the term of the loan.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Convertible Subordinated Notes</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">On May&#160;24, 2011, we issued $12.5 million in aggregate principal amount of 7% Senior Subordinated Convertible Notes due June&#160;1, 2016 (the &#8220;Notes&#8221;). The Notes were issued pursuant to an indenture (the &#8220;Indenture&#8221;), entered into between us and Wells Fargo Bank, National Association, as trustee, on May&#160;24, 2011. In connection with the issuance of the Notes, we entered into a Waiver to our Venture Loan and Security Agreement with Horizon, dated May&#160;18, 2011 pursuant to which Horizon provided its consent to the offering of the Notes and waived any restrictions in the Loan Agreement.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The Notes are senior subordinated unsecured obligations which will rank subordinate in right to payment to all of our existing and future senior secured indebtedness and bear interest at a rate of 7% per annum payable semi-annually in arrears on June&#160;1 and December&#160;1 of each year, commencing on December&#160;1, 2011. The Notes mature on June&#160;1, 2016, with an early repurchase date of June&#160;15, 2014 at the option of the purchaser. The Notes are convertible into shares of our common stock in accordance with the terms of the Notes and the Indenture, at the initial conversion rate of 172.4138 shares of our common stock per $1,000 principal amount of Notes, equivalent to a conversion price of approximately $5.80 per share, subject to adjustment. If the Notes are converted into shares of our common stock prior to June&#160;2, 2014, an interest make-whole payment will be due based on the conversion date up until June&#160;2, 2014. Upon a non-stock change in control, additional shares of our common stock may need to be issued upon conversion, with a maximum additional shares of 25.606 per $1,000 in principal amount of Notes being issuable thereunder, for a total maximum of 198.0198 shares per $1,000 Note. Certain customary anti-dilution provisions included in the Indenture and/or the Notes could adjust the conversion rate. At March&#160;31, 2012, the Notes are convertible into 2,155,173 shares of our common stock.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The conversion feature within the Notes is not considered to be a beneficial conversion feature within the meaning of Accounting Standards Codification (&#8220;ASC&#8221;) 470, Debt, and therefore all of the gross proceeds from the Notes have been classified as long term debt. In connection with the issue of the Notes, we incurred approximately $1.3 million of debt issue costs which were deferred and are being amortized to interest expense over the term to the early repurchase date of June&#160;15, 2014.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Also in connection with the issuance of the Notes, we entered into a Securities Purchase Agreement dated May&#160;18, 2011 pursuant to which we agreed to prepare and file a registration statement with the Securities and Exchange Commission (the &#8220;SEC&#8221;) registering the resale of the Notes and the shares of common stock underlying the Notes. The registration statement was declared effective on August&#160;10, 2011.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Mortgage Payable</font></i></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Effective October&#160;24, 2011, Cereplast Italia S.p.A (&#8220;Cereplast Italia&#8221;), our wholly owned subsidiary, completed its acquisition of an industrial plant and the real estate on which the industrial plant is located in Cannara,&#160;Italy. The Deed of Sale between Cereplast Italia and Societa Regionale Per Lo Sviluppo Economico Dell&#8217;Umbria &#8212; Sviluppumbria S.p.A, provided for an aggregate purchase price of approximately $6.4 million.&#160; In connection with the acquisition, Cereplast Italia entered into the following financing transactions:</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">Mortgage loan with Banca Monte Dei Paschi Di Sienna S.p.A for the principal of $4.5 million. The loan bears interest of Euribor (6-month) plus 5.7%. The loan is for a term of 15&#160;years with interest only payments for the first two years, payable January&#160;1 and July&#160;1 each year and principal and interest payments thereafter according to an amortization schedule. 20% of the principal is guaranteed for 10&#160;years by Gepafin, a local government agency; $0.5 million of the principal is guaranteed by Eurofidi through December&#160;31, 2016.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">Credit facility with Intesa Sanpaolo for up $0.7 million. The facility is for a term of eight&#160;months with a floating interest rate based on Euribor (3 month), currently 5.85%. Interest is deferred for the first two months of the term. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">Credit facility with Unicredit Bank for up to $0.8 million. The facility is for a term of 18&#160;months with a floating interest rate based on Euribor (3&#160;month), currently 5.93%. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.</font></p></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">LEASES</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We currently operate out of El Segundo, CA, Seymour,&#160;IN, and B&#246;nen, Germany.&#160; The leases underlying these three facilities are summarized below:</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt" size="2">California Facility </font></i><font style="FONT-SIZE: 10pt" size="2">&#8212; The El Segundo facility consists of approximately 5,475 square feet of corporate office space. The lease commenced on March&#160;1, 2010 and has a term of five years. The lease was subsequently amended on April&#160;1, 2011 to add additional office space. The lease term relating to the additional office space expires on May&#160;31, 2013. Our current monthly rent is $13,389, with 3% annual escalation.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt" size="2">Indiana Facility &#8212; </font></i><font style="FONT-SIZE: 10pt" size="2">The Seymour facility consists of approximately 105,000 square feet used as a manufacturing and distribution facility for our products. The lease commenced in January&#160;2008, with a ten year term expiring in January&#160;2018. Our current monthly rent is $25,000.</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.5in"><font style="FONT-FAMILY: Symbol; FONT-SIZE: 10pt" size="2">&#183;</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt" size="2">B&#246;nen Facility</font></i><font style="FONT-SIZE: 10pt" size="2">&#8212; The B&#246;nen facility consists of approximately 1,000 square feet of corporate office space. The facility is subject to a lease with monthly rents of approximately $2,000 expiring in December&#160;2018.</font></p></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">6.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">MAJOR CUSTOMERS AND FOREIGN SALES</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">The following customers accounted for 10% or more of net revenue in the periods presented:</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="3"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Three&#160;Months&#160;Ended&#160;March&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Customer A </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">64.8</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Customer B </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">17.0</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Customer C </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">10.2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Customer D </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">34.2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 70%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="70%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Customer E </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">24.2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Our net sales were made up of sales to customers in the following geographic regions (<i>in thousands</i>):</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="41%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 55.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="55%" colspan="9"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Three&#160;Months&#160;Ended&#160;March&#160;31,</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="41%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">2012</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">North America</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">84</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">81.7</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">238</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">3.3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">International</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 30pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Germany</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">3</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">3.1</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">4,687</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">64.7</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 30pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Italy</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">6</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">6.2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1,533</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">21.2</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 30pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Other</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">10</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">9.0</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">782</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">10.8</font></p></td> <td style="PADDING-BOTTOM: 0.375pt; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Net sales</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">103</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">100.0</font></p></td> <td style="PADDING-BOTTOM: 2.25pt; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">7,240</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">100.0</font></p></td> <td style="PADDING-BOTTOM: 2.25pt; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">%</font></p></td></tr></table></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">7.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">INCOME TAX</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">We are subject to U.S. and California income tax.&#160; Subject to limited statutory exceptions, we are no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for years before 2006.&#160; We are not presently liable for any income taxes nor are we undergoing any tax examinations by the Internal Revenue Service.&#160;&#160; No Deferred Tax Assets or Deferred Tax Liabilities are included in our balance sheets at March&#160;31, 2012 or December&#160;31, 2010.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Our policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.</font></p></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">8.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">COMMON STOCK WARRANTS</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">In connection with the registered direct offering of 3,125,000 Units effective November&#160;2011, we issued warrants to purchase 2,343,750 of our common stock. The per share exercise price of the warrants is $2.20. The warrants are exercisable at any time on or after the date that is 180 days after the initial issuance on the date of closing and will expire on a date that is five years from the date of closing.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">In connection with the issue of 2,596,500 shares of common stock to accredited investors pursuant to the Securities Purchase Agreement entered into on January&#160;26, 2011, we issued warrants to purchase 649,128 shares of the Company&#8217;s common stock. The warrants have an exercise price of $6.35 per share and are exercisable for a period of five years commencing August&#160;1,&#160;2011.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">A summary of warrant activity for the period ending March&#160;31 is as follows (<i>in thousands</i> <i>except per share data</i>):</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <table style="WIDTH: 100%; BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="41%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">2012</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 26.5%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="26%" colspan="4"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">2011</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="41%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Number&#160;of<br /> Warrants</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Weighted<br /> Average<br /> Exercise&#160;Price</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Number&#160;of<br /> Warrants</font></b></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold" size="1">Weighted<br /> Average<br /> Exercise&#160;Price</font></b></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="TEXT-ALIGN: center; MARGIN: 0in 0in 0pt" align="center"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt; FONT-WEIGHT: bold" size="1">&#160;</font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Outstanding&#8212; January&#160;1, </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">4,219</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.09</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1,273</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="BORDER-BOTTOM: medium none; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: windowtext 1pt solid; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">4.44</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Issued </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">649</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">6.35</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 20pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Exercised </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 1pt solid; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#8212;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Outstanding&#8212;March&#160;31 </font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">4,219</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.09</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1,922</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.08</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1%; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 41%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="top" width="41%"> <p style="TEXT-INDENT: -10pt; MARGIN: 0in 0in 0pt 10pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">Warrants exercisable at end of period ,</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">4,219</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.09</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="BORDER-BOTTOM: windowtext 2.25pt double; BORDER-LEFT: medium none; PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 12%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; BORDER-TOP: medium none; BORDER-RIGHT: medium none; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="12%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">1,922</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 2.5%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 1pt" size="2">&#160;</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 1.3%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">$</font></p></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 10.7%; PADDING-RIGHT: 0in; BACKGROUND: #cceeff; PADDING-TOP: 0in" bgcolor="#CCEEFF" valign="bottom" width="10%"> <p style="TEXT-ALIGN: right; MARGIN: 0in 0in 0pt" align="right"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">5.08</font></p></td></tr></table></td></tr></table> <table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">9.</font><font style="FONT-SIZE: 3pt" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt" size="2">SUBSEQUENT EVENTS</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">On April&#160;30, 2012, we entered into a Subscription Agreement for the sale of 1,000,000 shares of our common stock at a price of $.50 per share (the &#8220;Shares&#8221;) in a registered direct offering.&#160; The net offering proceeds from the sale of the Shares will be used for general corporate purposes. The closing of the sale and issuance of the Shares was completed on May&#160;7, 2012.</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">&#160;</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" size="2">On May&#160;1, 2012, we received notice from NASDAQ that our securities do not meet NASDAQ&#8217;s Listing Rule&#160;5550(a)(2)&#160;minimum bid price requirement. Under the Listing Rules&#160;we have a period of 180 days to regain compliance.</font></p></td></tr></table> 3940000 1059000 14744000 14787000 4406000 4285000 966000 828000 24056000 20959000 13752000 13928000 3151000 3315000 10601000 10613000 43000 43000 1321000 1182000 183000 211000 0 0.001 0.001 495000000 495000000 18933139 18933139 19027204 19027204 47000 114000 7285000 11000 45000 103000 7240000 638000 6538000 -535000 702000 129000 250000 1216000 2043000 1345000 2293000 -1880000 -1591000 18000 -2386000 -1750000 -2386000 -1750000 -2384000 -1797000 -0.13 -0.12 18948644 14873018 18948644 14873018 176000 216000 42000 -121000 -584000 19000 19000 64000 43000 6417000 -138000 -28000 -121000 403000 10000 -147000 76000 -315000 -1337000 -289000 97000 -2311000 -8943000 115000 89000 15000 -100000 -89000 18000 1000 454000 2502000 11372000 -472000 13873000 2000 -47000 -2881000 4794000 151000 119000 2391000 7185000 84478 88000 9587 10000 83877 414000 4062 20000 12000 59000 23000 112000 524000 159000 2000 -47000 EX-101.SCH 7 cerp-20120331.xsd XBRL TAXONOMY EXTENSION SCHEMA 0000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0010 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0035 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1010 - Disclosure - ORGANIZATION AND LINE OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 1020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 1030 - Disclosure - CAPITAL STOCK link:presentationLink link:calculationLink link:definitionLink 1040 - Disclosure - LOANS PAYABLE link:presentationLink link:calculationLink link:definitionLink 1050 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 1060 - Disclosure - MAJOR CUSTOMERS AND FOREIGN SALES link:presentationLink link:calculationLink link:definitionLink 1070 - Disclosure - INCOME TAX link:presentationLink link:calculationLink link:definitionLink 1080 - Disclosure - COMMON STOCK WARRANTS link:presentationLink link:calculationLink link:definitionLink 1090 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 8000 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 8010 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 8050 - Disclosure - CONVERTIBLE SENIOR NOTES link:presentationLink link:calculationLink link:definitionLink 8020 - Disclosure - DEFERRED TAX BENEFIT link:presentationLink link:calculationLink link:definitionLink 8030 - Disclosure - CAPITAL LEASE OBLIGATIONS link:presentationLink link:calculationLink link:definitionLink 8040 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 cerp-20120331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 cerp-20120331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 cerp-20120331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information Cash Paid During the Year For: Cash Paid During the Year For [Abstract] Represents the number of shares issued by the entity under private placements during the reporting period. Shares issued under a private placement (in shares) Issuance of Stock, Shares, Under Private Placements Common Stock Issued for Services, Salaries, and Wages Common Stock Issued for Services, Salaries and Wages Represents the stock issued by the entity during the reporting period for services, salaries and wages. Proceeds from Convertible Subordinated Notes, Net of Issuance Costs of $1,275 Proceeds from Issuance of Convertible Subordinated Long term Debt The cash inflow from a borrowing where a lender is placed in a lien position behind debt having a higher priority of repayment (senior) in liquidation of the entity's assets or underlying collateral and can be exchanged for a specified amount of another security at the option of the issuer or the holder. Director and Employee Services Services provided by directors and employees during the reporting period. Director and Employee Services [Member] Exercise of Common Stock Warrants Represents common stock warrants exercised during the reporting period. Exercise of Common Stock Warrants [Member] Prepaid Services Prepaid services received by the entity during the reporting period. Prepaid Services [Member] Prepaid Services and Rent Prepaid services and rent received by the entity during the reporting period. Prepaid Services and Rent [Member] Settlement Agreement Costs associated with a settlement agreement during the reporting period. Settlement Agreement [Member] Amendment Description Early Termination Fees Fees associated with early lease termination during the reporting period. Early Termination Fees [Member] Amendment Flag Board Member Services Services provided by board members during the reporting period. Board Member Services [Member] Stock Issued During Period Values Fees Associated with Early Lease Termination Fees association with an early lease termination Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock for fees associated with an early lease termination. Stock Issued During Period, Shares Fees Associated with Early Lease Termination Fees association with an early lease termination (in shares) Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock for fees associated with an early lease termination. Stock Issued During Period, Value, Board Member Services Issuance of common stock for Board member services Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock for board member services. Stock Issued During Period, Shares Board Member Services Issuance of common stock for Board member services (in shares) Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock for board member services. Stock Issued During Period, Value, Settlement Agreements Issuance of common stock for settlement agreements Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock for settlement agreements. Stock Issued During Period, Shares, Settlement Agreements Issuance of common stock for settlement agreements (in shares) Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock for settlement agreements. Stock Issued During Period, Value, Vendor Services Issuance of common stock for vendor services Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock for vendor services. Stock Issued During Period, Shares, Vendor Services Issuance of common stock for vendor services (in shares) Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock for vendor services. Issuance of common stock from warrant exercise Stock Issued During Period, Value, Warrants Exersice Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock from warrant exercise. Stock Issued During Period, Shares, Warrants Exersice Issuance of common stock from warrant exercise (in shares) Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock from warrant exercise. Stock Issued During Period, Value, Private Placement Issuance of common shares under a private placement at a net price of $2.00 per share for the year ended December 31, 2010 Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock under a private placement agreement. Stock Issued During Period, Shares, Private Placement Issuance of common shares under a private placement (in shares) Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock under a private placement agreement. Stock Issued During Period Private Placement, Per Share Issuance of common shares under a private placement, per share Per share value of common shares issued under a private placement. Stock Issued During Period Value Share Based Compensation Per Share Range Low End Issuance of common stock as compensation, minimum price range per share Minimum price range per share associated with the issuance of common stock as compensation. Stock Issued During Period Value Share Based Compensation Per Share Range High End Issuance of common stock as compensation, maximum price range per share Maximum price range per share associated with the issuance of common stock as compensation. Current Fiscal Year End Date Sale of Common Stock Price Per Share Sales of shares made pursuant to an effective Registration Statement on Form S-3, per share Per share value of sale of shares made pursuant to an effective to a Registration Statement. Accounts Receivable, Net Accounts Receivable, Net, Current ORGANIZATION AND LINE OF BUSINESS MAJOR CUSTOMERS AND FOREIGN SALES Revenue by Major Customers and Geographic Region Disclosure [Text Block] MAJOR CUSTOMERS AND FOREIGN SALES Disclosure of the entities revenues from major customers and by geographic region. Deferred Tax Benefit Disclosure [Text Block] DEFERRED TAX BENEFIT Entire disclosure of deferred tax benefits of the reporting entity. Capital Lease Obligations Disclosure [Text Block] CAPITAL LEASE OBLIGATIONS Entire disclosure of current and noncurrent capital lease obligations of the reporting entity. CONVERTIBLE SENIOR NOTES Convertible Senior Notes Disclosure [Text Block] CONVERTIBLE SENIOR NOTES The entire disclosure for convertible senior notes. COMMON STOCK WARRANTS Common Stock Warrants Disclosure[Text Block] COMMON STOCK WARRANTS Entire disclosure for common stock warrants. Document Period End Date Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income Accumulated Depreciation and Amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated Depreciation and Amortization Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Filer Category Entity Public Float Entity Registrant Name Entity Central Index Key Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus Document Type Additional Paid in Capital Additional Paid in Capital, Common Stock Purchase of Property and Equipment, and Intangibles Payments to Acquire Productive Assets Expense related to vesting of employee stock options Stock or Unit Option Plan Expense CONSOLIDATED BALANCE SHEETS Amortization of Loan Discount Amortization of Debt Discount (Premium) Capital Lease Obligations, Current Capital Leases, Current Portion Capital Lease Obligations, Noncurrent Capital Leases, Long-Term Cash and Cash Equivalents, at Carrying Value CASH, BEGINNING OF PERIOD CASH, END OF PERIOD Cash Interest Interest Paid Increase (Decrease) in Accounts Receivable Accounts Receivable Deferred Loan Costs Increase (Decrease) in Deferred Charges Increase (Decrease) in Deposit Assets Deposits Intangibles Increase (Decrease) in Intangible Assets, Current Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense Prepaid Expenses Changes in Operating Assets and Liabilities Increase (Decrease) in Operating Capital [Abstract] Increase (Decrease) in Accounts Payable Accounts Payable Accrued Expenses Increase (Decrease) in Accrued Liabilities Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Common Stock Subscribed, not issued Common Stock, Shares Authorized Common Stock, shares authorized Common Stock, Shares, Issued Common Stock, shares issued Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding Common Stock, shares outstanding Common Stock, Value, Issued Common Stock, $0.001 par value; 495,000,000 shares authorized; 15,757,305 and 12,992,195 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively Common Stock, $0.001 par value; 495,000,000 shares authorized; 19,027,204 and 18,933,139 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively Convertible Subordinated Notes Convertible Subordinated Debt, Noncurrent Cost of Goods Sold Cost of Goods Sold Liabilities, Current Total Current Liabilities Liabilities, Current [Abstract] Current Liabilities LOANS PAYABLE Debt Disclosure [Text Block] Payments of Debt Issuance Costs Proceeds from Convertible Subordinated Notes, Issuance Costs DEFERRED TAX BENEFIT Deposits Assets, Noncurrent Deposits FOREIGN CURRENCY TRANSLATION Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations Loss on Disposal of Leasehold Improvements Gain (Loss) on Disposition of Assets Gross Profit Gross Profit (Loss) Impairment of Intangible Assets Impairment of Intangible Assets (Excluding Goodwill) CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME INCOME TAX Income Tax Disclosure [Text Block] Intangible Assets, Net Intangible Assets, Net (Excluding Goodwill) Inventory, Net Inventory, Net Liabilities Total Liabilities Liabilities and Equity Total Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY Loans Payable, Noncurrent Loan Payable Loans Payable, Current Loan Payable, Current Portion Stockholders' Equity Attributable to Noncontrolling Interest Noncontrolling Interests NET CASH USED IN OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Nonoperating Income (Expense) TOTAL OTHER EXPENSE, NET OTHER EXPENSES Nonoperating Income (Expense) [Abstract] Liabilities, Noncurrent Total Long-Term Liabilities Liabilities, Noncurrent [Abstract] Long-Term Liabilities Operating Income (Loss) Operating Loss Preferred Stock, Shares Authorized Preferred Stock, shares authorized Preferred Stock, Shares Outstanding Preferred Stock, shares outstanding Preferred Stock, Par or Stated Value Per Share Preferred Stock, par value (in dollars per share) Proceeds from Issuance of Common Stock and Subscriptions, Net of Issuance Costs Proceeds from Issuance of Common Stock Proceeds from Noncontrolling Interests Noncontrolling Interest Activities Shares issued under a private placement Proceeds from Issuance of Private Placement Proceeds from Long-term Capital Lease Obligations Proceeds from Capital Leases Proceeds from Sale of Property, Plant, and Equipment Proceeds from Sale of Equipment Property, Plant and Equipment, Gross Property and Equipment Property, Plant and Equipment, Net Property and Equipment, Net Property and Equipment, Net Provision for Doubtful Accounts Allowance for Doubtful Accounts Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS Payments on Capital Leases Repayments of Long-term Capital Lease Obligations Payments made on Notes Payable Repayments of Long-term Debt Restructuring Costs Restructuring Charges Retained Earnings (Accumulated Deficit) Accumulated Deficit Sales Revenue, Goods, Gross Gross Product Sales Sales Revenue, Goods, Net Net Sales Selling, General and Administrative Expense Selling, General and Administrative Selling, General and Administrative Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Award Type and Plan Name [Axis] Share-based Compensation Arrangements by Share-based Payment Award, Award Type and Plan Name [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] CONSOLIDATED STATEMENTS OF CASH FLOWS CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME Payments of Stock Issuance Costs Proceeds from Issuance of Common Stock and Subscriptions, Issuance Costs Stockholders' Equity Attributable to Parent [Abstract] Shareholders' Equity CAPITAL STOCK Stockholders' Equity Note Disclosure [Text Block] SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Supplemental Cash Flow Information [Abstract] Income Taxes Income Taxes Paid Assets, Current Total Current Assets Current Assets Assets, Current [Abstract] Weighted Average Number of Shares Outstanding, Diluted Weighted Average Common Shares Outstanding - Diluted (in shares) Weighted Average Number of Shares Outstanding, Basic Weighted Average Common Shares Outstanding - Basic (in shares) Restricted Cash and Cash Equivalents, Noncurrent Restricted Cash Common Stock [Member] Common Stock Property, Plant and Equipment, Net [Abstract] Property and Equipment Research and Development Expense Research and Development Preferred Stock [Member] Preferred Stock Assets Total Assets Other Assets, Noncurrent [Abstract] Other Assets Deferred Loan Costs Deferred Finance Costs, Noncurrent, Net Scenario, Unspecified [Domain] Statement [Table] Statement, Scenario [Axis] ASSETS Assets [Abstract] Statement Statement [Line Items] CAPITAL STOCK Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES: CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] NET CASH USED IN INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Cash Provided by (Used in) Financing Activities, Continuing Operations NET CASH (USED) PROVIDED BY FINANCING ACTIVITIES Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Stockholders' Equity, Period Increase (Decrease) Adjustments to Additional Paid in Capital, Warrant Issued Warrants issued in connection with debt financing arrangements Total Other Assets Other Assets, Noncurrent Operating Expenses [Abstract] Operating Expenses: Total Operating Expenses Operating Expenses CAPITAL LEASE OBLIGATIONS Common Stock, Par or Stated Value Per Share Common Stock, par value (in dollars per share) Stockholders' Equity Attributable to Parent Total Shareholders' Equity Balance Balance Provision for Income Taxes Income Tax Expense (Benefit) Provision for Income Taxes Preferred Stock, Value, Issued Preferred Stock, $0.001 par value; 5,000,000 shares authorized and none outstanding Statement, Equity Components [Axis] Additional Paid-in Capital [Member] Additional Paid-In Capital Retained Earnings [Member] Accumulated Deficit Accumulated Other Comprehensive Income (Loss) [Member] Other Comprehensive Income Equity Component [Domain] Increase (Decrease) in Restricted Cash for Operating Activities Restricted Cash Stock Issued During Period, Value, New Issues Sales of shares made pursuant to an effective Registration Statement on Form S-3 (Registration No. 333-166307) at a net price of $2.91 per share Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Issuance of common stock as compensation. Stock at prices ranging from $2.82 per share to $5.10 per share for the year ended December 31, 2010 Stock Issued During Period, Shares, New Issues Sales of shares made pursuant to an effective Registration Statement on Form S-3 (Registration No. 333-166307) at a net price of $2.91 per share (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Issuance of common stock as compensation (in shares) Stock Issued During Period, Shares, Stock Splits Rounding due to Stock Split (in shares) Stock Issued During Period, Shares, Period Increase (Decrease) Net Loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net Loss Net loss Depreciation and Amortization Depreciation, Depletion and Amortization Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] Other Comprehensive Income Total Comprehensive Loss Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Shareholders' Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total Equity LEASES LEASES Leases of Lessee Disclosure [Text Block] Adjustment to Reconcile Net Loss to Net Cash Used in Operating Activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] ORGANIZATION AND LINE OF BUSINESS Nature of Operations [Text Block] Accounts Payable, Current Accounts Payable Accrued Liabilities, Current Accrued Expenses Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Gain (Loss) on Foreign Currency Translation Gain on foreign currency translation SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Loss Before Provision for Income Taxes Prepaid Expense and Other Assets, Current Prepaid Expenses and Other Current Assets Inventory, LIFO Reserve, Period Charge Reserve for Inventory Obsolescence Sales Discounts, Returns and Allowances, Goods Sales Discounts, Returns and Allowances Sales Discounts, Returns and Allowances Proceeds from Loan Payable, Net of Loan Costs Proceeds from Debt, Net of Issuance Costs NET INCREASE (DECREASE) IN CASH Net Cash Provided by (Used in) Continuing Operations Interest and Other Income Interest and Other Income Interest Income (Expense), Nonoperating, Net Interest Expense, Net SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Stock Issued During Period, Value, Other Dollar value of shares issued Stock Issued During Period, Shares, Other Number of shares issued INCOME TAX SUBSEQUENT EVENTS Subsequent Events [Text Block] LOANS PAYABLE Adjustments to Additional Paid in Capital, Share-based Compensation, Stock Options, Requisite Service Period Recognition Compensation expense related to stock option plan RELATED PARTY TRANSACTIONS SUBSEQUENT EVENTS Net Loss Per Share - Basic and Diluted (in dollars per share) Earnings Per Share, Basic and Diluted Interest Expense Interest Expense EX-101.PRE 11 cerp-20120331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
CAPITAL STOCK
3 Months Ended
Mar. 31, 2012
CAPITAL STOCK  
CAPITAL STOCK

3.              CAPITAL STOCK

 

Capital Stock Issued

 

During the three months ended March 31, 2012, we issued shares of common stock as follows:

 

·                  We issued 84,478 shares of restricted common stock valued at approximately $88,000 to various employees for services rendered during the period.

 

·                  We issued 9,587 shares of common stock valued at approximately $10,000 pursuant to a settlement agreement.

 

Valuation Assumptions for Stock Options

 

During the year ended December 31, 2011, we granted options to our employees to purchase an aggregate of 300,000 shares of our common stock, with estimated total grant-date fair values of $0.7 million. We estimate that stock-based compensation for awards not expected to be exercised is $0.2 million. During the three months ended March 31, 2012, we recorded stock-based compensation related to stock options of $23,000. The grant date fair value was estimated at the date of grant using the Black-Scholes option pricing model, assuming no dividends and the following assumptions:

 

 

 

January 14, 2011

 

Average risk-free interest rate

 

2.29

%

Average expected life (in years)

 

6.0

 

Volatility

 

41.9

%

 

·                  Expected Volatility: The fair values of stock based payments were valued using a volatility factor based on our historical stock prices.

 

·                  Expected Term: We elected to use the “simplified method” as discussed in SAB No. 107 to develop the estimate of the expected term.

 

·                  Expected Dividend: We have not paid any dividends and do not anticipate paying dividends in the foreseeable future.

 

·                  Risk-Free Interest Rate:  We base the risk-free interest rate used on the implied yield currently available on U.S. Treasury zero-coupon issues with remaining term equivalent to the expected term of the options.

 

Stock Option Activity

 

Under the 2004 Employee Stock Option Plan adopted by our board of directors (the “Plan”), our board of directors may issue incentive and non-qualified stock options to our employees. Options granted under the Plan generally expire at the end of five or ten years and vest in accordance with a vesting schedule determined by our board of directors, usually over three years from the grant date. As of March 31, 2012, we have 34,375 shares available for future grants under the Plan. We settle stock option exercises with newly issued shares of our common stock (in thousands except, per share data):

 

 

 

2012

 

2011

 

 

 

Shares

 

Weighted
Average
Exercise Price

 

Shares

 

Weighted
Average
Exercise Price

 

Outstanding—January 1

 

373

 

$

8.65

 

73

 

$

22.40

 

Granted at fair value

 

 

 

300

 

5.31

 

Exercised

 

 

 

 

 

Cancelled/forfeited

 

 

 

 

 

Outstanding—March 31

 

373

 

8.65

 

373

 

8.65

 

Options exercisable at March 31

 

193

 

$

11.77

 

133

 

$

14.69

 

 

The following table summarizes information about stock options as of March 31, 2012, (in thousands, except per share data):

 

 

 

Options Outstanding

 

Options Exercisable

 

Range of Exercise Prices

 

Shares

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contract
Life

 

Aggregate
Intrinsic
Value

 

Shares

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Remaining
Contract
Life

 

Aggregate
Intrinsic
Value

 

$

0.0 - $5.31

 

300

 

$

5.31

 

8.91

 

$

 

120

 

$

5.31

 

8.91

 

$

 

$

5.32 - $22.40

 

73

 

$

22.40

 

2.67

 

$

 

73

 

$

22.40

 

2.67

 

$

 

 

The aggregate intrinsic value in the table above represents the total pretax intrinsic value, based on our closing stock price of $0.62 at March 31, 2012 which would have been received by the option holders had all option holders exercised their options as of that date.

EXCEL 14 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\Y,F)F8S%B-5\Y.&1C7S0T-F%?.&)F8U\T,&-D M,C`W.#8S-F,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]21T%.25I!5$E/3E]!3D1?3$E.15]/1E]"55-) M3CPO>#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D-!4$E404Q?4U1/0TL\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/34U/3E]35$]#2U]705)204Y44SPO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-50E-%455%3E1?159% M3E13/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I!8W1I M=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\>#I0#I%>&-E;%=O M7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$"!+97D\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^ M36%R(#,Q+`T*"0DR,#$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^9F%L2!#=7)R96YT(%)E<&]R=&EN9R!3=&%T=7,\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A M;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ M,RPY,C@\F%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S+#,Q M-2D\2!A;F0@17%U:7!M96YT+"!.970\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4L M($-U3PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^)FYBF5D M.R`Q.2PP,C3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879AF5D/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`P,"PP,#`\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E M<'0@4VAA'!E M;G-E'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&5S/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#,X-BD\7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6UE M;G1S(&UA9&4@;VX@3F]T97,@4&%Y86)L93PO=&0^#0H@("`@("`@(#QT9"!C M;&%S6%B;&4L M($YE="!O9B!,;V%N($-O'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\Y,F)F M8S%B-5\Y.&1C7S0T-F%?.&)F8U\T,&-D,C`W.#8S-F,-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO.3)B9F,Q8C5?.3AD8U\T-#9A7SAB9F-?-#!C M9#(P-S@V,S9C+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E(')E M;&%T960@=&\@=F5S=&EN9R!O9B!E;7!L;WEE92!S=&]C:R!O<'1I;VYS/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#(S/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2!3:&%R92UB87-E9"!087EM96YT($%W87)D/"]S M=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/B8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R`\+V9O;G0^/&9O;G0@F4],T0R/D]R9V%N:7IA=&EO;CPO9F]N=#X\+VD^/"]P/@T*/'`@F4] M,T0R/DQI;F4@;V8@0G5S:6YE6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M2!S;W5N9"!S=6)S=&ET=71E M2!D;W=N6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE2!I;F-R96%S:6YG(&1E;6%N9"!F;W(@2!F2!A;'1EF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=415A4 M+4E.1$5.5#H@+3`N,C5I;CL@34%21TE..B`P:6X@,&EN(#!P="`P+C6QE/3-$)V9O;G0MF4],T0R/B8C M,3@S.SPO9F]N=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#-P="<@F4],T0R/D-E2!S=6)S=&ET=71E(&9O6QE/3-$)U1%6%0M24Y$14Y4.B`M,"XR M-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T(#`N-S5I;B<^/&9O;G0@F4Z(#$P<'0[)R!S:7IE/3-$ M,CXF(S$X,SL\+V9O;G0^/&9O;G0@F4],T0Q/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R`\+V9O;G0^/&9O;G0@2!O2!B:6\M M8F%S960L(&5C;VQO9VEC86QL>2!S;W5N9"!S=6)S=&ET=71E2!S=6)S=&ET M=71E(&9OF4],T0R/B8C,38P M.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3`N,C5I M;CL@34%21TE..B`P:6X@,&EN(#!P="`Q:6XG/CQF;VYT('-T>6QE/3-$)V9O M;G0MF4],T0R/B8C,3@S.SPO9F]N=#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#-P="<@F4] M,T0R/D-E6)R:60@4F5S:6YS)B,Q-S0[('!R;V1U8W1S(')E M<&QA8V4@=7`@=&\@-34E(&]F('1H92!P971R;VQE=6T@8V]N=&5N="!I;B!C M;VYV96YT:6]N86P@<&QAF4Z(#$P<'0[)R!S M:7IE/3-$,CXF(S$X,SL\+V9O;G0^/&9O;G0@F4],T0Q/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R`\+V9O;G0^/&9O;G0@&ES=&EN9R!L:6YE(&]F(')E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE&EC86X@<&%T96YT M+"!A;F0@96EG:'0@<&5N9&EN9R!P871E;G0@87!P;&EC871I;VYS(&EN('1H M92!5+E,N(&%N9"!A8G)O860N($]U2!C;VUP2`T-2!R96=I M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'1A8FQE('-T>6QE/3-$)V9O;G0M3HG5&EM97,@3F5W(%)O;6%N)RQT:6UEF4],T0R/C(N/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,W!T M)R!S:7IE/3-$,3XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@ M/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T M>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)R!S:7IE/3-$,CY"87-I6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE2UO=VYE9"!S=6)S M:61I87)Y+"!#97)E<&QAF5D(&1U65A2!B92!E>'!E8W1E9"!F;W(@82!F=6QL('EE87(N)B,Q-C`[(%1H97-E M(&9I;F%N8VEA;"!S=&%T96UE;G1S('-H;W5L9"!B92!R96%D(&EN(&-O;FIU M;F-T:6]N('=I=&@@=&AE(&-O;G-O;&ED871E9"!F:6YA;F-I86P@65AF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL M93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE6EN9R!F:6YA;F-I86P@2!A;F0@97%U:7!M96YT+"!T:&4@ M9&5F97)R960@=&%X('9A;'5A=&EO;B!A;&QO=V%N8V4@86YD('1H92!F86ER M('9A;'5E(&]F('-T;V-K(&]P=&EO;G,N)B,Q-C`[($%C='5A;"!R97-U;'1S M(&-O=6QD(&1I9F9EF4],T0R/D-A6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE2!O9B!T:')E92!M;VYT:',@ M;W(@;&5S2!H879E M(&5X8V5E9&5D(&9E9&5R86QL>2!I;G-U2XF(S$V,#L@5V4@:&%V92!N;W0@97AP97)I96YC960@86YY M(&QOF4],T0R/D-O;F-E;G1R871I;VX@;V8@0W)E M9&ET(%)I6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE2XF(S$V,#L@5&AE('5N2!C875S92!T:&4@<')I;F-I M<&%L(&%M;W5N="!O9B!T:&4@:6YV97-T;65N="!T;R!F;'5C='5A=&4N)B,Q M-C`[(%1O(&UI;FEM:7IE('1H:7,@'!O6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE7,@9G)O;2!R96-E:7!T(&]F(&=O;V1S+B!4:&5S M92!C=7-T;VUE2X@07,@82!R97-U;'0@;V8@=&AE(')E M8V5N="!D971EF4],T0R/D]T:&5R($-O;F-E;G1R871I M;VX\+V9O;G0^/"]I/CPO<#X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE65AF4],T0R/DQI<75I9&ET>2!A;F0@ M0V%P:71A;"!297-O=7)C97,\+V9O;G0^/"]I/CPO<#X-"CQP('-T>6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0G('-I>F4],T0R/DEF('=E(&-A;FYO="!O8G1A:6X@2X@5&AE(&-O;G-O;&ED871E9"!F:6YA;F-I M86P@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF M;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)R!S:7IE/3-$,CY2 M97-T6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE&EM871E;'D@)#0S M+#`P,"!O;B!-87)C:"8C,38P.S,Q+"`R,#$R(&%N9"!$96-E;6)E6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)R!S:7IE/3-$,CY&86ER(%9A;'5E(&]F($9I;F%N8VEA;"!);G-T M'!E;G-E&EM871E('1H96ER(&9A M:7(@=F%L=65S(&1U92!T;R!T:&4@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)R!S M:7IE/3-$,CY!8V-O=6YTF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=- M05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R M/E=E(&UA:6YT86EN(&%N(&%L;&]W86YC92!F;W(@9&]U8G1F=6P@86-C;W5N M=',@9F]R(&5S=&EM871E9"!L;W-S97,@=&AA="!M87D@87)I6UE;G1S+B!-86YA9V5M96YT('!E2!B87-I6UE;G0@:&ES=&]R>2P@2!L979E;',@86YD(&-U2!I;B!E&AA=7-T960L(&%N9"!T M:&4@<&]T96YT:6%L(&9O2!I&EM871E;'D@)#4N-"!M:6QL:6]N(&%S(&]F($UA6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)R!S:7IE/3-$,CY);G9E;G1O2!O9B!R87<@;6%T97)I86QS('5S M960@:6X@=&AE(&UA;G5F86-T=7)I;F<@;V8@8FEO<&QA&-E6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`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`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0G('-I>F4],T0R/E)A=R!-871EF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$N,R4[(%!!1$1)3DF4],T0R/B0\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/C(L,SDY/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R M/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE. M.B`P:6X@,&EN(#!P="`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R M/D)I;W!L87-T:6,@4F5S:6YS/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN)R!B9V-O M;&]R/3-$(T-#145&1B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@8V]L MF4],T0R/C0R/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,B4@8V]LF4],T0R/C8Y/"]F;VYT/CPO M<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D]B6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3DF4] M,T0R/B@R,CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/BD\+V9O M;G0^/"]P/CPO=&0^/"]T6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[($)/ M4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@ M4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q+C,E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU M;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN)R!B9V-O;&]R/3-$(T-#145&1B!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/CPO=&%B M;&4^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0G('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL M93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL93TS1"=& M3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE2!A;F0@97%U:7!M M96YT(&%R92!S=&%T960@870@8V]S="P@86YD(&1E<')E8VEA=&EO;B!I'!E;F1I='5R97,@87)E(&-H87)G960@=&\@97AP96YS92!AF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\=&%B;&4@6QE/3-$ M)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/D1E8V5M8F5R)B,Q-C`[ M,S$L)B,Q-C`[,C`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`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N M,R4[(%!!1$1)3DF4],T0R/B0\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@F4] M,T0R/C4L-S0Y/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D)U:6QD M:6YG/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U!!1$1)3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U!!1$1) M3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@8V]LF4],T0R/C$L-C,P/"]F M;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D%U=&\\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$(T-#145&1B!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@8V]LF4],T0R/C$Q/"]F;VYT M/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T M9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@ M34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I M>F4],T0R/D9UF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@8V]LF4] M,T0R/C,R-SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[ M(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3DF4],T0R/C(W M,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/C(W,SPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P M:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R M/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@ M,&EN(#!P="`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#%P="<@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U!!1$1)3DF4],T0R/BD\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U!!1$1) M3D6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B0\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT M('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)R!S:7IE/3-$,CY);G1A M;F=I8FQE($%SF4] M,T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\=&%B;&4@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/D1E M8V5M8F5R)B,Q-C`[,S$L)B,Q-C`[,C`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`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D%C8W5M=6QA=&5D($%M;W)T:7IA M=&EO;CPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3DF4],T0R/B@T,3PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XS M-S5P=#L@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`R+C4E.R!0041$24Y' M+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/B@S.3PO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XS-S5P=#L@4$%$ M1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P M="`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/DEN=&%N9VEB;&4@ M07-S971S+"!.970\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B8C,38P.SPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD M;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N M93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=) M1%1(.B`Q,B4[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O M=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E. M1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0 M.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$ M1$E.1RU43U`Z(#!I;B<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET M86QI8SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)R!S:7IE/3-$,CY$969E6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE"!A"!AF4],T0R M/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P M:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/E1H92!B96YE9FET M(&]F(&$@=&%X('!O"!P;W-I=&EO;G,@=&%K M96X@87)E(&YO="!O9F9S970@;W(@86=G"!B96YE9FET M('1H870@:7,@;6]R92!T:&%N(#4P('!EF5D('5P;VX@&EN9R!A=71H;W)I='DN)B,Q-C`[(%1H92!P;W)T:6]N(&]F('1H92!B M96YE9FET&%M:6YA=&EO;BX\+V9O;G0^/"]P/@T* M/'`@&5S(&EN('1H92!S=&%T96UE;G0@;V8@:6YC;VUE M+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W`^ M#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S M='EL93TS1"=&3TY4+5-464Q%.B!I=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE MF4@ MF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=- M05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R M/D-E2!R:6=H=',@;V8@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I M=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE6EN9R!A;6]U;G0@;V8@87-S971S(&5X8V5E9"!I M=',@&ES=&5N8V4@;V8@:6UP86ER;65N="!I2!T;R!R96-O=F5R('1H92!C87)R>6EN9R!V M86QU92!O9B!T:&4@;&]N9RUL:79E9"!A6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQI/CQF;VYT M('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)R!S:7IE/3-$,CY#;VUP M87)A=&EV92!&:6=UF4],T0R M/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P M:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D-E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$F4],T0Q/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R`\ M+V9O;G0^/&9O;G0@6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)R!S M:7IE/3-$,CY#87!I=&%L(%-T;V-K($ESF4],T0R/B8C,38P.SPO9F]N M=#X\+W`^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3`N,C5I;CL@34%2 M1TE..B`P:6X@,&EN(#!P="`P+C5I;B<^/&9O;G0@6QE M/3-$)T9/3E0M4TE:13H@,W!T)R!S:7IE/3-$,3XF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@/"]F M;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@&EM871E;'D@)#@X+#`P,"!T;R!V87)I M;W5S(&5M<&QO>65E6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,"XR-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T(#`N-6EN)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0G('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL M93TS1"=415A4+4E.1$5.5#H@+3`N,C5I;CL@34%21TE..B`P:6X@,&EN(#!P M="`P+C5I;B<^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@ M,W!T)R!S:7IE/3-$,3XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@/"]F;VYT/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@,3!P="<@&EM871E M;'D@)#$P+#`P,"!P=7)S=6%N="!T;R!A('-E='1L96UE;G0@86=R965M96YT M+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3`N,C5I M;CL@34%21TE..B`P:6X@,&EN(#!P="`P+C5I;B<^/&9O;G0@F4],T0R/E9A;'5A=&EO;B!!'!E8W1E9"!T;R!B92!E M>&5R8VES960@:7,@)#`N,B!M:6QL:6]N+B!$=7)I;F<@=&AE('1HF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\=&%B M;&4@F4],T0Q/B8C,38P.SPO9F]N=#X\+V(^/"]P/CPO=&0^#0H\ M=&0@F4],T0Q/B8C,38P.SPO9F]N=#X\+V(^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@ M,&EN)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\<"!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/C8N,#PO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4 M.B`P:6X[(%!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\ M+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN)R!B M9V-O;&]R/3-$(T-#145&1B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^ M#0H\<"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@ M,&EN(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4] M,T0R/C0Q+CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P M<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W`^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3`N,C5I;CL@34%21TE. M.B`P:6X@,&EN(#!P="`P+C5I;B<^/&9O;G0@6QE/3-$ M)T9/3E0M4TE:13H@,W!T)R!S:7IE/3-$,3XF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@/"]F;VYT M/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U3 M25I%.B`Q,'!T)R!S:7IE/3-$,CY%>'!E8W1E9"!6;VQA=&EL:71Y.CPO9F]N M=#X\+VD^/&9O;G0@6UE;G1S('=E M2!F86-T;W(@8F%S960@;VX@ M;W5R(&AI6QE/3-$)V9O M;G0MF4],T0R/B8C,3@S.SPO9F]N=#X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#-P="<@6QE/3-$)T9/3E0M4TE:13H@,3!P="<@'!E8W1E9"!T97)M M+CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@+3`N,C5I M;CL@34%21TE..B`P:6X@,&EN(#!P="`P+C5I;B<^/&9O;G0@6QE/3-$)V9O;G0MF4],T0R/B8C M,3@S.SPO9F]N=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#-P="<@F4],T0R/B!792!H879E(&YO="!P86ED(&%N M>2!D:79I9&5N9',@86YD(&1O(&YO="!A;G1I8VEP871E('!A>6EN9R!D:79I M9&5N9',@:6X@=&AE(&9O6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`M,"XR M-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T(#`N-6EN)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0[)R!S:7IE/3-$,CXF(S$X,SL\+V9O;G0^/&9O M;G0@F4],T0Q/B8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R`\+V9O;G0^/&D^/&9O;G0@F4],T0R/E)I6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<@F5R;RUC;W5P;VX@ M:7-S=65S('=I=&@@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQI/CQF;VYT('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)R!S:7IE M/3-$,CY3=&]C:R!/<'1I;VX@06-T:79I='D\+V9O;G0^/"]I/CPO<#X-"CQP M('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE2!O=7(@8F]A65E2!E>'!I2!O=F5R('1HF4],T0R/B8C,38P.SPO9F]N=#X\+W`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`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1) M3DF4],T0Q/B8C,38P.SPO9F]N=#X\+V(^/"]P/CPO M=&0^/"]T6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D M:75M(&YO;F4[(%!!1$1)3DF4],T0R/C,W M,SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!" M3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\ M=&0@6QE/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q% M1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)' M24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\ M<"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN M(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R M/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B8C,38P.SPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q,B4@8V]LF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y' M+51/4#H@,&EN)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\<"!S M='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN(#!P M="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/C,P M,#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1) M3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D5X97)C:7-E9#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D-A;F-E;&QE9"]F;W)F96ET960\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT M(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@ M4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@ M0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;B<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/@T*/'`@6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ M(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T M9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P M:6X@,&EN(#!P="`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D]U M='-T86YD:6YG)B,X,C$R.TUAF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$(T-#145&1B!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\<"!S='EL93TS1"=415A4+4%,24=. M.B!R:6=H=#L@34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/C,W,SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1)3D6QE/3-$)U!! M1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C$Y,SPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD;W=T97AT(#(N,C5P M="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N93L@4$%$1$E.1RU" M3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`Q,B4[(%!! M1$1)3D6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1) M3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/CPO M=&%B;&4^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0G('-I>F4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S M='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G M('-I>F4],T0R/E1H92!F;VQL;W=I;F<@=&%B;&4@F4],T0R/B8C,38P.SPO M9F]N=#X\+W`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`P<'0@ M,3!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R M/C`N,"`M("0U+C,Q(#PO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(E.R!0041$24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[ M(%!!1$1)3DF4],T0R/B8C,38P.SPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I M=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#@E.R!0041$ M24Y'+5))1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU4 M3U`Z(&UE9&EU;2!N;VYE.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0 M041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$(T-#145&1B!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0X)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3DF4],T0R M/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@'0@,7!T('-O;&ED.R!"3U)$15(M4DE' M2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$ M(T-#145&1B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0V)3X-"CQP('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#@E.R!0041$24Y'+5))1TA4.B`P:6X[ M($)!0TM'4D]53D0Z("-C8V5E9F8[($)/4D1%4BU43U`Z(&UE9&EU;2!N;VYE M.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN M)R!B9V-O;&]R/3-$(T-#145&1B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0X M)3X-"CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@ M;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/ M33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO M=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$R,#PO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(E.R!0041$24Y'+5)) M1TA4.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52 M+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/C4N,S$\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/C@N.3$\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@+3$P<'0[($U!4D=)3CH@,&EN M(#!I;B`P<'0@,3!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G M('-I>F4],T0R/C4N,S(@+2`D,C(N-#`@/"]F;VYT/CPO<#X\+W1D/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U!! M1$1)3DF4],T0R/C6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C(R+C0P/"]F;VYT/CPO<#X\+W1D/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3DF4],T0R/C(N-C<\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3DF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#@E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE'1087)T7SDR8F9C,6(U7SDX9&-?-#0V85\X8F9C7S0P8V0R,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'1A8FQE('-T>6QE/3-$)V9O;G0M3HG5&EM97,@3F5W(%)O;6%N)RQT:6UEF4],T0R/C0N/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M M4TE:13H@,W!T)R!S:7IE/3-$,3XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#L@/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I M=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE2!I;G1E M6UE;G1S(')E M8V5I=F5D(&%F=&5R(&9I=F4@9&%Y6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE2!A M="!A;B!E>&5R8VES92!P'!E;G-E(&]V M97(@=&AE('1E6QE/3-$)U=)1%1(.B`Q,#`E.R!"3U)$ M15(M0T],3$%04T4Z(&-O;&QA<'-E)R!B;W)D97(],T0P(&-E;&QS<&%C:6YG M/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0Q,#`E/@T*/'1R/@T*/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQB/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/D1E8V5M8F5R)B,Q-C`[,C(L)B,Q-C`[,C`Q,#PO9F]N=#X\ M+V(^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/C<@>65A6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0G('-I>F4],T0R/D5X<&5C=&5D('9O;&%T:6QI='D\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X- M"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$ M24Y'+51/4#H@,&EN)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\ M<"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN M(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R M/C,Y+CD\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T)SX\:3X\9F]N="!S='EL93TS1"=&3TY4+5-464Q%.B!I M=&%L:6,[($9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0G('-I>F4],T0R/D]N($UA>28C,38P.S(T+"`R,#$Q+"!W M92!I28C,38P M.S(T+"`R,#$Q+B!);B!C;VYN96-T:6]N('=I=&@@=&AE(&ES28C,38P.S$X+"`R,#$Q('!U2!R97-TF4],T0R M/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P M:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/E1H92!.;W1E6UE M;G0@=&\@86QL(&]F(&]U&ES=&EN9R!A;F0@9G5T=7)E('-E;FEO6%B;&4@2!I;B!A M2!R97!U&EM=6T@;V8@,3DX+C`Q.3@@2!R97!UF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D%L28C,38P.S$X+"`R,#$Q('!U&-H86YG92!# M;VUM:7-S:6]N("AT:&4@)B,X,C(P.U-%0R8C.#(R,3LI(')E9VES=&5R:6YG M('1H92!R97-A;&4@;V8@=&AE($YO=&5S(&%N9"!T:&4@F4],T0R/DUO6%B;&4\+V9O;G0^/"]I/CPO<#X-"CQP M('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=4 M15A4+4E.1$5.5#H@+3`N,C5I;CL@34%21TE..B`P:6X@,&EN(#!P="`P+C5I M;B<^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,W!T)R!S M:7IE/3-$,3XF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#L@/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<@65A6QE/3-$)V9O;G0MF4],T0R/B8C,3@S.SPO M9F]N=#X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#-P="<@F4],T0R/D-R961I="!F86-I;&ET>2!W:71H($EN=&5S82!3 M86YP86]L;R!F;W(@=7`@)#`N-R!M:6QL:6]N+B!4:&4@9F%C:6QI='D@:7,@ M9F]R(&$@=&5R;2!O9B!E:6=H="8C,38P.VUO;G1H6QE/3-$)U1%6%0M24Y$14Y4.B`M,"XR-6EN.R!-05)'24XZ M(#!I;B`P:6X@,'!T(#`N-6EN)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R M/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=415A4+4E.1$5.5#H@ M+3`N,C5I;CL@34%21TE..B`P:6X@,&EN(#!P="`P+C5I;B<^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,W!T)R!S:7IE/3-$,3XF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#L@/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<@2!F'10 M87)T7SDR8F9C,6(U7SDX9&-?-#0V85\X8F9C7S0P8V0R,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'1A8FQE M('-T>6QE/3-$)V9O;G0M3HG5&EM97,@ M3F5W(%)O;6%N)RQT:6UEF4],T0R/C4N/"]F;VYT M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,W!T)R!S:7IE/3-$,3XF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@/"]F;VYT/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE2XF(S$V,#L@5&AE(&QE87-E6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,"XR-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T(#`N M-6EN)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[)R!S:7IE/3-$ M,CXF(S$X,SL\+V9O;G0^/&9O;G0@F4],T0Q/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R`\+V9O;G0^/&D^/&9O;G0@F4] M,T0R/D-A;&EF;W)N:6$@1F%C:6QI='D@/"]F;VYT/CPO:3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/B8C.#(Q,CL@5&AE($5L M(%-E9W5N9&\@9F%C:6QI='D@8V]N2`U M+#0W-2!S<75A2!A;65N9&5D(&]N($%P'!I28C,38P.S,Q+"`R,#$S+B!/=7(@8W5R6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,"XR-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T(#`N-6EN)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0[)R!S:7IE/3-$,CXF(S$X,SL\+V9O M;G0^/&9O;G0@F4],T0Q/B8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R`\+V9O;G0^/&D^/&9O;G0@F4],T0R/DEN9&EA;F$@ M1F%C:6QI='D@)B,X,C$R.R`\+V9O;G0^/"]I/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<@6UO=7(@9F%C:6QI='D@ M8V]N2`Q,#4L,#`P('-Q=6%R92!F965T M('5S960@87,@82!M86YU9F%C='5R:6YG(&%N9"!D:7-T28C,38P.S(P,3@N($]U6QE/3-$)V9O;G0MF4],T0R/B8C,3@S.SPO9F]N=#X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#-P="<@&EM871E;'D@,2PP,#`@'1087)T7SDR8F9C,6(U7SDX9&-?-#0V85\X8F9C7S0P8V0R,#'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'1A8FQE M('-T>6QE/3-$)V9O;G0M3HG5&EM97,@ M3F5W(%)O;6%N)RQT:6UEF4],T0R/C8N/"]F;VYT M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,W!T)R!S:7IE/3-$,3XF(S$V M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#L@/"]F;VYT/CQF;VYT('-T M>6QE/3-$)T9/3E0M4TE:13H@,3!P="<@6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`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`P<'0G(&%L M:6=N/3-$8V5N=&5R/CQB/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@ M,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ M(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1) M3DF4],T0R/B8C,38P.SPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5))1TA4 M.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;B<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,3(E/@T*/'`@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$(T-#145& M1B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\<"!S='EL93TS1"=4 M15A4+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX] M,T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/B8C.#(Q,CL\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z M(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/ M54Y$.B`C8V-E969F.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$(T-# M145&1B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\<"!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/C8T+C@\+V9O M;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN M(#!P="`Q,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D-U6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U!!1$1)3D6QE/3-$ M)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U!!1$1)3DF4],T0R/B4\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS M1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\ M+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!0041$24Y'+51/4#H@,&EN)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q,B4^#0H\<"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@34%21TE. M.B`P:6X@,&EN(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G M('-I>F4],T0R/C,T+C(\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/D-U6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\=&%B;&4@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T)/ M4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5& M5#H@;65D:75M(&YO;F4[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U!!1$1) M3D6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`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`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE'0@,7!T('-O;&ED.R!"3U)$15(M4DE' M2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$ M(T-#145&1B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4^#0H\<"!S='EL M93TS1"=415A4+4%,24=..B!R:6=H=#L@34%21TE..B`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`P:6X@,&EN(#!P M="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/C@Q M+C<\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@ M'0@,7!T M('-O;&ED.R!"3U)$15(M4DE'2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/ M4#H@,&EN)R!B9V-O;&]R/3-$(T-#145&1B!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0R)3X-"CQP('-T>6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3DF4],T0R M/B4\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#(N-24[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$ M5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4@8V]L6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$E.R!0041$24Y'+5))1TA4.B`P:6X[(%!!1$1)3DF4],T0R M/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T*/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`S,'!T)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0G('-I>F4],T0R/D=EF4] M,T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!0 M041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$(T-#145&1B!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,B4@8V]LF4],T0R/C,\+V9O;G0^/"]P M/CPO=&0^#0H\=&0@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C M8V-E969F.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$(T-#145&1B!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\<"!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1R M:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/C,N,3PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1)3DF4],T0R/B4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C,38P.SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$ M24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN M.R!0041$24Y'+51/4#H@,&EN)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M,B4@8V]LF4],T0R/C8\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4] M,T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R M)3L@4$%$1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q,B4^#0H\<"!S='EL93TS1"=415A4+4%, M24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1R:6=H M=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/C8N,CPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1)3DF4],T0R/B4\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!- M05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@0D]21$52+4Q%1E0Z(&UE9&EU M;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I M;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$ M.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;B<@8F=C;VQO6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O M=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3DF4],T0R/CDN,#PO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,"XS-S5P=#L@ M4$%$1$E.1RU,1494.B`P:6X[(%=)1%1(.B`R+C4E.R!0041$24Y'+5))1TA4 M.B`P:6X[($)!0TM'4D]53D0Z("-C8V5E9F8[(%!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$ M15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/C6QE/3-$)T)/4D1% M4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#H@ M;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R M/C$P+C@\+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B4\+V9O;G0^/"]P/CPO M=&0^/"]T6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U!! M1$1)3D6QE/3-$)TU!4D=) M3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!! M1$1)3DF4],T0R/B8C,38P.SPO M9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^ M/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!M961I=6T@;F]N M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;B<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E(&-O;'-P86X],T0R/@T*/'`@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3DF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`R,'!T M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/DYE="!S86QE6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR M-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y' M+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$P+CF4],T0R/C$P,SPO9F]N=#X\+W`^/"]T M9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y' M+4Q%1E0Z(#!I;CL@5TE$5$@Z(#(N-24[(%!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]2 M1$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0 M041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@ M,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@ M;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z M(#!I;B<@8F=C;VQOF4],T0R/B4\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@F4],T0R/B0\+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I M;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N M=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!W:6YD M;W=T97AT(#(N,C5P="!D;W5B;&4[($)/4D1%4BU,1494.B!M961I=6T@;F]N M93L@4$%$1$E.1RU"3U143TTZ(#!I;CL@4$%$1$E.1RU,1494.B`P:6X[(%=) M1%1(.B`Q,B4[(%!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'1A8FQE('-T>6QE/3-$)V9O;G0M M3HG5&EM97,@3F5W(%)O;6%N)RQT:6UE MF4],T0R/C6QE/3-$ M)T9/3E0M4TE:13H@,W!T)R!S:7IE/3-$,3XF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#L@/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)' M24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/E=E M(&%R92!S=6)J96-T('1O(%4N4RX@86YD($-A;&EF;W)N:6$@:6YC;VUE('1A M>"XF(S$V,#L@4W5B:F5C="!T;R!L:6UI=&5D('-T871U=&]R>2!E>&-E<'1I M;VYS+"!W92!A"!A=71H;W)I=&EE65A"!E>&%M M:6YA=&EO;G,@8GD@=&AE($EN=&5R;F%L(%)E=F5N=64@4V5R=FEC92XF(S$V M,#LF(S$V,#L@3F\@1&5F97)R960@5&%X($%S6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\Y,F)F8S%B-5\Y.&1C7S0T-F%?.&)F8U\T,&-D,C`W.#8S-F,- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.3)B9F,Q8C5?.3AD8U\T M-#9A7SAB9F-?-#!C9#(P-S@V,S9C+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)U1%6%0M24Y$14Y4.B`M,"XR-6EN.R!-05)'24XZ(#!I;B`P M:6X@,'!T(#`N,C5I;B<^/&9O;G0@F4],T0R/D-/34U/3B!3 M5$]#2R!705)204Y44SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ M(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/B8C,38P M.SPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/DEN(&-O;FYE8W1I;VX@=VET M:"!T:&4@&5R8VES92!PF4],T0R/B8C,38P.SPO9F]N=#X\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XZ(#!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0G('-I>F4],T0R/D$@2!O9B!W87)R86YT(&%C=&EV:71Y(&9O M6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`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`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`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T)SX\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0G('-I>F4],T0R/D]U='-T86YD:6YG)B,X,C$R.R!*86YU87)Y M)B,Q-C`[,2P@/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!M961I=6T@;F]N93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$N,R4[(%!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&UE9&EU;2!N;VYE.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[ M(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@ M,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&UE9&EU;2!N;VYE M.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/C$L,C6QE/3-$)U!!1$1)3D6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)TU! M4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE'0@,7!T('-O;&ED.R!"3U)$15(M4DE' M2%0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$ M(T-#145&1B!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4^#0H\<"!S='EL M93TS1"=415A4+4%,24=..B!R:6=H=#L@34%21TE..B`P:6X@,&EN(#!P="<@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/C0N-#0\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN M(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE M/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I M;B`P<'0G/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C M,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$ M1$E.1RU224=(5#H@,&EN.R!0041$24Y'+51/4#H@,&EN)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q,B4@8V]LF4],T0R/C8N,S4\+V9O;G0^ M/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE&5R8VES M960@/"]F;VYT/CPO<#X\+W1D/@T*/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A M;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,7!T M('-O;&ED.R!"3U)$15(M3$5&5#H@;65D:75M(&YO;F4[(%!!1$1)3DF4],T0R/B8C.#(Q,CL\+V9O;G0^/"]P/CPO=&0^ M#0H\=&0@F4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X-"CQT9"!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z M(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F M.R!0041$24Y'+51/4#H@,&EN)R!B9V-O;&]R/3-$(T-#145&1B!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q,B4@8V]LF4],T0R/B8C.#(Q,CL\ M+V9O;G0^/"]P/CPO=&0^#0H\=&0@6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L M93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@ M,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU2 M24=(5#H@,&EN.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]21$52+5)) M1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;B<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,3(E/@T*/'`@6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P M:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ('=I M;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z(&UE9&EU;2!N M;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q%1E0Z(#!I;CL@ M5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"3U)$15(M5$]0.B!M M961I=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E. M1RU43U`Z(#!I;B<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3(E/@T*/'`@ M6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I9VAT/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C,38P.SPO9F]N=#X\+W`^/"]T9#X\+W1R/@T*/'1R/@T* M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,3!P=#L@34%21TE..B`P:6X@,&EN(#!P="`Q,'!T M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0G('-I>F4],T0R/E=A6QE/3-$)T)/4D1%4BU" M3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@0D]21$52+4Q%1E0Z M(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN.R!0041$24Y'+4Q% M1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=(5#H@,&EN.R!"04-+ M1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I=6T@;F]N93L@0D]2 M1$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU43U`Z(#!I;B<@8F=C M;VQO6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1')I M9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ('=I;F1O=W1E>'0@,BXR-7!T(&1O=6)L93L@ M0D]21$52+4Q%1E0Z(&UE9&EU;2!N;VYE.R!0041$24Y'+4)/5%1/33H@,&EN M.R!0041$24Y'+4Q%1E0Z(#!I;CL@5TE$5$@Z(#$R)3L@4$%$1$E.1RU224=( M5#H@,&EN.R!"04-+1U)/54Y$.B`C8V-E969F.R!"3U)$15(M5$]0.B!M961I M=6T@;F]N93L@0D]21$52+5))1TA4.B!M961I=6T@;F]N93L@4$%$1$E.1RU4 M3U`Z(#!I;B<@8F=C;VQO6QE/3-$)U!!1$1)3D6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!-05)'24XZ(#!I;B`P:6X@,'!T M)R!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'1A8FQE('-T>6QE/3-$)V9O;G0M M3HG5&EM97,@3F5W(%)O;6%N)RQT:6UE MF4],T0R/CDN/"]F;VYT/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@,W!T)R!S:7IE/3-$,3XF(S$V,#LF(S$V,#LF(S$V,#LF M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V M,#LF(S$V,#LF(S$V,#L@/"]F;VYT/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@,3!P="<@28C,38P.S6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)TU!4D=)3CH@,&EN(#!I;B`P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE7,@=&\@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC&UL/@T*+2TM M+2TM/5].97AT4&%R=%\Y,F)F8S%B-5\Y.&1C7S0T-F%?.&)F8U\T,&-D,C`W ).#8S-F,M+0T* ` end XML 15 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2012
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2.              SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation

 

The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”).  The unaudited consolidated financial statements include the financial condition and results of operations of our wholly-owned subsidiary, Cereplast International, S.A., a Luxembourg company organized during the year ended December 31, 2008, for the purpose of conducting sales operations in Europe.  Intercompany balances and transactions have been eliminated in consolidation.  The results of operations for interim periods are not necessarily indicative of the results that may be expected for a full year.  These financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements.  Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance and the fair value of stock options.  Actual results could differ from those estimates.

 

Cash

 

We consider all highly liquid investments with an original maturity of three months or less to be cash equivalents. At various times throughout the year, the Company may have exceeded federally insured limits.  At March 31, 2012 and December 31, 2011, balances in our cash accounts exceeded federally insured limits of $0.25 million by approximately, $0.7 million and $4.0 million, respectively.  We have not experienced any losses in such accounts and we do not believe we are exposed to any significant credit risk on cash and cash equivalents.

 

Concentration of Credit Risk

 

We had unrestricted cash totaling $1.1 million and $3.9 million at March 31, 2012 and December 31, 2011, respectively.  The unrestricted cash and cash equivalents are held for working capital purposes.   We do not enter into investments for trading or speculative purposes.  Some of the securities in which we invest, however, may be subject to market risk.  This means that a change in prevailing interest rates may cause the principal amount of the investment to fluctuate.  To minimize this risk, we intend to maintain our portfolio of cash equivalents and short-term investments in a variety of securities, including commercial paper, money market funds, debt securities and certificates of deposit.  Due to the short-term nature of these investments, we believe that we do not have any material exposure to changes in the fair value of our investment portfolio as a result of changes in interest rates.  We actively monitor changes in interest rates.

 

Concentration of credit risk with respect to accounts receivable is limited to certain European customers to whom we make substantial sales. As of March 31, 2012 we had one large European customer that accounted for $7.6 million, or 36% of our accounts receivable balance, which is past due. We have another large European customer with $6.1 million, or 29% of our receivable balance. Agreed upon payment terms for both of these customers are 90 days from receipt of goods. These customers have acknowledged to us their agreement with the amounts owing and no amounts recognized in revenue or recorded in accounts receivable from these customers are in dispute. To reduce risk, we routinely assess the financial strength of our most significant customers, using standard credit risk evaluation methods with reference to publicly available and customer supplied information, and monitor the amounts owed to us, taking appropriate action when necessary. As a result of the recent deterioration in the general economic conditions in Europe and the slow payment by some of our European customers, we have established an allowance for doubtful accounts of $5.4 million to reflect management’s assessment of credit risk associated with these customer balances. We are working with all customers to mitigate credit risk and ensure collection of all outstanding amounts.

 

Other Concentration

 

During the three months ended months ended March 31, 2012, we did not have any significant suppliers that accounted for greater than 10% of total cost of goods sold.  During the same period in the prior year, we had three significant suppliers that accounted for 34.5%, 17.2%, and 15.0% of total cost of goods sold.  No other suppliers accounted for more than 10% of cost of goods sold during these periods.

 

Liquidity and Capital Resources

 

We have incurred a net loss of $2.4 million for the three months ended March 31, 2012, and $14.0 million for the year ended December 31, 2011, and have an accumulated deficit of $59.3 million as of March 31, 2012. Based on our operating plan, our existing working capital will not be sufficient to meet the cash requirements to fund our planned operating expenses, capital expenditures and working capital requirements through December 31, 2012 without additional sources of cash.

 

Our plan to address the shortfall of working capital is to generate additional financing through a combination of sale of our equity securities, refinancing existing credit facilities, incremental product sales and collection of outstanding receivables. We are confident that we will be able to deliver on our plans, however, there are no assurances that we will be able to obtain any sources of financing on acceptable terms, or at all.

 

If we cannot obtain sufficient additional financing in the short-term, we may be forced to curtail or cease operations or file for bankruptcy. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be forced to take such actions.

 

Restricted Cash

 

We had restricted cash in the amount of approximately $43,000 on March 31, 2012 and December 31, 2011. The restricted cash amount consists of a “Certificate of Deposit” which supports a “Letter of Credit” for a leased facility.

 

Fair Value of Financial Instruments

 

The carrying amounts of our financial instruments as of March 31, 2012, which include cash, accounts receivable, unbilled receivable, accounts payable, accrued expenses, loans payable and convertible subordinated notes approximate their fair values due to the short-term nature of these instruments.

 

Accounts Receivable

 

We maintain an allowance for doubtful accounts for estimated losses that may arise if any of our customers are unable to make required payments. Management performs a quantitative and qualitative review of the receivables past due from customers on a monthly basis. Quantitative factors include customer’s past due balance, prior payment history, recent sales activity and days sales outstanding. Qualitative factors include macroeconomic environment, current product demand, estimated inventory levels and customer’s financial position. In certain cases, we may have access to repossess unsold products held at customer locations as recourse for payment defaults. The fair market value of these products are considered as potential recovery in estimating net losses from uncollectible accounts. We record an allowance against uncollectible items for each customer after all reasonable means of collection have been exhausted, and the potential for recovery is considered remote. The allowance for doubtful accounts was approximately $5.4 million as of March 31, 2012 and December 31, 2011.

 

Inventories

 

Inventories are stated at the lower of cost (first-in, first-out basis) or market, and consist primarily of raw materials used in the manufacturing of bioplastic resins, finished bioplastic resins and finished goods. Inventories are reviewed for excess and obsolescence and a reserve is established accordingly. As of March 31, 2012 and December 31, 2011, inventories consisted of the following (in thousands):

 

 

 

March 31, 2012

 

December 31, 2011

 

 

 

(Unaudited)

 

 

 

Raw Materials

 

$

2,399

 

$

2,565

 

Bioplastic Resins

 

1,918

 

1,959

 

Finished Goods

 

41

 

42

 

Packaging Materials

 

78

 

69

 

WIP

 

60

 

 

Obsolescence Reserve

 

(211

)

(229

)

Inventories, net

 

$

4,285

 

$

4,406

 

 

Property and Equipment

 

Property and equipment are stated at cost, and depreciation is computed on the straight-line method over the estimated useful lives of the assets. The estimated useful lives of the assets are between five and seven years. Repairs and maintenance expenditures are charged to expense as incurred. Property and Equipment consist of the following (in thousands):

 

 

 

March 31, 2012

 

December 31, 2011

 

 

 

(Unaudited)

 

 

 

Equipment

 

$

5,749

 

$

5,434

 

Building

 

5,906

 

5,906

 

Land

 

32

 

32

 

Construction In Progress

 

1,630

 

1,743

 

Auto

 

11

 

37

 

Furniture and Fixtures

 

327

 

327

 

Leasehold Improvements

 

273

 

273

 

 

 

13,928

 

13,752

 

Accumulated Depreciation

 

(3,315

)

(3,151

)

Property and Equipment, Net

 

$

10,613

 

$

10,601

 

 

Intangible Assets

 

Intangible assets are stated at cost and consist primarily of patents and trademarks.  Amortization is computed on the straight-line method over the estimated life of these assets, estimated to be between five and fifteen years.  Intangible assets consist of the following (in thousands):

 

 

 

March 31, 2012

 

December 31, 2011

 

 

 

(Unaudited)

 

 

 

Intangible Assets

 

$252

 

$222

 

Accumulated Amortization

 

(41

)

(39

)

Intangible Assets, Net

 

$211

 

$183

 

 

Deferred Income Taxes

 

Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences.  Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases.  Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment.

 

The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any.  Tax positions taken are not offset or aggregated with other positions.  Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.  The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

Interest and penalties associated with unrecognized tax benefits are classified as additional income taxes in the statement of income.

 

Revenue Recognition

 

We recognize revenue at the time of shipment of products, when the following fundamental criteria are met: (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred; (iii) the price to the customer is fixed or determinable; and (iv) collection of the sales price is probable.

 

Certain of our product sales are made to distributors under agreements with generally the same terms of sale and credit as all other customer agreements. Revenue from product sales to our customers, including our customers who are distributors, is recognized upon shipment provided the above noted fundamental criteria of revenue recognition are met. The sale of products to our customers who are distributors is not contingent upon the distributor selling the product to the end-user, and our current agreements with distributors do not have any rights of return.

 

Impairment of Long-Lived Assets

 

We review long-lived assets for possible impairment by evaluating whether the carrying amount of assets exceed its recoverable amount. Our judgment regarding the existence of impairment is based on legal factors, market conditions and operational performance of our assets. Future adverse changes in legal environment, market conditions or poor operating results could result in losses or an inability to recover the carrying value of the long-lived assets, thereby possibly requiring an impairment charge in the future.

 

Comparative Figures

 

Certain of the prior year figures have been reclassified to conform to the presentation adopted in the current year.

XML 16 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2012
Dec. 31, 2011
Current Assets    
Cash $ 1,059 $ 3,940
Accounts Receivable, Net 14,787 14,744
Inventory, Net 4,285 4,406
Prepaid Expenses and Other Current Assets 828 966
Total Current Assets 20,959 24,056
Property and Equipment    
Property and Equipment 13,928 13,752
Accumulated Depreciation and Amortization (3,315) (3,151)
Property and Equipment, Net 10,613 10,601
Other Assets    
Restricted Cash 43 43
Deferred Loan Costs 1,182 1,321
Intangible Assets, Net 211 183
Deposits 47 47
Total Other Assets 1,483 1,594
Total Assets 33,055 36,251
Current Liabilities    
Accounts Payable 1,496 1,813
Accrued Expenses 2,472 2,760
Capital Leases, Current Portion 75 73
Loan Payable, Current Portion 1,897 1,855
Total Current Liabilities 5,940 6,501
Long-Term Liabilities    
Loan Payable 6,955 7,307
Convertible Subordinated Notes 12,500 12,500
Capital Leases, Long-Term 226 245
Total Long-Term Liabilities 19,681 20,052
Total Liabilities 25,621 26,553
Shareholders' Equity    
Preferred Stock, $0.001 par value; 5,000,000 shares authorized and none outstanding      
Common Stock, $0.001 par value; 495,000,000 shares authorized; 19,027,204 and 18,933,139 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively 19 19
Additional Paid in Capital 66,644 66,524
Accumulated Deficit (59,321) (56,935)
Accumulated Other Comprehensive Income 88 86
Total Shareholders' Equity 7,430 9,694
Noncontrolling Interests 4 4
Total Equity 7,434 9,698
Total Liabilities and Shareholders' Equity $ 33,055 $ 36,251
XML 17 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Share-based Compensation Arrangement by Share-based Payment Award    
Expense related to vesting of employee stock options $ 23 $ 112
Director and Employee Services
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued 84,478 83,877
Dollar value of shares issued 88 414
Settlement Agreement
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued 9,587 4,062
Dollar value of shares issued 10 20
Prepaid Services
   
Share-based Compensation Arrangement by Share-based Payment Award    
Number of shares issued   12,000
Dollar value of shares issued   $ 59
XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 19 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
ORGANIZATION AND LINE OF BUSINESS
3 Months Ended
Mar. 31, 2012
ORGANIZATION AND LINE OF BUSINESS  
ORGANIZATION AND LINE OF BUSINESS

1.              ORGANIZATION AND LINE OF BUSINESS

 

Organization

 

We were incorporated on September 29, 2001 in the State of Nevada under the name Biocorp North America Inc.  On March 18, 2005, we filed an amendment to our certificate of incorporation to change our name to Cereplast, Inc.

 

Line of Business

 

Cereplast, Inc. (“we” or “Cereplast”) has developed and is commercializing proprietary bio-based resins through two complementary product families: Cereplast Compostables® resins which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables™ resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources. Our resins can be converted into finished products using conventional manufacturing equipment without significant additional capital investment by downstream converters.

 

The demand for non-petroleum based, clean and renewable sources for materials, such as bioplastics, and the demand for compostable/biodegradable products are being driven globally by a variety of factors, including fossil fuel price volatility, energy security and environmental concerns. These factors have led to increased spending on clean and renewable products by corporations and individuals as well as legislative initiatives at national, state and local level.

 

We are a full-service resin solution provider uniquely positioned to capitalize on the rapidly increasing demand for sustainable and environmentally friendly alternatives to traditional plastic products.

 

We primarily conduct our operations through two product families:

 

·                  Cereplast Compostables® resins are compostable and bio-based, ecologically sound substitutes for petroleum-based plastics targeting primarily compostable bags, single-use food service products and packaging applications. We offer 13 commercial grades of Compostable resins in this product line. These resins are compatible with existing manufacturing processes and equipment making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Compostable line in November 2006.

 

·                  Cereplast Sustainables™ resins are partially or fully bio-based, ecologically sound substitutes for fully petroleum-based plastics targeting primarily durable goods, packaging applications. We offer six commercial grades of Sustainable resins in this product line. These resins are compatible with existing manufacturing processes and equipment, making them a ready substitute for traditional petroleum-based resins. We commercially introduced our Sustainable line in late 2007 under the name “Cereplast Hybrid Resins®.”

 

·                  Cereplast Hybrid Resins® products replace up to 55% of the petroleum content in conventional plastics with bio-based materials such as industrial starches sourced from plants. The Hybrid resins line is designed to offer similar properties to traditional polyolefins such as impact strength and heat deflection temperature, and is compatible with existing converter processes and equipment. The Cereplast Hybrid Resins® line provides a viable alternative for brand owners and converters looking to partially replace petroleum-based resins in durable goods applications. Hybrid resins address this need in a wide range of markets, including automotive, consumer goods, consumer electronics, medical, packaging, and construction. We commercially introduced our first grade of Hybrid resin, Hybrid 150, at the end of 2007. We currently offer four commercial grades in this product line.

 

·                  Cereplast Algae Plastic® resins. In October of 2009 we announced that we have been developing a new technology to transform algae into bioplastics and intend to launch a new resin family containing algae-based materials that will complement our existing line of resins. The first commercial product with Cereplast Algae Plastic® resin is now being produced and sold as part of our Sustainables resin family. We believe that it is important to enhance research on non-food crops as we expect a surge in demand in bioplastics in future years, thus potentially creating pressure on food crops. Algae are the first non-food crop project that we have introduced and our R&D department is contemplating the development of additional non-food crop based materials in future years.

 

Our patent portfolio is currently comprised of six patents in the United States (“U.S.”), one Mexican patent, and eight pending patent applications in the U.S. and abroad. Our trademark portfolio is currently comprised of approximately 45 registered marks and 21 pending applications in the U.S. and abroad.

XML 20 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Mar. 31, 2012
Dec. 31, 2011
CONSOLIDATED BALANCE SHEETS    
Preferred Stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred Stock, shares authorized 5,000,000 5,000,000
Preferred Stock, shares outstanding 0 0
Common Stock, par value (in dollars per share) $ 0.001 $ 0.001
Common Stock, shares authorized 495,000,000 495,000,000
Common Stock, shares issued 19,027,204 18,933,139
Common Stock, shares outstanding 19,027,204 18,933,139
ZIP 21 0001193125-12-234493-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-12-234493-xbrl.zip M4$L#!!0````(`).`KT"M&H'WE%D``.;$!``1`!P`8V5R<"TR,#$R,#,S,2YX M;6Q55`D``]:VLD_6MK)/=7@+``$$)0X```0Y`0``[%U;ZO&XW&^/F_'\*`W0MCI58O#EJ-Y@$3RM.^5),7![&M<^M)>?#O M[_[ZE^=_J]?9F1$\$CX;+=@;88P,`G:FS4P;'@$!5J^G#[X22ICTT]ELM7N;'KU2$0@5\8G(W^KU_ONFV4K>?!B90)[B?QD,05GZ*5\< M3*-H=GIX.)_/&WBEH*?5 M;G8ZK?3Q0*KWCU#'VR-N,^J@N@GG.8,QMR-Z.KF!]%OU9JN> MH;N9/6K+(YUWTB=;AS^]>3WTIB+D]>J(I=5'[=;Q8SIR3Z0O^*(BCA5>8Z+O M#^'&J@$LZ2B1J]7O]P_I[@%,'6//\>>I)2G?BC&C6Z?18B9>'%@9S@(4F:Y- MC1B_.,"IJJ<3TGBP_@$[=(2<%7@:K.4A8M)_<7"%S_W0W"E3+E!)+R5#?TP;7YTN6G50Q\?7Q?E79!DP8A.=`R@F MMH&>EE+)[U5>$LHOO%(TI_3.QS`G4.'PYJM08MF]NO56\U.85.MK-*G6[B;5 M^G0FU?PJ%%@PI^:G0:BKK\B<2GC]26)7@M?_/9=&>)$V`^5?0&Z@%T(,A;F7 MGK!O1#@2YC/H*_J[OGA2FGS41ZN&N8?)IXE^/W?H8BB@!0]F!A!/YY,ZW'3 M6JNRSV)27TX\2TWJ";7^8*CU99E8^PFUOG[4^O("X:T1,R[])Z3:SIQ6JNM/ MB$ZQDLZ.W@W/*]82"FYC([Y+2HNG\$1**+U5)(Z45E*F^;%KB">#ID?VH@Y2 MW0I#/"HL?'D/UEE5([YX'8=8M]:F:IQ;#[JHZ-44"^S.A=*A5(\SW*2(*L=E MHNG=PKB7M9=ZV+F8:2LC.[!61/9:*R\V!BR8='K')ZT#Y@M/ACRP+P[JG0.6 MV,Y;K.JFE5J&=.D*6<_1,>##\\--+,J"W$138=9)T=XDQ9(,K6[_J"3%2OH[ MB-#90Q&MHY/.KD*XNRG7HYT'WNFUNZT24T?Q,2[=/<;6Z32[W)XKXGM]_81P\3"?RWY2`8RDL)6)#G961WM M8Q2C+,=J'CN*TM]#*9`/M/<1YHS/9,2#UP!RXF84R`F%]JI$K>;.VCDNF\KC M?/:2:1]T/.[N+=5KS=4:*V[M`9$G%0=>07Y[_GOAXTG_>$<)UEIL:W>H['6; M9:3<9*F/<-\'0EV(VH6_5I,[8<*BFC()=@=3\(^J^I?I[R#!/DC:ZR\9X289 MSK2Z%R:2<&,8C[3Q,?L1_KD812ORE]U!M=5&B4H^N@W'#Q%R'[C].&*N1I\5 M&=CN\-L^V@KI/ERT?5"XW>Y]B'`%3UTAT.Y8#(&SVUZ'!?L)L1<@]WLG:R%Q M"S$RYKN#<;O7[7;6L=[,8U]XCA>U7 MG+9,>4N^>V6MNW`>^+Y$%^#!+9?^E4HX.K?5NK]\IH^MF?GO+ MMP^^UKO]3L6Y=I6P<)_6S5CX,V**-<)[<:4\'8K7VMIK$=V,[_A#)N[NZ'NR MM)C;A?''D7H?N#XY^7ARDPE/=>`+8R]^C66TR$3;'^.[^6!5PEOR78?>-^%\;(^P#Z"&)N&;[6ATGH4 M&3F*(\R_[S3&?I#`Z""`1Y;$W3T"@(6<;)BA?23ZI*/<)Y"`)6[RA`\?9R%M M&2A_O2\=[1YIELN)FYCM*=H^06:Y!KF;<+=&C`5DM/YR@G4$$CQ8>:ID\.(@ M,K'8K*NTHWDU]5MN;LPP0G`F1NEF1<:PA+)7UY<;&>;;'.=F/\0<)V M-PJ[-%V?4%RWLS2(HRE`WF_"S\3L[:33=(/*K:N;ZR2LT%[I&:PI#0^NE"\>OA$!%N`6<;7TTU_`X2\^2,,#G(ILRG9S+N8;L"T3`O>:,>FL- M]5:S_H,C6GQMF=@M;=Y>N(W=C&I[#=5B=\%:*CF3`=SS\?YEP+/)[W;6$!^# M-0A'M_1B3B^I65Y*Z_'@9\%-5>ZC-:3K:3/N8U26C,8]]U;,,&RJ"6)&G&]I M==?P^AFW53=1J?*ZE`&DTR#$1)O,/+N]-2R&X#CP/,N(,LS$N5H4&9=(+D]\ M/OQ+N)(/Z_B1J2]/>H7".A;.-LI,3M8P^:&UBD6!PM(:A#!:G_[R3H;#L6LS96QUR]<]:A!=J%O0U?G;P MCTGT[*]_(8JF\-O/?\]2+G<7/]W5KZ[/+Z[O3EF]V6AWI7K&W@S>OKJZ/F5- MJ=S_9A%S]X@V4D!Q4B*7-]=W]#ZZO_#.ZN M;J[9X/JTDLDVD_>&S/A2OY&;KARSG@;+:=XH]H8;;YI?:9T0EVX-Y&)CB&8^XXKQ-#5@D68Z-LS#':DQ4'0B MY.+C:6-XQIMB!Q\]2M+`I2SUJN7<4)PO9BZ^-F][+14I_V5LX9>U3QZWC4CK MS)#]R_U]TFXWG\U%]D?K&=.&%>YE!`J/?,NFW$*^&2DB#NGF2.HZ'DSW&60S$K*4:&IT/)FR:*[QQ9EKA\9'X34_ M]B)&&8@4]C3W)8BP]6Z-AYJ(,8XM;`0513HY. MVIDL_Y)I18Q`*G_O?Q&`H>-OP=',GDYG-):!A"+!E8%9@?$:'N3I05(`L8-1@-P!=B>0>(.`( M54@;\;C<5R#$6"IIIZ@/)S$(9W%P])A*^((]QF/N04J*M\2OL9P1C*(8.@9[ MEA-%.`K7>+87!1QI&PH8W0L;T1NC!?/U7,$:5?`PD\78/R9^?B21[L!"?!&B MG:(E*ZWJF<$P,I@:\P*!$4[Y!3M(K(!>RHRE!IZ!WF31=\M.$)7Y%)SM$)[U MQ01,D0AGMH(^.1)H%+Z18"]L$N@1.2%,-&?W''%B@6:,YJ,-,,K]9ZRME0$; MQP(L&^*Z8/"8<@'\P9N1I!+V9EP2SL([:N4E8T))"^D`=:AH**&Y1B=#30W%T&` M_Q]@N05%OL??L(C$>0+S@E`W93A()5``T#!2X"O3_;^>#J)AL7!-(*@ M;MWQ!P=C8--!3.D9S!>VD!M<>?\*)@0!!CNYX9:;^01\@"S..)JV@2L^/)?8 M!%EM;NTVQ_UE6X.WQF#*"E_G`7B22F8:&*T`Z,R8GJ;Y\6D&MP\!(P)T.44! M$W-MG1<]BNG$4@+QQ8QD5^7N4C,YWJIF,ER$(QUL)^9)9UG,KZ=D\CN45K;- M2RL9*<%&EA!_4%+*(&.>B,AEV[F+Y*Q&?(*1'!X(1#W&X*DJ+'S;B) MG)6#UW0IKB^%*D MP4XX+%$>5RN>JVHTY>)"'H@:A>+-GQVC6D\`]=D`:HUYYGE(4OE*"E_=[G+A M*RMYP726:D_EFE=>;\RK7VD]`Q;IX&AX#=?$AIILG:V6**1+G7-%[6$ M>B.#U/5<">,8Y:4Z%FCM4%,7PDXZPZLA$F>U%"XJ,:(\&]SWX9=U$4`)*E6" MJ',0F1FW(S.&^3?O150J*/$XTJ'&,=107HOGW=/HE/TM4/^PL*>J5RA\C(J% MX%5+1PMS%]-$;83WL32@<`IG*%AQ++7TKU:W6<.R$-J\0,V."?P=;=?F@;&; M3&Y,6U-+@7)E2/P3+(&?@/WS`?L@F'#!;AT$+RV`&^Q*L1LOTJ45DS/M/NZ\ M1C+09D6A M8IV492-T)K@3<.`S32BY2J'K=*&X`LD7\4%*2^'#B8;?FL[WJ\BO,_`-DBW* M=-2(M,[I"UZ:NB7A]I8:1,A7>IZ4T&4IF1`!0"F,`6Z>4NZQ?^=@[BH-9I'BJD*0VW@)'%['&1Z M8;+#5MBQ*O.N6DIEP'N5!5HGC4X7N[%60=UQO]'M?GYL_AW"!>Y+0J:#,X`F M.M:!U#1962Q$9S02)P"F")>.[G&;-HZ\4Q(W,:E_Q):VO=\UAL6%T;W4!*'S*91RBM5N9.-O(L68^Z9?KUG,_3?X3T=X2O=QM M6/GX3*$CZ@SNPE!]]XTKY=\BG@#$XI\WXTN`)X5X2/."'F;/I?4"C=Z/IQ[R MG>+DLR1TM@0_9"7LG7B(7@:%XY&]=2W*U(WXY^MU;/])>QV'[]Z`DG_&[L;A MU:OKJ\NKL\'U'1N7YU=73PU/>XK[TMN)17CBO[L6F.* M#O_4G;5MPP;W/-=8GRS?$QUB+2+%2-<:0"!92(QG^-4_DRQZ@8CQ*6VCO')" M_Y@)IE9P!YLK?7K$P2B69H'N+!!;!,E7@\%M,4@V"HZ*XL>*PZ(ZW=)+&=3S6,J8[E!E>9EK[D9E%CQ8,N28'" M-54,&X,&Q'#V.GX0L/*#1)4EZF;:!2N@Y+OJ+XJ%"1LNO.'JN?`J>SR=%G6+ MGM1P=!D)*J')Z)37EUO$SRP9*Q4#+'7'!)<X25=\Z)+F#%B)GO4W?OUO'#A0$7AK%_ M;C7PHA]AE00[Y,BW$-?!\WZ-)?@V;H-Q]PE:K`"$_#VX=SH5;AT!R_)PEO;: M``CP\=@MMR&"A?390"SMZJ1AU%TO1K95#$`FK$@K^3$OVBNLGGEOSNS">+^`.[YT&EC+=HIJ#BL@1W>Z!0Y"CLX&$37YZA@>(6&3ACWL"D_#:ZT8J"G+H-Q'/'A" M8-P=PW]-LK&"90*?84)4AA'@4SGBD\3F-GGN^M!=RU,PT#KMK.`@DJS9;I8" M5?(-+N=9*(,`00-;FXO%G!K>/\YNHSS?'#6:Z04\J&`QI0*<"A;%0?V8E#,Q M3\.L"SM,74T39DW3'A]VO-*>8BHO4I\#GFEZ*ZWYSET1%8AHZW8OD4:Q+=^# M$TZ4=XGQ?G<36_-&NXUS:%1^H@;EA2.C4=%(ZP MY)HL-AT4MP#YC#2IE5BDVAO'"ML/?#&*BE-!%I2?/J4HX[MOT1<'>Q[3H5.: MQUQ(1>7Z1&>VJ#5+BBCM!.;!@F*-"\%N1\O%"R25G77-*D?E/!CU6)B;7*7< M4M\<9L&DWIQ(>?XK88\GKH:ZDA&>-5K_XI>"3E\@8"Z%G&*4IR0OP37*"-(4 MP@`.@OW3UY&MRW*2(S-@D#RK:4%^Z,6P``JQYP?NSJ>PK`%KHE4D-4ERVN=U M93%(!3 MW+_PPM!7'72/@&/NKKE6,63TF\SGB^P,)Y">D2M1WU+:\IJ_XH;@O5=Z'@A_ MXB8NIOH8."Q/_]FAO-"6KN+UG#85`7>4+BSM/3UQQ5*8=P!OH=#A:8S:^'D1 MNJKH9(V[/!SL%I!V%D?8KJOA%=RFSS$:%@>15.CY'/-;6ZD99PUSB:I#;2<*GT^A1N_9/HB7^&'`E;BODV]`=;GF&-3[UH\@I0/)<&0E1W@R.S` MQK@!2RK`"@N1<]O&*6B5U9M.!2QW7%*\.E* MLNC2$`P0H]-O$22@G)3_L9\;_V$5+Z^Q%VK162G#!O_?WKYP*:"=] M5(28S>@HY0VAU@WI;4 MR`[`)[.U75ES[27:222I9]46V^ MJVAZNVJ\DZ)8;U:7!^\[N`"")I-)LN,/79&)EBQZ>KS4H:(7+5#)B#6ZOV!P M,JKO#_N68]:Z;%V@Y,72<1.1%BERSRR1!NN+$*+0SD9*.T?GGCF"9:8L$8$6 M/1727.WT5`X02B'DN*@1.)[*B&;NPH0XK]:32,X\7Z*JB8L4,8R9JA;'_`>P M#BK9U-W).(S(\Y614Y`"?9P^.ARC5(:L18@@/$&3@0`,101AGBG.@5D*R:P8 MN74\#`I$DXAO@*@#'GKZDU!D1P]+W&'F%,XS@ET":336'? MA!<+(U*:R MEW0Z>L1I,D92XB.-U#XQPR;1%=FI(NQV$N67RR046:22-E_3IFOBJ"6F,AX4 MBXM0X["0X`7@`^'ZP%HMBD>I/.(KQ)B7"A"*#(PPKT2<&W-YK#)K.+$Y)LUQ:#8VP)(Q8 MD<$<$?4%>6Z&,:``8T`V;H2)C7,RV5I<]-*3(0WB_,F#D6^.93W$XGR>,`H9 MG>8C71#KCR"*MG(:9>B[D1_L`MW)ENG2/#!M(#L9,0V)/@Y3H$OI)\XXC__, M?\].W=(CF!92%+`[-^+M/CE74*?^* MAV231U)1;DY\G)*M-WC;J%=JM1H*W6)'9-4H_S![$":G$VD'GHP%D8D*]G2# MS?"VW53>:1BH18<,Y)*7??N&^NB%QD>IZ?=DWN%.G.L6+$HO%_PN.?W MZ+@GKN+0KD4=K)#0BCV73=TS">?C5`@QL@03M<@2M,[W=>*3C%!K(M=5\B+R M%2UP0*79HN0Z^3)^&-;G;6[N,M5URZI!*-B!C`E?V-%G3I\9+#=U;!2Z?/&9ISRE2T!!CTN&?+`]$!;\5+7_I*>(.FC& MTB9\-7-Z$X\>'[;*P&YTTO0$EH"+Q1OA25;HL.*)?V3(BP//L)HB<5L%,/8L M6(;$Y&Y\\)7JSEB)*BYC%UF6*U=26\9$0Q&\'T-TW_0R)WV9U24R.FHG*:K< MHZ-QD+_4BSVG\##6##,D,5%:GFH&CH@5Q_U/1%X028XO12O0L+VH/(4-N">I M+T*C1?L$/,^>JYT5&+LI86I8VR%'`AJF2UOTAK<5'R("+>QVPC\.0&'@SL);3\X>!:V6:* M[W]>7S[^"P>KO?ND?;Z]O[RZ/[NXO;GIWCW`'"C8R8$1M MVQL1C$S><8MPP_OS#+?_KU#0Z9*="/IOS7U?77?ST")D:OZ=^MZ/>[[N7E M]?>O9Y]O'Q]OOPF,?=*B+V^NOCR&7X6@MQ'RZ.?[<.CT*X^W=^*;-ZA]V<#Y M]4W/]4&MQ9"V,X`NM6.]];8.VQR(SS]#7/3`Y)A9]#^UF;WLMHJ_TDT/"N/2 MJ#;71::1BTO1?:%[<_T5\&F*1.GDQ?M6Q0GGQ%.W856V32J\Y7/YH/3*\>F-RA.JO4=(3-?[NP@TO]V^TBL M5=N[PN(<[@_%-\<4W_G26SRR:3P;E?KYN>)^Q?V*^T^2^YNMYO9Q?63DN@[O ME\"V73?0N$^C]7.2E1%>'K4_U;5F.*1<=+DNB\^*1VPKMK`OB:E7SO6.(CI% M=#LFNN;VC?0M!:G*17(ET+\G$%OZ$J5)?L4T2>5>'H54W;BY?AC"MY&3M:'H M5]'OP=!O3JZ?T5Q.Z6XEG+NCT7W MGH!S__/Z3GE$1R%'3]0C:M44_2KZ/5SZC5N"&#O`O7+MRV1>'+)K?YON@7`O MNQ\H3VL[$E;5C)9&6K\W\NH^5R;S:KW=1&X]"E*?0E).@9,B\0,B<6,3$8S% M)'XP48PB!%X"\^($HA>ICDT5[#"G7,&2&BI&U0!I(%KBV1LMG5PM?7XS\KUT M?M`F4N[WL'5(`V:/^"[86[T<]]3V\]5K<9`A#W=,185QV M%!8W!%!'M`[/7NF'C=:?\/IP<2-4>),&=@J/;F"L:ODD%O=35BV"58O@)7:L MMZYZ*6>S'M4`2_4K/?1.6*I%<`DV0;&<8CG5(OA8>*X$QW/*F%.:174S50I% MM0A63*68JN2;K(RQXS;&3B!7:L[A@\H7*'&]C&H0N@$DJ@:A,%2STFZH]L"* M^Q7WGR;W-^J-[>/ZR,A5E1CNKSUPP&P\@M^CQBI=K549"[>/K0"J63G?07ZA M(CI%=#LGNH,IN3MPM7L"X:0;XEC*ESP*67JBG5?JV^^EJNA7T>\ATZ_RYDME M5ARR-W_A.I[/`U-49UP[6+4PX-13#8%++ER/S='2*ZWZ/EL&*J([2:)K-^K* MNS\2-7P"WGTW\%WE'1V%+#U1[V@C??H4_2KZW9=WWU;>_6F9%8?LW7\)N"-: M%H@F!%_8JVA?H-RL/3)M2WM M>CCB[C/%@A!UI^]^96M9&CZ4H7GD84A]H[W]:*[B&<4SBF=41..`#:H#BFCL MT5.F[W=Q?DJ0*SQQU>,;81MJ%:0;#P!;- MI2]3[:R5LUDF4:Z*BL,X7-`[[04;',"BRC-W=S MN>FQA6F*,$P)#*H#"L\L>:]*!=[?9W^S4W)H]WO1V5;=VP-JA52N&\PV>UG9 MX?58TFN5EK[/HT$E@)0`4@+HM`50;?N5#Z<6\I1_JEL/E[^7W2?.@.&M;%UQ M']XTV.K"P[EH2UTCF+WK4#@\T=U^(\Z&A#-[C+?\C>`QQY<7"OJ<6!1^^M.K M)NO4ND.7^^R_:]^0:+,^#>\5]")0*ZG??5?KY5Q_V&=]G\87(*;@FEZWNKQ0 M75ZXPH[UUM42Y;Q&0%W-H6Y26^8LOFP[K"XL+,$F*#93;*8N*3QD/CN"(R)E MM"EMLIXV.;:\R;)MK+J84#&28J2#VEAE=!VWT56R1.=MI.\L<4"@,IS+6[*V MTV9="V3/OHY:WQH[J"U15*NH=L-4:ZBV\2=6.+6K/-]M5T2ECZ_W*'E/-,?N MI&+Y>RO":.RF`N.`J/N8JI%.E:KKF[AVNGA=4>G2$@^T8.@4`Q/[+BE2?MY> MU3SJFE73NF.Z3: M(WG-Z^^OJCKFH(Y)U/F(.E'9@1V8F06_!![6-F"E@\U(C]G,'T?E%R]/E-/> M6+.B4>#U='4(IZ8[<&`Z2^N['!ZS\(Y%M%]].ARYG'!XE_7A9>J85%:'8.D\ M\7%*V_7"@A$8U83AF:^9A,,[,-@+X9;\-3-Y!"*CN1#`(V3F].FJC\=\^&!$ M1$3ZNZB2!+_G%%X2]3!#-\!R%[)EY[^3O]PN!W?+F'\`$W`[87KF42'7@[A_5' MX/G13F%1#V#9E%C$CR8`.8!G<7&XU>1%C@/D0N.'+/B`?U.'F#XNMUH:7BLA M^S\^82F40_M,E#,1@=B1Z[&H"BO%/R%-]9D#A,:(+6N_1(_VZ#=@709BP0HX M\N_+$S.?*H*V1147DA%Y)LP6+$A1N@#%5E*D";#8C#[C'B\@43%;!*<@0"`^ M#\B',`=EU@B^IJ]D",#B(\@1IAU8D23CU'/MP`]Y@XQ&0+8>DCJ2XT#R%`A` MX&_@2W@9GG'&&?F0PI,'6/L3)`#2,`+H]OM`XX)Q!@-.!^)\X(7Y3YH+<_/D MO3D#XAJ'E,J%(AK.)!K.$`UG.$NX,P)4_PD6)#KG(PQ#2KP`^8UX4FP3#FSC MAT)),`J*G'#;Q501K@62FS7<2$R)B7`/K_0HXBYB;XE@6*5ORXT3R\/)`)>@ MSJ60):_X#@E`5W#0&IGE/J4DC.3<$"`/182+O>4BK/DYN!90TU24F@H<@(G1>TI%,7D34PL2@1*P&7UB"T$ MKO>$VT1L%RD>P87?TTM@F%E$P]K($8@E6P@\L8`7-X`]`\H=D;%$F2LFFL`< M/C])T4JLS0^4Y>%\DK!F;SBRD6G#\ZS/0F*Q+$&`(/)_U-ZS#PD"0%UX`?&PECI2ZT*OHD[D M:+2)">DK\WSO$[R:?M<"E?],P=!^`BYS33-`4U$\E'Y*Z'O.S%A$FJ#K@T4+`QT,@!(EI(@A(?._9\^I4;!&F9III>,1&_`K1V;XA]O#EX^3=S<$ MT@7E:&8A"MV`1T04HE(0"+'$/EFPWZ"``]_EH,`[@7(5ME"8\SB@["@@?3^4PNB)"",JWO]DQ*H6"8X^=X<3<`$X"&STFI>V M"#,_`"NX8A5IZ"L3MK`T?R).BEUE820(6P,L-'1D\E@(5A:Q9MJ&"SFK*DPC ML?04@TZ!GPLE`HFFH0G[#.M"T`2@TF6-GP.[S;8C2SC"4LA6U+'.`H_RBO3% MQ93`D##2Y,YE)K9<,?$3$=T4QC)JZ(S@Z?13#^S!0+#2`1:_N!=>"(LQ1)L]\:@RV2`1?BR5(@=H7HP M!B7L\]BA"L>2#HF&%B2R-J@U8=7+YZK:+;#3'X$U$..C8\ACAU3HQDAOIJ`` MCH[]9QO>L+4^,:5$P@XJ5#"[%;I&J?"9,%3A3UC=D(3#(C=+0*O:ET!>B&H! MC%XFM")GH-2^97JS*OBUB#B&.P:2AOX5,!%NP/$3Q,&*P.N-@Q9BN4H* M%5;YZ/?B3H-\_\(&^??G*LDSUU8*35C@!.PQ!$:K0*/4F3V,(`-#)"XG,`CP M&[)OI)I'\#2:$M):L-R1GP3E(B6-(\^B\N7.FO[Y2^"=#0@9?;SE`^*$&:T7 MP/28B"8^=!WK+@7+;?]+%!)\B"."E\PS@?5AA?#T`P,CI\],XOA=TT19"/QZ M!^.9X)4_TE?_L^V:?_[V][]IVC^CV1]\^`I#6B"?L(6N/_X.)E4R;/R:QJQ? MWSR20]G]];>:E"\K=-4UY]F@ZF M!81XMYZ\.E6_M&5AS^&X[MWU8_=&>WB\O?C?TLB!@Q/X9(2C:((-M6O/ M"ZBE)/Y2)ZKR\$.$7)[`9=*&,.Z3AYX5R.OISD(:RJF*]H+Q!\0RN)6$R_,L MTQT.T<\4>T"\,#;C'5P7N4(R<2F1^#`>]EQ[.2@[]6DH#TV.*94>%^C39X;'YQSY`@]LK(1OY#'BDM;ZQFE*L8!B`4L[KS0[[5FR>";9 MZS5!]J,`X^&.B*J1]#%I'$0[3N+>M]7R>YP0TX5='(YDL`+EC;1C;N4WRI!9 MT9`1#JLT8')[MJ$-HPL;9L"![#%<%>(^C%LGPA^^`.XPGP@VYW62#`GDL7I- MLD_"=2(`G>*\BHP]I[OYHI4J9CT3J3]]PKCD3S'`VUJUK8%G9^.1N?8S:10< M9CKAH&,#@0]M`A_:"YB0">;"8\$H7TJ^DN3Z M?;8)`/%@@@N.F!R%*3$,6_G"FBQJ5S`H%PSQLX-G/>+@SXHSVU(GB21AQH.S M78^L`W*GL7YQ9:>AVNFI+F"J.>OAM@-;IJ_>OXD3$#Y.-EIOJ-ZLA\%FJ?#^ M_M3)VC4\OCM:I'+V68S;Q=/=`9AMS/OSK(^67ISIB0GITTZHJC14[9=*7?)G M5(U-M$(XK9*_*2R^6XS"4LCGV:KS0`1O[).+&W_>L_#NG@_[E+RE:U!31I%Z M#%UC6M7:WD1EZ3K&'$8+NA.V57]W;>++Q#MEEAZ%##TAL[2A5Y59NF.S5/YY M.!THU*GZ'D[55SO1G87$J\B,3Y14SB'1G+EFC"L.PB9.`^6IF3Q9&Y%Q6,U" M.8U.].7Y%]&>$X4I\^V3+'P\DGQB,!)GIBB"QR%%`9EWG(?ZBK<.G[<>*1]N MAJOP"-V.S\(#3S9$D4OI&$;MD\>&(UOFL,LN,?%O^B=1E<\\,_`\F;O^T/VL M?7=3C0'T6EM4#M)G:KNCS-6^40Y][Q M5.T+GJK%O3SN@:0_SINY`%\!6Z%A)WL"S3C("[SD$GJAV^#CF%';BJJN['&J MK1$\^*/Z4-4>N>A$,];^2[E[9KJB$%ODEH;UTYP."7-$NA7H,0W+&,$(I4Y2 MBIW6KW=DDJ5SLC84KU7,)MY"Z+<:IJ&S6WD]8E/A:RHC\4)GUXI",)8MA M;P?@)/8L^T-Q?A3H" MFCY.BOWK:'@>)2!X1FD"F,<.4MR2C?I$KRCQ"PH!SWRB5F#3N(?)/!150"@% M`H:P@AJEEIQ-M+[P,SF@5:TKO-]YR:?"N*@W*O5V,TJ_360:)L-*.T&.ZDW@ M1"36RBSW#';C/-E0Y#GTQ1Y/ESE-)OEJ[V.&%P:+&W@$K1>LKA_Y%2P/D6_C MZLB'CQ-,609V.,WDTL;:)U:-U>.C94W"*NL9\Y'FO.TWM=1HS3[UVF9RJ=%Z MAU7O*`3@QT;I]GN91%/408JQ%&,IQMH\8ZD<[;*RE?QS%WDORBI3RJ,LZ%8% M/^55%P_"(=_@[N9A=@,6P5(&P5S*6L\R*-_NGC3_;F^GD9$3&]`HW;8OP]0_ M*:;DR=Y-/:[](M<0IM!GO[P*@W4)I=QA5HO2KHH[E795VE5IUU/D7Z5=CT:[ MJOC,@<5G-EJ5-".&L\^JI-O`]WSBX&EE=+RO&SE])Z:W394L[>_.WNW8'>J: MWH)=GMO;OZ57LDX5#SQ`87I"G3W+84DJXBTW\1Z` MP:`(61&RDL**>(^8>)445@=(Y77R#O8`Z0)[@=DVM0#%O$^9OU<_[JBC726L MKME'==PI2.<3I7`5SU6DIX2K$JZ*PI5P/4K24V=FZLQL>Y6G4_V153CL*"3N M"<5R53FH(MJ#MB94V9^B8"5V%=$>$]$JL:O.S$KHY!WLF5ET04]XNXRX0X7X MT]?;J$C8KF.]1M5HPJ9;;@![HN*]VY/7^OD^#8ZCINY527-FA7[I@I*;**-? M%3NS"^*71T]YB]5UO=IN*T94:N98U4Q=J1FE9I2:V3<;-JJM\[VYYZ4CL`WY MW?)/]![WPQ8EO,7W45P.;]ONB[B76MY.&@R'A,-#>'U\W^5#(JYV)3TWP"G3 M=^F2^=?,YE_K6@GO=577NI;U6E?]?&W)<+XP"GJ*EXFIRT[60/9N,P[KG7VX M!C!KBF_.2[?;R]R1$$9KDTU/)]\H9E/,IIAMB\QVE9R1[)#9U%4CJR`[Y9.L M:LGM..U^EB&XW?C8/HW'99CNGCB#U+T^;G^*_29O_5GK'C"E^(Y6\>U%[W7* MM[_'=*'>7B]94[Q;*M[=WD9W3O,RO5>I4>5R*X&@!()RN97+K42#$@W*5CA*EUMEG*R" M;/GG)C).U+7'9:B(+^U]R.WB]R'O8B/;RY;\K+2Y6ZT%JE5KVIGV%J\HTU;? M]4U91ZKCS&X8:*;54@+N6>SN'/65D8HU]JQ;#M!&*&>Q[4ZVJU7<$MB`6[;T MOK5**]1VG^'5# M>?I'SQI*[RN]?TIZ7WGZIR#5E,)7GK[B#:7QE<97&K\,=RBJ6SCL;?90W%;_ MW@-+.]I<`M'R>#O`+!]P`0Q,\S&,:J.VOSR?-1.9R\7L:^)HEKV^P?*`?:F? M7=Q>IBAL?SJBG*;IQHS,I;%37@-0R'G%A"5@PB,6\T:UM8/+:A2-*4&O!'T9 M/'W%BBP+>V)``@]2AV`PZ3L&4;OC04@\N)`[-`"-K4GOZ9AZS$+WV%\ MXKI!_PG`L``1U;7(ZI^_!-[9@)#1QP=<:CCWU5\!\\??79]>,@]Q$7#Z2%_] MSS8\\]O?_Z9I_XQ>NZ0]/^E#;6N6V(S/ M.FM5HXE").^T4_ZV:1IN3&_7U,CRW7KRZE3/DSW]-7TB.P/VZ77?W':_/X"P M_K_=SS=7I9$HFQ1R;#9.'O_O#4S/0/HP,X2H&+R_@RP#+M-N7.)H=V2[!"D\[%&>0&=(L5VK:"]4$RV,0-B"8G`UHF5031Q+>Z!FP$$J M:EW00'0(/VOO49A'1I!1^R2>C7^.?]`_?0`CQ'_2+MSAB'B>]B^7L_^"I/\2 MB.L`Y??.N*+=W%Q,#TH=*P):#E;54!-F)P,=Y3XS"S#2=SF`+W6=C<^8[G#( M?/$0JK!FM99@`*2KC3H'G@$E)U0>/".'%JL6?WZN:)2`7@M5+!FZ03B846UJ MX1C5Z+474%!]6!G@$E14I$G=>1L@IAH21+BGU<]3\,'N/X'*Z\/>B+E1X^', MQ'HFC@G*+Q%.$M3T](ABVN,!X>/D.;TMYM3%G,3VW-3$VL+YM)^P?B`+MP=& M)OP&RMG51F2,9`/DX\G[?(GC!$.-_A7`'L#O.!!L%,%!8:SWY$,*'..=!COV MOC?QW<@.I-5BL7X?1H;)P9CP7]">>,]2#PN#PJ$2=.WF^O/MO78/4U5P^?$2 MI&'"`#4,K9(`]H0")5ID[,&P0#-4/-L/*1*@]`)XP8ZH_SU+SUFMU][%J."P M3L8E)H;D3YJ@PG7L,2)G*$PP)$PQ!^/PF\,BF(4Y(^@KGDUB+GX3?@?J=$PV M@F_!L(O&<1"]3XP#4^:,E*:-KI,")#;'Y#8+C`A$P-LOP.(^H-AQ?;3Y^MP= MBLDD%P(;@YW6@W5['J`/A]`:[S0;,1P.K_5IABI_XM83QQ?/>I$,B5$44DS+#PEV&&H:Q1>CD--83L+,8N;+T0Z\[P@Q/LS[.F8 M$MA!PG$[)A"/3!R`20\^@*8W:I5:K28OY19$@1(4!@]O_>Z+%T.9C2(.B#:R MU5.N0J/:J$E)S2D0"!)9GX`9+[V5<)00&D](+?`NC&G1C/P0D1U0+EZ7;:$/ M$),0?1U1!Z:.&0.^'T83"$9`(H0GV5`*K*>YD`1"7.-7GVUB_GGV8()3@'B0 MW@DN$!\8NA:U4P\G]Z<#;P1#Z:M\+`V9',D5YCMN'MJH-O=R3T!CY5A-;RUZ M6:H1Z%RR[F6I:8,AZ)E;L&80^DA[?.Z78_1E&BMO_JK8$N[P,BR5XQ`8E=0' M\`QVR&FJE^XJR$[%%$O92W>>[MI',9WOCA;IMWW6M%R!$6FB=9C?OGYG2DW5 MFNZJUG2E:M]=EYHN5FA[2R\3;F3.;5"J7O$(ZA7G:(W99L"AB/9G%^,0-O/' M>Q3P*G5F"1F\2Y.2IVOKFY)+QTN&QV:.M7V- MKHS>78C.C=M'Y96PW\',5G:HLD,/1-+>,^_/LSZGJ0-B'MZKI6S1\@K48[!% MC6J[H6S1#=FB\D^5F9P"J8MI1&PZ$\&?RM.2>0F.&7#,F'E;JS:F3_S=OF;1 MGB_3%V!,#_,#9&(QB$WXK4_%VR*!B6-:D#AV'[K*A)6-> MN`X@U6>8,?`08!(`9-Y[@3*BTS-RWS&TDEYQD-F9R73M]YJZ>R#$6* M5%P#D&2%)3F)[7?:`W68R[.;DMXML4&:!FDK!E!LZE8$I MAQ$\&8(Z"K@7A-E%!&&UPBS2R1&OHU_2HU:R.:A1ME_@"4[_B:DEVA?"!Z[V MF3A_5K3O!"4-++[K>:[)Q*<*I@;Y//!\*C,`<]%;U7+2IA!$7`?F.4820BPQ M+SWV)V'/,F\*,]662985>,-92)G)FRD"),9\T*Z..4AQNLP`GQ"KOM M23;STFP6."+'$9-O98:LP'2HO3"+C0/IIE_!71`V7YA(.PRW-)4'25^9YPL5 M!YO9#P2E17.'DR&G]6!^D=2*C_4PUR_6@IBD)YR-4$`D.;HCF40/`PW9&7X% M\XZ%D`$52[B'+#0A),3XTZD+>IQ\B@=$%9$T2!US9NZS'K%B@E29B)PSI91+ M%-.)P&(.\QF(,3FOAR!&>Z6WC6I#KW?F M@8";^587*9MY^B`489BD#'9W1%WIR>*<33("`?,JTB0!O6^;U4Y-C"XFKR#5 M_@$"4[QO_0$B5L@+[3JSR@1_D;"#"W+&-9K55:Z6WESFS M=SBT@H4"0\(%-'"*90#`BNF2B&A*)*[S3K4&_T1SIF;"(:O:!>PB01S`7H-T MY&/8$)^=6J$M,.Q":RS$)T$@4[#@ M6U>OH0*\P-HY3S#PI`OW<)5E0CF%=$%\4?7A@;F1;P/-*"T1ZLH>1R.(=Z(2 MDGSX@44M"BR+:*7@`)FBS@2>Z08#4"\IW-5"<[,T-'1HX9YO('$&!&A"U=VN MDGP4$^6MZ;O97.\XU@-V%AV!WO&U:]PG$`W54;6;47F3CV3C)FCAH&D,`MY] M<8`7P%0'M99SU*HVXLK?5+GC#`,AA?6<[:GZ:__% ME9G,E3@&]F_B3)3*"SGT[\#.?!?'N,2O*8?]T9,#+H3^+BS+!_KG?69>&*$"6X^K[_;%TLNEZ"4]+B; MT:PNV]'NA@(&O-O^#79XR6N`%_>V:ZC>=MG;NPZ8R=?I;7?5?;AZ.%B7=`<@ M_:0IB8%-C41()9"^CZT]T$'@6&Y%N^A6X,,8Y`)/1T^^RW.-S_(KH]'ZY%"P M\;^"B"/..!U^$+Z2X-^)8*J')X*8>QP*&!;E,`3#(>'B)*%';?=%11:4@E]! M1JP6>)ZI_>$9T-H.J,TOD?Z;$UY>6C"EXW_(&0FK)7I6'&!ZLLE:-L37K#3: M3"DS131A M$VY\>BP\W\!0+OTKD+*##&G4V:\+/KL].;0NDS.L=$;!+$#%U+(WEPQ)")LD M_ST\6F3BR&8BHRYT_>M5[19/V:60DTZ+.&V4P>&W>KU2[YR'>0_U=YK,--*H M9Q);Q#^4TZ%D4JEDTK5C,>*D!5)*F&Q".#V*8U>AZY>11GJM*;ORI>11X,DL M!4PD<@(8Q`]XE"=HX7DIZ\E$G<2K`'\F;*UH!:;OY0LNH,FI6*A1JW7BO"4_ MZB8H9(B0#=*1RGM/[RP0#H98F9(`2@*42@)DS>U8$&S#,)F8:AEQ,"4,%A@G MZ0A).I$SLC20L=.CC/;8X#>CG M\3?RA\LO1,8BY5[7L;Y2=\#)Z(F9\B1Y7D2CJ2(::3K-.=$Y'/FQSCEH]]^W M]]K%CX?'VV]7]P]:]_LE(.K^ZOKK=^VA>Z."'8L,FR2!P8PX41Q_!J(1M#R^ M%'V_AYBF"9+&`0G&)0M'*<0C8!?7PIQ-<8<)M0XN-E'V;KHK%OBV:^M6^+9K M*Y?X]M;;NIWU62U+4?Z1MMO<;UM;H[6?1M!&ZQT:)"@$X,=ZZ?9[F2:WCQAV M3C;]FSB#2SY?83PK]?-4W<<.F5)UP%T%V2D37BD>I7B.E,I5/_5R[/`RJ@:] M]0WN[78:#\]I@Y?:T[ETM9Y-4;Z]/6GNW=Y.'S`;Z\KJ*RE''8'5M\\F@`LC M1P=@Z94AP+9O+5Y:PVR_=Z$KPE:$K0B[9)9(R^G&(SA-RC&>NSM`/0P5?*0_].#3U"3DYQGX5^J%2;9GT_@E1:QG,@T/US#=D1<@_ MU:76Z;MY`R[:4N`U1N$UMT-BB^F&ER$?2N2WA>#N/.,N,`([\E[ MCP"*AD'B:3?PB&/)RY+%MQ]4DXO]-KEHK.T_-%9G_;(6^Y35XS_2VJK]5BLV MF_MI9EB-^SQZ^^YR_TGK#BEG)E''&'L]?-M-TX%J?94M MV(Q56+I0_A0?O"WK=M6J[:+[M0'-O_S&S?+>.+.\A]$=O=I6-L=>4B>4K:%L#65K;#X9K%Z@)84R-I2QH8R-K1=>5.M; MMS6.+>.MW+5H!8YQ2QZ-N\:PK$/DK;![M(Q+5R54QASWE:J%DG,2HR0"4G65 M+3F6CJE,31%;R;&DI)PBO`,FO),G-E6*>WKY`/4M>"!?*8>'5E'Y$C/_ M+@L;RZ?CIT,]BGP5^9;:4LB)3N:D(2JB/?$B\@.0M8U*JZ,.\96\/3!YVVKL M(/5$'0>5PF?;R7'0-IRQ:Y_8^W3%5)SJ^`.DTY)1$=P1$5Q9B4PUP2RK'W-L M\DRO-.O[#`B5CMB43-M2[J>^QV[GI3OG.5!?X=C/=V[])\I5N*9,^<);;A-0 M/'%X%S48!V)#;/^6*\4RBF4./:AZOI';X*KU=A-5XBGQRA9*^DZ=1PY`K;0[ MJG.XTBLEXIF2\HE>V\A-WXL5BSJP*X43OG0PHX0E7"K!?.MHVG.][3;[9!Z( MX:*(7!'Y>D2N"%L1]E$2MI+>BLB/GL@581_N.:PJN"OL+QK;:,`;77NE(H$E MC00:5:,)FV^Y0<]6W?$.H#O>+O9NC59YN]B\\G;(TVNJ.O/D))TZ]RC(*[5- MG*C+;3TMAMGN@;HR"91)H$R"C:5!5(R&2K!31D&9N$49!2H9(AL`DW]&U[8O M\\S?__;/7TS*1Q_OZ3-U`OIY_(W\X?*+Z!;SKF-]C:\MOQ>WEE\RS[1=+^#T M$7COL^V:?_[V][]IVC\#[VQ`R.CCM6/"NX_D->=)C5E`HF30:N$IA(/<>T_[ MO[ZYQ)L+_Z._^4U01/H.<5S[&:+DHPQZB<]],F3V^.,_)I#YCXJ/7U0\REG_ M4SKFEXX/6K.X)@ZOU8#PD(SR`FSRMXWKE^K41D^-+-^M)Z].W5NVI[^T96'/ M*1__?G'[[4I[[/Z?&81>PN#S[D'Z237"@2."WA_4]#7?U7Y4'ZH:<2SM`@16 MW^4.(QH3?*?YY+6:VIN'Y"6;#9E/4=P2/_!=/M;HJTE'V,K9JV@O7IZ?K4HIS8%?$J%1,#-Q-;UIO++XC@?_D M@%4$#@`[<)DS$(_EPO-$M;"1M:V%HD][H/R9F;2:2^+?7>V2]BGG@#\0;5K7 M\ZCOX?HS7]\`B,R6BT1P`$8[L.!'(`PWX%J/V,0Q82N?*+Y.?&WZ]F\-9:$< MV:3#'N53O]:FI87BEABD6\#SR+69"23B(?5R:KH#!YZ`78`]IYZO$=/D`6P+ MIS9!EH"G`B=^SA)$TZ,.[3/8)0`S?I&^CJCC21:`OX@MMAIW=P0_&_VL_N_7WW^^-#:5BYA-+EVD&^<4`Q@C(!_\!_$MJ$@VWLH8RP-(MQ M5)MN'_0"R@.WK]4KNM&LU&HU[8>#$@7\$1S@F8)>>9Z0\7C=K]#&S/-01+V$ MS(PR:A2`LB`@?HQ*O5&OM)LU'!T5BRFX']8'/%[5'@&B$:KP)U1"])5RD\%; M(P[Z#=]`B.-Q04B^!5>K)E^+OTZ]*<0!Z"JA3@%;&LR$^K8/"Q9C66@5^$_P M"`RF=VKPQ=A+_8-XI2CJN3KZ`UQ*%1:9ZW*DV@5$$[GL!KBK:0"E%Y4DN8DLQY!JWH MPFX`:>+>"G,11WR@9A!:>W<1U78'G-(A&'.:N-Q9O`^/P]C_)DY`^#C%!2UA MZ2SFA%;C')BKDP(79P=E.,(>P6*\CJ&W/WDY+!(/^$2>4:7G<,K;5K7>3/$2 M4N@D9PB#%)]AKH7OI&@4YZ2.B;3=#0;@52D+G@CPR%0".(W MW#:@0Q"AS!^+#?"ER,,MH(Z%")^RK%%^$'0^;-M]\;3W"!_#T1E*(S?P8'-E MCHOX5HM_EVY2B@I`XI#DP0\?2X.G);SN]8A5O*=G^)\74,VIEF;W[ M3#D9T.R75V%8-J&4.XS/*OVKN%/I7Z5_E?Y5'*[T[U'K7Q7C.;`83YEZ(FRC MA]YMX'L^$0?-<9*!\6DZCT&O3"=GJ;*A/98-[;K/C:H4FL=&C8JAGRL&.0$& M467#VRD;WM)VK5$IO`&S^QA*AIO5FI)LIR#9E.HO>.F=T59]=DZ!093J5ZK_ MI%1_H]IH;%VR'5OO@P-O`CH[$EGR[I[7LKAFCYIXS0.6=*VRA`)+*\Y40[K5?'+YJR/C4?I#L-(481<%D)6@E\) M?L4O2O`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`DJ]UCQ?%\JN:;H!/'0O2!6WY#OU+P+. M4:9&P.DK(U!OM!N-#&SS)BH`DE$$7XUVIUT0J&L'Z='E8W@@!J*^,EX`*:T, M!.EQEYBQ46#9#:/37'+..TY'A%E7\@9U(*5;$!*\ZWG4]R9WH+GRXL];V;4O M,5MQ\%H%,-4Q.NL!F`]*>V5,&8U:,XNKE2?M%%B_43N?D"AS-\,%Y>"/[VQP MG0`W*'%&J%^^D&@[JGG@R$*R,\W M4KZ[CIF58)W5%4PC"]WR,39\#`ZI-J#AZX>C7M``L.OKJN)9SO",`" M>JQ3GS"[%D]7',#S(AK-T/4U00032>)\KB>[>$7[+'WP4_,(!NJ-(,%7-Y3:$WHS?XJ)PR^P0[Q[^DR=@*(R\#(> ME5Z;ZX]7-M*YI]KP\_`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`-@1] M:[N87P[Z98ZN$Y"+V+1ZNS49'%PXXSHP%K%Y)WVVU6$$/?S,//CZB\LOW:#G M]P,[R@9+8"NB0!I3N2LS)Y(@358CR.@T//Y`^3,SJ?=`;,(9Q>C93R"8!+[& MPDA%KL\2GNFN/._:X"X,:N3IXV9HBA0$-T[_2)$",!OM^5%P\H[3(9;5Q6`6 M<1GTB;RI1;,5!JZ([;X><-?#$6$<@S2W_'N8@&4 M^F3<8,%\A<$K%%LQ-@Q=E'K+TI`5"G'KQF3JQIRYBH#5+!(&;]06<<4*4(7' MDJFDVP2X(JI$GXI?+)QP$8C9#.$$O$)1)[VQB%NSTQ4%KH@*:4_%P]8"+1([ M=V2<$7/-0G&=R53/A?,5!J]8$*A>7U8,+P\?!^/GAI$>LV7M4`SB0D61&_#I MG"^&<&+*=8!M:Z=.%S>-7WV+-[+ M"V8FP!<,J4V[[+Q+43%: M#-X*5-PJ<@Q\ID_D^JT'S'865L2E.IL@HDVNZQY4OB3)V_Z-ZPP>*1]>D!'S MB7V#(OFV9[/!Y"(*G3-GS?`5YMT`P$4\+WU[\**_G@!7Q.EJ-!L+P<-99HL3 M_%6<@5R'9>4BU3Z!JE!,KUF;BIPMF'`V@-%CM_U4Q"B!KXB>T_5Z>S:`N1,N M)05DL<+R4F!^J?`L\=:8@'T]8+:SL$(^71W#Z]M:V56_3TV@NJM7\XDX`WI/ M?'KKY-?GS%];$;V:W;%U8=G6R@HE$TQXNIM=VPP*F+^,8@D%G'(=L>41H=`WRB>IN:A3!L`]!MJ\6/#.4:L7)6.P=_:(XU7! MEBIGLLAG'\A>A8X;M9:Q7QPO3<=&">@X#/TOI%W=6`;6K>)U$:@"IQ,]4(K@ M]%:TI\-X5W3ZLKKU7Y^&8FK8#4R=:QOE[-2"N;/5V=+<>/781X?9O[[Q>4"7 M*4C7?LDW]PHCL6DTN/P//#9ALB&S4W"?6.B&+1-9W/G0);7CPMX&UL550)``/6MK)/UK:R3W5X"P`!!"4.```$.0$` M`.U=ZW/;-A+_?C/W/^C[9)KK^)6.9YS88Z=-OW4@$I+14H0*4'[< M7W\`'Y)(`N""(L4UY[XTM;B[V,,CB^<>#E3PD,F#LX*?__/UO/_[C\'!R+BA):#B9ODP^4R%8%$W.N5AR01(E M8')X6!#^3&,J"M)/JS]8(E>3JSA1+25D3B>_?2-Q.#D[/OGAA]\_'Y_DG!&+ M__R@_S,EDDZ>)?L@@P>Z(-<\2!OX>/"0),L/1T=/3T]OGJL/%_.CM\?&[ MHS67E4+_=5B0'>J?#D_>'KX[>?,LPX.)\D,LT[8!C13D2L,2]=.[@O;DZ+?/ MU_>I\HOW]_E#X]4-Z;3#+_"1[1.SJ;Z']_ MN;LJ,094T&5$9/(FX(LC37%T1B+=V/T#I8EJ,161O"SIQP/)%LN(%K\]"#K[ M>*`$+)7O3MX>O\L\]UV9_ZB](O>)PLN"QLG-[$I!<$';:&,0LH-*YT0^?(KX MDVRCRA9S-UZY3WCPYP./0M6)+O]:L>1E1P^9!&ZK&I`H6$5IS[M6?Y<:H\\) MC4,:%LUI9;V@EK93M!3QH"0]TAV>B[(MN?"TL\R(G*9]0(U1#2LJNA1Q(I->5I M%&OT5])M**5X'GQY-X!\@P=[&IH>3MK#5C()6M(`"5B@\II$/"54O2. M!E0I/8WH%YI8NC>`M.CM3E*$>/"PS0T#MZ`\^F^Q1/\J?E1ZZ#\"&$T';J[HU=FS*/U#DNT;E7V0EAX^;RDL:1JL+E)'JAPO9$].'+_@#@0 MAMS?4C<20/)R@'R/!R!\247R$P\7=5",75@PF5M"@ZL%)T9RR0A3O-5" M6T?#"[H4-&"IH>K_(YJ&+`Y/%UPD[+_I[U;SZNE@IV(WJ6-'8O%CM"<7>J&Y M.QU,H^/AD,#?>F5_X7%@S)"<-+D_+328WGP0,RRO/`LKMN3WCLI$L$#!U#S3 MMD;8GS'WEP_C<%AP1Y[O8'\)+\9F-'Q\Q&-[,U[0&56JA9]8K!>!S[G> M-(/IJ2 M*&SIT99RYN5E.T$]N`@6CTUQXP`K;%&M!!!M.;BH2=V2%UV0E4Y"",M5C1L[+B-=)MXV^@0AQQD&BSJ-E'8IBCG9,D2 M$EU3(NG--&+SU#!+]&'$ZST>;F*L./`R$@"&)GG8IA_7G,3N$=]!4;R^3118 M`]YL#B#*1B&(YQ?6::63IIZ=X9A0-B=HL#FD/4S[E=3I1V+L]K;-+%V M9B^>XKT-XT$,C#96PY`"E(QM@+"D(';80.G=J=YK@8NGM4"H-$O%EOG55YJN MXGRU_%87\E6PDD2PZ2K1(^17KFWA<:(BH%29IP>BJ*QBJ5NA>0BZ$HH"E8W+ MAKVXT'O%L2LML`V.CI]'5QU@CVF`( M()QU"=@&^=,P9-H"$MT2%E[%>7:VI7AUH1O,4*QX`QBP(L#;6``F(#*Q)+>K?0A3_G-6')M/-%7>;`YO;=^,-QXT5=\N?F<")*50\3+E0JH!'7D/;2TWB/?8TN#GA>LPIGOTZW5`X.Y,MG>^QZ5 M0-Z#C5ND)1Y,VR+&7GB7/NF(% MB8UGB1A[#>Q)1>4*^&2:(Q M]+FDUQ#\"R:+^[Z2E8AUV?TTBOB3/MHJ4V-,:(!S;<,#PH4<+]Z&PP$$$6U& M%)X+*_1AZ)M9JNP]C\(*="Q/U^L=E:?HWA!N_5TOAQHG]D"NDY?\_C#KO*'Z MO#IKV#Q'F\\UV0+)Z@PRL(?XCDJJO*=OO+A00U+$TUMP;6$1W4&C2+6AN6JWBF!NWZDF<#5:DX M9*#"6=AI,J>Q*&,0@#UIMFWA^:0PSN9Q=N(V>/DJ2"Q)D(8H#M._\H"%?ZQD MDM]>F19RC?7;6V*[Z7'?;6_?(+F_MD=9\Q\R?GUO*]BS;<;\0O\QT(ZGS6>) MAAJ8]$<:E!)JF'UD2OFSEU\DU;N=#6_DRK#2@C,'E1?G8$.V11R]`IQ&4)K)K8"LDH\3C$ZG]`[$:NL6 M$)X@!F'E6RW@"8OYZG$`_3AQZ';+WN8IZ^8M2$13B#&:4/E\#`2+%A87'&LL MHT6DVSG[`&5-`PLNT5R&:/H%E5_MW/(6Y]^^`A:%#>`IS9PU@8>@@WS)K:.>]'K(&L"*] M;6WJZD#_,G_CW,R*3XE9OOY3P7<+SO5A?P].=,CUA2#?Q540Y`(5RJX8\%`$ M>YYA,D9OH@'@=)O,`?H?/=-[5'-`->`#)DA= MB/YLEF_ M%&ECZ^Z@SM:!C8N54(C)FDP_U'8K%*`2>AN1@!H6$]NP;EL*9L7T;9J&0/*= MW-+P91ISV^MO88+;1'XDUF7,_0,1]$Q9'>IK+6@L4V=Y`-,M``!/FX#Q@!3D MHEZ@:FL9^:JVRZ0O]"E]4KNPV8<'`,LMGO$@T>:(7L"WU=B^3\NZU)*?*)6G M4G)]I)R&WUCR<$E$])(N)^KU'C5!\AP#?44"X`<7.1YTMG1C+^"%Z]+;%+@% MML\X$>%GNIC2]5%A#Q@[N`&(-7*/!YS-SND%A\9F>SMCVP)R]S11UNL\^'0N M:/H_/IASL4.21R/[>%`'<$\_B:.QW=[.Q;;`W:\T#GF;4<[,",!:E7$\*'.Z MI!=\55L$'&W=&[*^$2%(K`^&*R.5>A[8LK$"T%5G'0^^&MS2"\+J;0).K0YZ M0\KZ;E"]E3(,6:;H+6%Z$3O;\F">SZ=NN$D-DW=4^4RJD.9]*_/('0WX/&:& M:6RUN:]E7JZ^K#PT3C-;=;V_J`H[^8N^Y^7"4#58M^J"1WZ,W5?C'UR]< M#NH5X96&(2U0<0@(M0L:^BIR.RA)==VTEP9[QN";VG^7GS MK:JQ;EZ0V=CJL2TC;$_Z03ZJ]T$_/1P3`%O[K[-.FUFS2Z$6(@&"7*2EVI[P MV[)LVS&*QU7"S6SRK.%:F""(Q5/%[0FD\(INQ[C$5]W-].JTNMM*)`27KZ6Z MVQ-JNRKT=HSIUU;SS;1N7?1M9(<@&6/9MR?4MBD!=XQ0S.7@/%]I70]NY@?E MJ!@KPGUEJ&VJPUWGIY@KQ9F*;4K%+DX(#)$5BWL"H&?AN&/H(2TB9\JUJR*[ M>2'`0U='[@EZWC7ECL'WZNK+[E%[AD[VCM!70Y%R)9"DMNS3QT04"31 M`Z(X!4`2^]=/%0X2!.K(`G$DT7KIEHG,K#P^)++N7_[YN@@.G@F+?!I^/CQ] M=W)X0$*7>GXX^WR81$=.Y/K^X3__[W__YY>_'!T=G#/BQ,0[>%H=?"6,^4%P M<$[9DC(GY@(.CHX*PB\D)*P@O4I^]^,H.;@.8]Y2[,S(P;]^.*%W<'9R^O// MOWT].OD?\I?CH]?7E[>O3ZQ MX!UEL^/W)ROROKSB#^__W^>HO1)8PL`R>*W[ET<2PHCL^<0#3V M,"=$:)B*B%=+\ODP\A?+@!2_S1F9?C[D`I;8@ZM M!0GCV^DU1^N"--%&(F0'EHB2HEYC94N',8-VM.8M]U@IWTJ4AJ M)V0/,77_/:>!QY/!Y7\2/U[M&#Z9P+*J#G,+;?,_RPJOWR@_C(\]?W&S>)%%GODIU3>5UH)6_&\2BG1]Y-&%XXF!J`2:_[E.Z('S1(+/AVJ"V(^%D3*" MX\'->72>-C"HFK+UL&I&_G#;A$WH)VS;&([+0E(.4:M,.V5TH74R->B]T>S3 M05W,04P/JNR4\0\'+WY/1/6;O0*?W(!&Q/M\&+.$;'ZDO(!]C2^#E)N_6V0F M_L`0W@>7A`[SZ>355P)61E,-]C9-ES'79-L*!K:C3&$626&02MJ"P+:$+20, M%]1*N% MC23FO[U'%_7MZRIY$G(TN!8OHCV(*X7G"1%]9&TD%S59`:S0#Q541.0JSI1S: M;4F;L-8DX$C%8O!C$GKB?V(PX=D)N)+1)#YW&%OYX>Q7)TBJE;053^XB(,^@ MX5<%F38SN8Z*2@,"'$#!.,`R<5V:LD>Y^=N/L,938P`H?MO\>;P^#!NO.T:6 MCN]=OBYYE4IXFKF-YX1MF5`)HP5'[AP0!]:@VYL+P@)(;`Z1OR$JYW1EG*Y\ MPQO@G4,I#]I/0[_7=$E8O+H+'*YMZ(G*82FZ$SSW*$IR&Y;UFPUA05>P-[!4 M7[_#!.+X0BMU_<)H5!TKA1&;T)`3#X0#JVCKT"&SN8P+2$-:M.0-H*GDDT42 MB#4K%V3)B.NG2T[XWP%)HQ9ZDP5EL?]'^KO2J'K5WZK830^A);%[@M*._-@$ MS^VI@CQ#UOLT$%+`MW)O4&=A;ZN9$5&/J52H?Z.AJQWE!-'F_C+0HBNB;&S3 M5T\&23C"?D^X/K[+04#]HRYTVP8!T('#`-T!R>4D:-M30#)IA4< M1=8%F1*ND'?EAV*ISSF-REK6OS=@^MQ]`'KLT+$UV0HQ`.$X:I+K,';"F?\4 MD-P<$E^^ND$B%J9_H=1[\3=+AM;CK7"6]3@LA`4[8AH8;@4:F'PA-/( MY]_;BCVUO*(G6Z<3%1EV3``-M$P>*IDX!FZE!D`J5$AEBC_D$-.LXJT0B&/` M-]-+.CPO'9='V*.0:@M9.('EA;OQG2<_X,J2B!>?]5T8BEZB+5ON&3@;RI50 M#:TVKY&""Y:OGAKXBUU27[^$RDQ8!PJ6Q536P:<6]I8A`FVH`ARD2[&*%2!W MSDHL_]"OJY$355;45(F&QP-@08W6,D7T->MIJN+0Q)HEQ*N;4`^WGFX3<14= M]J"#[+.*NTHBCL[^N;/T8R>X(4Y$;I\"?Y;.FRCB#R->K['4$Z-&@I6E<#B8 MQ"(I"Z@3ZO.^AJ(H!&04J$-NM@D>9ZDL=!T'16Q-V6_OTGJ+^5R3R`?NE)R1L$4Y2]42O)IDG>%E),/C M03]2!S!,$7OY0)U<'HZR_IR&SX3%8O;@(7GB.OEAMG#F*58.TEKQ%)4>C`<[ M-)J8;H458`,XDH2B5%4#!TJO[Q[L%6`L3;8#BUDXDMZ"S!)(P0$I-/"#`&*: MW1=%+A!=[T$=8G5@,82S2;W8?G6(Y>VM*WP=YNL+[L0Z6AZ9.&;^4Q*+RN:1 M"DC2,.;^YJK,TE,%2:3J9W0C?'UN2KO"]PB9G?JU*;C;5DH^8S9P_KMC^2JN MU%K9=G0-Q6:/8IUBL'G33I!$(7[8GEYM4X]\UV.]?3FF!N^F+18T5`)*]7C= M^:H^'AV4#![H%D?UQG$>A.)Y?J;1G>-[UV'>?2AI7YW+`S,4DWH`AM%!S]I+ MW8(1H@[*E2;W).;!(]ZEPT)N6[2UCVOJNWY]*P.48;V%PZE;>$+4 M05G6E11-5U[R%VK)R%RVD,.[1H7@W M_W6<<6UUD^-[X,E!];'?RIZZL;<]0B`:O=`MUF3-R^'T\[!P^NJ'E*4&9T94 MP*1ZG#NQ_GAT0#)XH%L8U1N7@^COV')2$\,[&7'L9*1QA##OQ-M]Y]AF*LM? MJ7^@&4EZF#M,S#)'+C>&>&=)_#WTHR@A7OYCJGJT.=]//>K46%1]A*J!J-&] M-"UZMK>1KP:*JEZ0$VQ?'?#<%7@>:O`YI3XS/FCO5/=9W#1O](^3@4?Y35-I MZNET+3EP@]Y>36]:VM[";+RB&4GG_9?CBO]N^#^[NY>G?E':X->=W+Q=SO,G MN9Q'-UOZ=E?/VUT]^WYO2S6X@]_:\G97CS'F3D!X-^.9A`D1Y]]$LI-D]41% MM!5$*`\P`%D$2/`*,2A7-*3*7OA1<1%!G+!0%&J3(*`OX@2M*#5!%GLX5QD, M$"Z\Z+"V&0@7B%R42PYJ8*\?<:[FN&WQHIP!ON6=$B?VPUE^JXCJ%CTC77'NFYH.972A=IECK9&$7O!/Q,!30_-SI6O+>(#T&Z.(-;1#G4"H#'.U,[,K5,`5<+S`X9U0E&N M9'\@Z8C]%Q)RPP)1*7H+;JTP*O:?B1PD=DQ%609DP@R;1H:#\0.5CK+O5[/, M]%DQ?4YP(\%D#CCH$D$H^V9K/37S5MOAU1-MC@B7$J$,,L@B<[Y1D-:@%5V,R>< MI0(#/0MJ4%A8"X>(7J@J-PQ^N4"1OJZX_\YIR!5.N,YY?J-A=$:FE.5+ZQ^= M5Q)=OO+O6W9:"ENE7@`M!>VAI35`.VP)*:[[\BWD=>A0%T4W:^!^UMJ4_.4_ MXT5^??3,0+4%7@D58N"9;(*"1B)'$?#AKXGCVDG*Y/J#S15PZP'8VFH%DE*<`QL`32#^(/YMS_2;/ MO$J;D6^)\./M-#4ANDWB*'9"\0ZDYE1@TH@W=Z@E+TH([6*_&5"6TA7P&GB6 M2F%$_E+4;($!S,2MAYB:>Y]`!O1!8YBIY2N`-O!H9WG<96M`1C$A#J;/'0F@ M1PD?6SO-@`%(1+KG++TK-G'CA''5SSFR9[4)+1U)^8[>&LE`P8>'EX*,*X?? M*'M]_VY-)E(`*"V")@=H4M@//$#-M`:%1C#278$M=P,5'YV.6^EFX`#Y!ZX? MG_8^D(!^'VVAJ#R#*IY69A*'SI:P24-S4M3/#Z[YUXO#$-P1+('K%66\+Q!F M]^FXJT?FA!%'H`A#Z*7_"M)YG(GW>Q+%PMP"X%)[XGW\VW#[RL^=:'X5T)?H;3_YVW[RM_WD;_O))9#H;S\YSL7L M;]O+_W3;R_GG6WP9[QA]]OD7]6SUG6>CZW"]^';"/_[/Z8DQLG5&JB'?5H46 M0T`M"459+7;B,<`(&E MENL'8@1ILZSRD0*=H(M#-Z].-XBCS\P59,EX3I3[@ M?P?9=$#T[`>Y+IR9T_G/IZBB:L]>.J`:PC1>,._NL# MG7;JH=P"7<[NMU-Q!WAQTM8=(PL_652K:"A]41*;Z4>*75M/]0%8@$XHS]BZ M7BP=GQ4'$,=..!.WUT^BB,31Y6N^O$`<,/7B;Z86BKGX)KS%3+T=[TB1O(L' M^T"UI7XH3Q_C+F#$B<@%R?Y?,CJ_75$QK&'/N-EQ"68<*[";^JX75%LHA_)P MMKH!1>6NO.[%AD4)8QG+0`!N`#`I+(U>*`,2WJ@<9K+&4';[ZZI?Y)=MRU>W M@^F5T*K1[SFN]/:W":I:2RA'/^MZ7X?//+-3T9,SHDE"JT32%NV>HTAM=YL( MVFH%95]:AOHEC?PX7=B7U:.`E*1BT62E.LN>0\KHA79S4[TQG-W@FNJ\V\[[ M/IYJ%3J,7`FL*OF>@TIK?9N`JC:T)SW.HO"[:/=LMY18M(-T_7+4CW?OMNS#NU8AL+99(!/2,0;80H40D3 MLN<0;>"I-O$*:Q[M;M6L[[RZN;ZZ%4?ZLV=R1YA/\_&8&DQAY&M`FLA'.W]@ MY:=^9@U,*B'-KU]X$(75M^&%'Z7]\72.6CIJ`J(MKNC1TXX4F38>Z@.6!GV0 MILW=5A!70-N.L%;VW8QH37FK7NUF]?BN*J(3ODOW,)X=1ULW2S*%2KW9)G76K?3&QK.'@E; MY,/K-V(<_?8I\&?2%-^`HU<[/B`#>JE>[0?^N*J)TZ4PTX)8G[S].9:NZO[I-YP\[4 MX`MZRC9\]4/*_'B5WJ482EV`G%%"=!=?]EL:`[13@7K@T83+Z92X MO*MY^>K.G7!&[KGFMZ%PUR1,UR>+V<%G)Q##(X"RN2UQQ8VX.XM#.5_0LI<` M=^KNW"#*LE;Q8C?OWC7OR^T1^IK;WGA*R@93`V\]E+\4$VX68RMNP*].D%1W M.5CQ%*XG?$B6R^PV%R4+5*P*V;:+;F* M>S>@7"BQT\QFP-T\4+FJ0JSEHUY%%G1\[R*]S_5Q3OZ?..R*,M6%ED#R4O+0 MDP\5>\OH4FO3MY``:ZU(+OI64,XD%U5X MFT26+XO,1"$-JM@!]>B\DD@:5^G3S9;=[:=[$5V=1?8!KDCKY^SN37<_G0-+ M1ZRB[R%OZX[Q6B4F=X'CIKFHME7;GK,(M@TGRJ]]<]L!U\+:R-Z#H>V-/57] M0>.-*B;MX&*="26,&EEL1A!4+&1`>JC[3K,[6."`5S?.B9>(S1M& M,R*5'=)[7-N6N[X:LC6Y_=X>VQ[J:'?>W4IL.VNZ+5,L7VU[ M$W#TIYM[26:9_$[D#IN`%BB-FACP)N8>WAW:2V0:OINV5J5O:R?6O+VF.S3Q MV_LQO:ADZB1!/)HWM1:6P/=TAM8S3JU/#.B@-T#B>.L1S>9,9+^(86; MD:[(O6JZD<(+ZID^8*71I9])F,M7W@GTH^WM2#\<85@LSV,6',6:0PC'2,%F M[ZT^8`?2JO4)'N6B\?1&!NW'4TNSGH^1THP46!"/]`$EA1XM[ZR%08*_Z M'D)(Y4"JD/XY\*3SSP"PJJC3UWZ62X<%*['C0.P_X(U=$45^,A,6WT(-X4B1 M!?9-+U\^C3*M;RA1H.J,<@VS1K4?/2-=[C<-W4@A!?5,'XC2Z*("U,`'3*35 MGEB=0?)E8=DA]-ERG_2FM6I?$LQ0="H!#%BA:3N9#F::`2J@/'9'H7BZ M*<$"A75Z/0C+]&/&H-(OO4&PK`'*DW92O6]3I41>E]_4J"O=5ZG7#/, MU*0UG,E(1P8THS>Z1)JL<81+H==KNW.-\W-$Q![2>#7!T'%FDYA33&RN?%,13UYUBC:S(%%%J) M$)2O[\3S_$PCL4/^.LP/_)3&&$2;.\E`BS7V-B:"<&`0B'+T^)[$7'OB73HL M],.9?`Y73[2^CT).A#7\(*-`<5=)0CG&.W'=9)$$XB3*=%9#V,/(7)1'SR0[ M1$.>$&SYBN0`Y\.*E*:FPY(&7#C*PQ:YBDR<&'U!LO]?A_71MGL:!%>4B3'% M"JH:N"NH<8MTO M$)+/S%GD/KT`0`94"1A7'@2YJ<-LJ&H?Y2B!]J7;!;$0"9!TB@RS.P#/E%JM M<6NOBS'-VF$7<;+]1E[2)_5Y2PL>0$HM\8PKBZJFO`=!&JA%8W8S`JRG#DJJ=B3V\4RBB+J^&`[ZXB-7 M:;N/10*S%0G(;W"1XTI_#5W987:$:]3R2'23SG>KV&XD$I))L6.[58":TO#N M@&]#76,.W_$MZ#/#2[;9621S#3<@;TNYQY6BS0[J,!M+&V]YRJ9)XFV,.2,[ M)*%B0EU3Z)CRI!WL++4PIC\+W/69ZB2'`MGD.AT[9%Q3RCZN;`=P49=CFM+6 M6[Z[K4F^:PX\,S]H>!(3]!KCQS@T:0<^6SW,PY(6\.LS[?U*0H\V*>[DC(!4 M5V4<5Y+3NJ7#]%9MM^7K!9LDMB;0TG%"DAD2<#5`B"F!@8$%;]N8M&"@ZC-= M%.+]GD1Q6A<^4L7*?/G<=FI]=F1'=$_X&QCY<7%. M^+26>;6^_A8PV' M8C,)H,T7N`!JC3+C]@M;D$(U,&_`L`,JX"2P_'?QGR`L``00E#@``!#D!``#M?6USX[B5[O=;=?\#[FRJTEVE MGNF73+*=W6A+MN4>[;HEKZ6>R6S7UA0MP383F7!(RMW.K[\`2(IO>"5>2,G] M(9FV=,X!Q/,\!P<@89R$*/K+=V^^?_T=@-$:;<+H]B_?[9)7 M0;(.P^_^8_Q__\^__[]7K\!I#(,4;L#U$_@(XSC<;L$IBA]0'*38`'CUJA#\ M`",8%Z+GN[^%:;(#LRC%+:7!+01__26(-N#D]9L__O&WCZ_?Y)K;,/K[G\G_ M70<)!%^3\,_)^@[>!Q=H31OXRW=W:?KPYQ]^^/+ER_=?K^/M]RB^_>'MZ]?O M?MAK<27(7Z\*L5?DHU=OWKYZ]^;[K\GF.X"?0Y30MA4:*<1Q#VO27]X5LF]^ M^.O'BR7M_*LPPK\Y6I=:V&8H:*4EW^I5WLZ;]^_?_T"__0X_/0"RYQ>C+;R" M-X#\]]/5C-O0^Q^(Q`\1O"5^N@BNX1:W2$VD3P_P+]\EX?W#%A:?W<7PAFUK M&\DH\N\+]JC<.O*8PV M<%,T3QH0^)BV7WIN;QNM:U:W!/@HKO^F-8P?<)_?O'W]+D/OOY!/?CM#Z]T] MC-))M)E&:9@^S:(;%-]3XDRNDS0.UFEAB/Z&OWRGHX*_)K](3>6'^J\BK=5^ M5PP3M(O7L-$?^A^M'Z+TF&M0R7Z&5DOW6]Q!$A!A].K3\CL0;K0,C`LI0&)> M)@/*0OJH]BIL8W6MB`'7Q M4?61_QFH:((4`9UV?K!&HM,@N;L,PLW9+L9#X.H._@J#^!S%'`*IBN>/0"YN M1!S5WJB0AHS4\(++'(6F^*R1*H^)!"`B(),!Z1T$1`I@L3_W2QAEGR-=O]2) M(M,J2=(SK'Y[:R<:.\44[J085>!S(?J_QX:OTD'>$&80@F=)LB/I[^)FF:+U MWY=W`4;G)YQ;Q9=Q^(@SL\MML(9D4$@:<.V@F3\0+4TC,G7HHPJK-ODX20=& M)KOT&N833,BL M@8>].;`I61M#/.E,R5\/,`[1YOM^.=L%><@`$G4>:Q@H*3U(R/_VSF*.T@/B M1:H%1[)LCE)%#>D6LRLT7W]RBB3P!0:F+6YSHBN M.%&UGNH8)7L4D2;2^WSN*2:*DCN/G!V->KG1<0-9* ME^13W'Z0_+8US4THHIES6\$4EF(_V6,_J6+_"VFIYSFN1_#SUJO\@]\@X;J, MT1K"37*.GUZ9\YVBZ!%BMU]OX7)WC>)-&-'PC*+;%8SOS^!U\QV#L9W\(1K8 M,8H(QOU7"0[8UC42+0:8]((?*+I;'1>J@+`+5%1`50?,44JBP1RF9%:VGZ&= MH@0'&_S)[]Z,WO[IQWXC@SE"D36PU"-&9W-E^#@XVNBMH?%G-P-C#,D8ZYRI M+E=P^4-,@!3;`,3(-Y[P$LMGR13+^>?0&(,STQ5.--?DM6<8W6S1EXPX`<`* M,?I"@F&2XF(PXLPV>LC5NG!3CSU\2:]OP'[MPDVT4Q$)E4OQ[G.,F M"23C69RMEV^?B.TUVF[Q;XJ#+5SQ0`D#W`=WH3X[^`> M[2(Z3`812DFG$KC>T4X%*6T//51;IPEZ3!HE?]VA+6ZYYQQ[$!&"DWT/*D*8 M[),+8[C&PF1+T?W#%CU!6$P'/D+R?K*Y24Y5OM@A)YIY9YRRXY&V;QI[XF1JE0UQ?:-++[V4#YJ.(4;?R.:? MX$$*/8:;;%%FDVMF"RPP5Q[R)@,7>.2E@P>%2$MO75TC\:TLW('/F63/&]"< MX(R35#C%F4&2,/T*XW68T.QDOWSX2Q#'092RTP0-C?P1*&D844>C3Q:2!;76 M^`Q2T1\70MFDO_("J1#LESLZ*$`=W%1GCX)BR9]!P,UV]N`!@ MR][Q?,DE\:PTL[,9YU,80 MK2ZC>?*][=':$@"R5T$9!(H-$WBP7]KO=UAPW^+,Q#@6!I(;0'F M;3MF#&1L-$(!=Z7>`@KLC7%XPGZ%V:@RU#%%V2->0]0FAIF]L#_^-9M1!G5= ML8ULLKA$!`:%;+9K>0`7`8&-\IH&%^R^4.-XY+0#'>8X2L`3DW>WASZ@&@!. M<7@=&.3H:MS&D_V".T5*Y M_$<*Y(Q`+VW?PM`L:H./>+[6N/P*[+_K%]YR-R+E)UZ'-5>\Q+1W;-@>@"T# M)#O_0O;P!DF"UB'=J_@E3._(CJ82.D&A->!AUP:N>`/N()%E:9RUC:BW[*`S MD,'5"DHXPZI5E*@,J/F#H`\A@>OO;]'C#QL8XH?QY@WY!QELW[QZ_2:O+O@O M^*/?)KC-#6GW#";K.'RH1IH<>"*1_!>S18R`+FK5#.$-^ MT2ST%%)YLG4$LR1+\"HYW62S0Q!OG\A62[+Q$ML^AYP7$W+!8FN#0-#L)9ZT M!S8V,H@:$;RUXZN-Z7>@\B4@W_;\6D[N3:3^W!NOX+CRE3=O_D%B??N!;:20 MO)#\U4H+(070%I(2MVD%1L/-"^W`B[NY8*``L[6#P#JPWO*"T$`21$MPX6T) ML`L7YTGB^3:XY66'U>^::6'VG9U\L-J.I40P-ZF0`5+)2NI'_AY(SE=[_NUD MC^&>9I9'1!CI'=-Y!GG="0KB389@X7X3J5S^,P1R1HB3MF\AIQ.UP8HM@[.&SG-G; M(/%D*76SC:.WG%@SD+S-"DPX69M5F)B\*2N+QV05D"\I07\.MCN8D#1QLI^M M_8(G:S21O"!3M4HVV7RI9M%D\?[-BDFS17.+O\IP==U.3P0+\38:&->*G^55 MR3-#(+.43=$FC=6`;"9'S57GB&:5G8,F&*.&AI698&K4.CGX])P+!8V&42,)P;7(9+.LT) MP3.GG9\)P<"8AR<$\^:]8-]F!(?%@K^Y6\-F-=ENY8-D2YN14:P0&N`&@*Z:4E@?DH%18!V`849OR]PYJ;POC MCK%-,MUJY?1:/2LR*)Y4]B?LCP4_+UQW6<8^8&1[7(=V#>[^5I>O6;099L;H MCC<=5H:=\L;5>F_G]$ZJKK*.ZRUB2'OK<'W64J3@&U-9=SV<'$\.++49GVF6 MQ[6B.(_K']O^%C]=0[Q;JG<@RYI.H-YIN?*@P>YSR=$YWGM<2CR@],\E?[HL M!+KECZ,%/D9!`9T5/I&ZPA(?6]W9I%'46W>+?)Q6NTT6F<94EOE8-36&F0+* M@:4TKU.`IL*TCF5%;5XW`&Q[6^MS#G%I"L@J-O3LX-UEO>^P`>YQR<\]QOM; M]&.R9YA9GTOZ=%CVJ,TS^^&<59W1`P[F\1T#W4N^6`![(,Z`CQG18"#QWS/M<"/<"^Q]7` M`\H+W=*HRWJ@:QHY6A'\&48;U&6W'UM1816PJ>AL"LGNH;N5OU9[W2:+#3,J MJWV9RK!?]8I`HS2'$P).8>Y6UU>;M?6$56\K>4X@*\W<'C.X#G^7GCVX=EFK M.R3`>ER9EN7I$JDJ;+&YH/YHCXZ7%5L,/" ML,]U+TO MEX[7"1C-=IMUM0P)QC',#/`EDPB1!G\+TJ&E!;8+4(W3U MDK!N2[+.<$OK9,L79@LU4.@]%_QV6>\Z/`1[7/5RA^2>5KY8T7V869@+>G18 M_W)$#U=K8-U2,;&NRCJ8GW@@[J?#M3`;<8!C26D][#!&-`F,U*9.1CD9VX3B MY*E/#/M;&W,'9?'Z&&OD.9`5,LN([K1*=HB8]KE6YA#6?:V7'4ZNYH8F75;- M7-'$T(#H\5N4[:6(96E MAUP)[+4&R5(P+P$.. MX8>]9_!(%H`(IN2K3/-W;[]__9H,=9DR?;E#!K\G&,0`1N3ZNC.XSBH.#_VLP@F(5NQ$'V:>YX(L'=;D')'%U9I9N8>[*[*ZY+&3H($;D[1_0/$23Q!<-&+*XP_>(&^3*.- MQMM5;9LJA7C5;;HK\*C[NQR6[-7H2L<"D,HMB#+$[`5!1@5J#%2ME=DBH`8! MM@BPR4&&FH[05BOVV)$Q"NO]RJ85BT(>$@_]E1<>#AV%&PF#A/R]5Q^!^S`* M[W?W^;OIF))PV.GM(&C8J8[Q64_U&T;MY/I[HWW&ML8OZS7;+_OB+*8535C,]XG) M@T_XFP"W%?7ZS:M\@H`_^NUT%\>86^=AL@ZVO\(@QHV?8?@UV"\3RY\I7\PHZLA:-\NS M!=;Y\8"K-,Z_`=E7@'Q'$EI`ONV7H%(G(M4'7J<03[HDA3(N3&:ZP18N;DYI M?*0DO"0!MOGZKYC!*@D7,U.)L-F(JM03PYFDK`W!N"=6'9/OR;B42631%%"9 MP6S\47,UTG-(8Q`1ZE0&A_Z09'<.Y`I0M"05ED@J>U#O@PW.D'8Q28+HUL8@ M`O#F!J[3\!&"*W@;)FFIQ__-MDO4:[*$VNX!J&CV1_^QRF>4;3`+^*:/YTQ*)&Y%/IA85! M0-(,GW-"Q7'Q+2B_'@$LT"]7E#R+=#Q09XE(H^1(3Z#1B]?\/-0)8DB,YF%F M5,Q-C@4\O"#K`#X&4[%%?!M$X3_I:#>)-A=AA"/[R2[!_TV2,SP)W*)D%\,5 M_)I.KLFPN&X&4@,+^8/I9,&(009]-J-5MX;Y;.MB;[RX^C"9S_YGLIHMYF`R M/P,7L_D4+,[!R:-$`??D`T2W>*\X'?XHC^["S8B`4E]J&QY^]VX,IB@&[I!!O^2,`UA`N+,=I)5^[VG M8].Z-C;A(>NV')YBVD[/R_"#HA=G?6F0]#+(>,_@#8QCN%D%7T]@!&_"5)[9 M:NGDCT]1QRAN:/7++"-5;8K/?C4+XT(,8#F0"PXSB]1#!>KDM#H7E51+S@T& M@E:S.4]()-G9V?1\>G4U/0.KR5_!R70^/9^MCA=SO`3K8%%G.3'R!3R>LYLG.*4DZEXP:E!YG$: M/(1IL+V`00(7U]OPED(MD:8"NONIEQ+@NH M,*A(#S,YZ8`9U-V;C5W!ROJ5?<+#@ZK5K,4[8DG^+D M8O:!OJ7M>57)#S9YZ4F:1&*'B'VV_46+F$4HGB.4EAIE+.70%>M2(F4U(*S!>KOM]5:`,"=756@VF*VA6> M=<6@0Y9QYQZZ>HH\LS9@ZO;/+=,4!TEE*^.**,AD`14>Z*Q#&RW*))3-.535 MU6GH':)V)QQ^D4JG&PN<0RHM#W1\`Q,/,U8Y6^*ZU,-NA)> MDRR\1L10WW,''YCES1Q\8M8HH]F?%RMNG568-&CH[#,9)1U#,FKTRS2#46M* M1#T5"W@T^/AQ,0?+U>+TO\`ODZNKR7S5^U"@XW[4R3M-,BFH5HG4!6NN2,2? M$^@HJ=#(WJ"FTS.'1%(=Q)1,C&LE%@K)R@Q@2!,`+6BH44R:^JOH*I+,+Q(M M9_R>`)GE^H<5W8VQQT_Q#Q=]UC-[7P!DOCK(\OE*D;0ON87>DWFGN.2F\5YP MZ:HZV5F.MJR&&KLTF5"FV(;)EC';?21JUW";)<>T8$\14V-@0];F->GF-R3_3A9N8K+&#W`.'VZQ(!,\7?3 M?^S"A^JMR>TASHK9]MAG:-96^+#RZ^Q&%=,N*84;LT9J4:AJBNX6J]H83""R M`V-6A+))D';@,K+.C&C'P#R]%3NE3'7XM",+?CSBC<#>7(N#(U"8'`%J=$1% M]G:_<505;-]8JO?@U/+N]QE+(WA+6CR2,;*9JW\;):T`Z6`9Z&J%=DHWV?\" MM]O_BM"7:`F#!$5P0R_`B!OL5I+-G[!$UBB^*/7#;&"7-<$/`&+-DJ4L-^QX:R6+2&:)ZH!6"+>V$#W]P69##G*!9H+\HV[[\'F<`04"_Q M+=+Q`8L#;(TF%11AXY81E(:G.%.[1?$3DPA,B1K^&Q(68,]LTP;:FX9E(*_+ M%]BFGX+BXR$@FNTDI/!46?BM"39A*_:V6[1>[JZWX?I\BX+F6COW^QI2:]]; MP"FC/1LHK9N58;0J72`T^PS0#X>`3Y9CD/19LK!9$6LB4^1=M[@L+L:)TGEP MWP2,2*2&SJ:(!8"R6[6!T99E&4P;"@52RX\!^7P(8.6X"JD\6A9DZY)-U$J\ M[C@AQ@E('&QGT09^_2_(3@`X,O44N"EC(_=EMVLEZ6V9EF:[#8U]FIM]#N@7 M`'\S!`#S/-9,;(6.K6>T==%6*BMQOV,0E]L]Z2U;R6*7)FD0;7!2S4:T@D(= MWD(%&UA7Z)$5X(O;D;)`I+ZG1.6$QRB[.S,!%<%!,$0%`4VZJ*.FSAV!7HM( M.D!SO5^YO.CV''_27":12#7V++>DK.Q:YK1M9]]RV[A\YW)3I]R[7+U(F7XW MC-W+/.^U]B^+W9P#GB/7@9L@QX5V3LPAP1OLV(5XWKPKR MJE8+YOE._<$!G>5)#M3Y3F>"O2+.@[L('JX!O\)F.1BO?M6`=?:5%2176[$# MWMRB'*]4L(0H^7,8F*P]^18,&7YI((](M,'&=)K'S;2;34C>ZF.\!^%F%N65 MV"J930,GZ@K%!E@%!;.M.\H]LK%I5:4QP58;N?JXE`%$"(1145.OYSTSZIY' M^KYI['*1ZE7VK_0/,&N7U;I&%]VBQ<77J#8;/$:T<7=5N<6;OWA^&3R14259 MH4^V-E>Z5*:WRZR;7'E_B' MWM&JL3?['X=PX\$^T*(/,Q<#)1R(!,\/LCQXKQ/T/D+^G306=!^D%VYTZ\/,$J: MV!8+Y8^))V3$)W'+%I)R;@-\\G!4QOD_0`RS/>P8#H\PH3NB<`B']P];]`1A M7N8CA[O[YE*BJGRQDBB7-UOG4>V/C75$A;8$ M"SU2[7%5A*0N%RC([D0G4CTO[2C['6F[IK&L(U.KK.KT#2YK:XAND457$!O8 M(F)[;($7N>3+XT,9=_G0)<[\!7#.-3SYT8<&K-6$4^%]@'MA%U=7-7IB6'-7 MUH;VQ52%*O]^OU%Q+&>0UTDU'2V[0HH-C)Q`8AWI15$^<&2UHI8S.)'P7`-4 MB2)P22)/WR?O[:))\Q(R4SSU'HKG^UOIU*)Q6UXBJ+P_33G+-*LT&@3S+%:B]0#"O'/UX/X,W,([A MYO0NB&]A\R22LCPWT+?D+7.-TQ]'-&NWIL.QIO:X^"#;"':*DKZ/?:C[6\`M M,42XM&JHB3CE&53V\F&G>,HR9V;6L`=:+GI\*%,/WQ9QUF_@?B"[C.F]8,Q3 MI#HJ@O#=5K%.-EZO[+.-T9(>X5H&^(RCHH,XS*>%!"'E)/@1<*ZI*:9=#Z!S MGJ([0!^)^/FG1PLQG!4?>!P MB-1^AY!'W"44APK+.@Q9P5!1D;7.S%8_['.QVH0>_TI-/N/V,L.C6-O'0EKQ M("$@TEY%3!XO`'*>T5M!4A:]LS][+GUN$S(ZT=<8-'U&VDFE1^@(53AD9?D1O5^8J6 M:2?KH95M>1J-ZM"0:V9\>H=MX&P!A_V]4#Z_I6=(+L+@.MR&Z0!S<"ED!)Q5 MA!N7NSQ]$8M[1ZJ[-1G',!6LRI2@+0X8?BZT_ON MN-5N3I->30/C_+/!3LD%GA=33(P7$<<:FA*:^0>9NU3>`<($Z7L!O0%/,VVA M3RO&V\6?Q]H@C1LCE[OK9!V'UW!SLDL_16&2X*[F'V;%Q;EGHVR8*BJ)&)DR M.^-LX5<8UATQZX'@*+2)X3'C7E906@#7NQ04-D:@9F4P!VBL(!391$KC,+:! MQ377J'XO"? ML%GO0$&2,]K6)*W&`T8?[(Z5]0;4:5S58XUT"2@%AL5/EENY].-C@,.MB@*? M.E[PXG1XL`";9G`?@20#3G!DP%$-R\;0Z3&HSFCTEP74NA0OF!92=HE1;]MR M$-T;UV!"KL,,GB,P&V!FT_0?'_Q,1_-@GPD+(.\2$'IE!W6C9'=!%&.3QZOK'#&!BJ0V6_P-`J MV*=2*=(B+-X=(RQXM?ALP:+'S&FQ2Y,TB#9A="M+GQBBO!RJ)FJ7`XQ>6,ZF MZBUH4*"JR,FK*B(#XP3+NWQB\+'`XT9%0T`0/\!Q.S>U@1_N[!0='X"41UUS M"/42:)GE^CE?MP.JE3K`G-:L!4Z%LKY-X0:\Z8>#FW?R*OB*O=?&;[,J;TO? MYH&6IG6[!9Y-G$[+-M?<_KO7W[]^_08\!#%X)!+_!O[P_L?1Z]>OR?_:*W+_ M!M[\./K3CW\:O7O](]T]_^;MZ/W[MZ,W[W^L3U#IEY5822YF^,]=!,&[UR-` M*$L%SN`:WE_#&+Q[0S_%WV$3#Y#>T;[M^8"C/@P5\M1^@:@U[#["^!JY@V)K M@-6'XOO1Z[=_&KU]_8<,BO\Z>O_NW>C-N_=R*'[$_K\K4/>6B<4W!XY%^:!N MB$6?8WF$P9B2`@K+W36*L1?)&3]R]2;_.C4=G?VHKZ1CR$F-?ED9+]3:$S%7 MQ<*X(@:J;:V77J"73:*<(!'1`=TR9]# M#/*#O0<4^AP'DG1Q\P&A3;)$V_;K1N:W^]C>^-:02\RV3#G3-"IB1UUV3#X@ M-WG3CP#YK&^XL[V!)(^P">":4!6J#6V[>7/-N.75JLY.SH+=8;N9'ZGL.-I? M,*IL1V>76^0+Y#^=)6"$6WZ+9H&):9U0IE3)0:#&#&V#J=&@X%$!\L5%0_CR(AXX!XK5=,TZ7F@2-_RXV`4EZG'2 M""?^XB:9^)Z%R7J+DET,5_!K>H);^WL#CQ*I_%EPI8Q8(&G;`@'X+?#1S],9 M7RPF\R6XG/PZ.;F8]@MYF=>0XB.N0YTC7.*<:\WF_)73B*VU/8N0R.XDN$Y! M^1WX3+X%].N>!T]3C/`"HBN4^(N,E\'3/;G(=G%#NDHV#9`=A_1.J@8B%23S MAR.4-.*#0A_,&"%N@,\*D=ZX^)(L]U".%-\/X>XO%;=?)XA`H21)+WBQ MFEPZ@$U6@!2M(=PD@+@*B-_+C8X25;S`:QU7/G/1[':Q6;1&]W`5?,UKV9S` M"-Z$O`F]IM8^5U74,LQ2M/IFFK.H-B;*8=1LC,^FY].KJ^D96$W^"DZF\^GY M;-5W)J.'`]312Z+QQ`R9)6[=E$I< MZR+N<)3V5Y+M[YP9R@M[J0^1ZO-NLH(M7:6!5UA8S6FLHF,X5]:9@X$_&;0& M!W]A<'IS`]?IXF;Z=4W+:U_AC'(1G0;)W23:D/],_[$+'X,MR:-P`IJ&T2Z, M;O-BNRAJ3A)MFIJ,E]>3%:SQ;Q?OEM#)+*-BGKT,+5:1ID#)XVMQ)*\GFSU@B:Q14E/HA1++JK4*REO@Q0:PY)E\1;F=?!EM"_`M2%_6.;).; MW3_$Z!'2]:I^V:SFX4YTKJ1A"==NH5$"CF]: MK(*O\AWI*J(U@O!$+;!$W`L;Z9:X&1EI.(KC#/MD!\\0\"_Q)=)YYBPFL#6: M=/`.$XN7@-G'2'[I%_X>8(%A[F"WAQ[!Y5ZV\>,SIM;3H#E,I;-?#95]C%51 M,221>J^LQ%REYD2\4C`P;DT(1@`+]LTH#?^C+OYI\DNN6>79(*!F+VY[P%D6 MQUE(&^+\TQG\^`'>.0!]!OQ'G,VC^`GWJQ78VU_M`WCU*T/VM%LQY4C-HH@+ M%<'Q_J]!Q%3&HT>B1]:$:"E1A:(3KUF^6[R#\[*`=8CNX\<8;0?V4CVC`0[^ MS.\V/UZHWGM11=5E9A.?@7*=0 M1D+->;V$B$FTH25TR?8L'/O)?K[TB1\WA.+M8,(1MX5:86^LA1U>*TK`9BM7 M`Q3=`9M]/AC`B]W,8H$*,-K$8&HQV=('DEP%1?N`8H9/"BQZQT4N^_LCA9E" M!+8-M.'$:GEI-"4UQ=AMOQJ64N_8),/#Q6QR,KN8K6;3[`7Z\J?)U?2GQ<79]&J)!X;__C1;_7KL MP.PZ4%B$IL>!`T6W*QC?7Z`@2BZ#I^QB^_H@(1`I!@2FB!G?!*T:!GJV90&! M6`IC^A?(_QS.`7^AMY#*TVV@GB%90;@?Q]L-JC;\3X,E_KL`P*$ZG1OLS-WN M,XB5W>"4+>=+[$,80\(0R-PV30,8R[`(OVWY9O@:1O5R@9>0PF-M0K@E6$6P M!W=;#EO&7F\&K;*R\R6*R?&-PW0_/X89`L!?!/L81BC&&>$LPBB`23-\\;[. M?V_[:R,D\UHSBUH,JWSPMH3'U>RY6*("DS2-P^M=6HQ.)`E#48I[LB7;&PKM M?F'-=1Z2/?`ZG)M2)98=^]]J&#."`0E@'!_W_!Y(W\F\J&7@9G_Q:@Y34MCA M,D:/X09N3IX^):3`75[3(;J=D`LFL\+G\D))=HSE3]'4F!%S[/P2"^\1C#O" MYZ2AZ?%\N@*GD^5/X--R>@9F\^+,QOP#F)RN9C_3Q:=^R6P)D,@N+.IAPLQF M&50.F"^V-F0.EBQTN(-I5OFHL`&NG\`+8@:$T4NPMP1*4X,LC#0L3O$&WX&R MZE`&=LYK1KM&K0STEMX*V?UE?88QI5=)EIJP&-0&\\+4,L8MQ3GQRU8[MFU% MO4%1TNJ<]V"82>_Q(KGY^<7BER4XOUI\9*;G?_[&-17H'"3;/.8:*$)%9[.S ME'EE_&;Z(),K,@*^G%E$D;5O.&X+S`L(S]4:5[_*C[*20U_TVYY/>LE=B92? M>H-=//$*87SC0W$0J9?C7$E6=NRBA>X)7:PF%WFMC.E?+Z?SY70$YM.>;_>P M`15N*+8)E@$$3-Z\2U5>%D!MI6:J_;&1^%RR5'2WGC&3* M(%-38)`O-%E;'W0+I?RE%G_('LXZ^24*:]Y=[:U3G" M=JUMIE>\+8>M4;^'?#![+(4.8VTXEEV?Q!1E;B1VZWU7AYE,0%`YMH2BVU=D MW^$@SW]J0T%AHWEW,/0ZY(2\PV("B3R M)\&4,"*$H$VS.,HVS$<]2WZ\:$VN!E"97^0FI/!0L#HP&K MN:0%%)"(5^*`?'*8[N>%-=L`\!?1+N/\BF2ZR9L6(T@FN_0.Q>$_X::!-S7A M_-'(A(TPK]83L^@G;8-/`8GJ>/\]H`*CK`I$`DJ9?OFAZ&BDYXXZ9\0Z)7UZ MQ)'59-(9G$AP;0$JR0`5'"6@>&'8$:3ZC<:+79JD040*7BJ$8X:T(![7I*T3 MB=$7^Q&YWH@>AZJZW)A<$1H>AUCN%I*(CP\!ARI*8A)YPY/SR&P)5J+8C(X5 M6#KAV0JT^@K0ET&\B.F='IN?@^T.7L*8=E88IV5*S'#-5[+(,EG/;`9O05NJ M9..::#,.BP(4@TP84&F`Q;,0/R3R2<'!X:`BJ)A$Y.GR^-@K%AT&?H>09`X# M#QB4CQ2*+\((;-!V&\0)>,"PI`-$SRMD;G&I-D0X0Z;/`0.M(=PDY_BASI)D M%^`'OK@Y1??W**)];HT5BO+[84(J;\A*Q?Y8H:.\+1$39=KC0@00B(-"B%P5 MF(EES,S*C_VKHX4I.W,)BDE:E4^2ENPN?0M M;<[6/C3'T,S&!Q5P'A_F^$.!/]3U,QX4126J)8`%PX%(G#$:L,6MT4W4&WM< MX[2B1C6FD&4Y[7<(,$&=G,J1VF.#ETH0 MMPRPOG/XRSA\Q#.-RVVPIE>Z*B7R/"5A-M]6!\GD1%&3 M,>9(-:TQ6+&/]L8<>8-JU)79:1"7B& M@\X2`VPZ2UMU]7Y"TK"S4<@3E-NC4`'F9X9;E8&H#^1Z'9?87?P0MP],J0F7 MHX]0V)2L"CTQ'F/$;0BY*%(=-\:,^I`Q`E2J=P:JN!KI.:3%,H%.C5A](4XF!I1\6020(UBY@-(`8/(>,R8!45!9_J:@;SE1ZX2CV9BUT(`I1 ME,5=+#-0PE3=*Z=+&PPRJI`]4W*BN$7.;^^T8JWX(*P3`.$>HUV4P2TY#W(9X`%@%0=1$JSI>YNS M,%EO4;*+X0I^34^V[:,8'33SYZ:E:<2M#GTTB]!Z#?(IIV-GG`L#*@VJXJ"4 M!Y^)!J`J/9=AZX(<9.#2.ETU#)3L'21DK8X./2"7C!U7TXO):GH&+B=7JU_! MZFHR7Y++/!;SGNM6^\(H;U#QCE*?0\Y#\$3F%\GB1F\O6`?-_9"CH6G(7^T^ M"M%:OX)!Q%^==D7\5;@(`,/-KFK;*#*W0$BU-;>XA[` M20>7O3AYT3[X'8N^4,L?-]_UR,0$HTDF9IV8U=:=C1-Y(WJ\ MHTKE"'`?;"`9!N8HA0F>BCP%U]N>:X=(O2DD#\/O`IX0:3$I,GLVMT_Q6G$9 MM3M#112/R?>'#A6=H&H'+#ZC9Y+&NW6ZB\/H]O0NB&]A.S7GB^RC)DO$D`'\ M5JW,B9GF1>!G*(QKGPZA-H;064CEX38QWI:LXMN+W^U%/0M.SZ)=S>W9%X?J M>'YX,W:]SSB6!F$$-],@CG"'DLEZO;O?T363,W@3KL-V/JBJL(]Q<@5#Y*OV MR)0%"NV(."%5'Q++7QPG6_V3*_@(HQW\@-`F8>V<%POE3X8G9$0=< MT66,-CB%RY[@(0.#%Q;=0*/':-C>PRX2X45"\[VCHE8M1T'9)E&F`B<"]KXQ M5.@M/LBY6]!9D@)X4SM.XY[^WF'QSG,K<*"5R>`PXYPR`)1CG#$$/,8W2.O$ M?8`1C(/M)-I,-O=A%)+;[M+PL;A1N1GQM)2*&*BH9,8&K9X9QDG5M@1443,Q MSN5P%,TDZ7;[NBS(A7LFEQXR4#>_->BGI%LAY'"`J'E$2)*>^L(C.3:D@,AC M1B+O2-$A8U$M:5!]%>X/C6^_H9&7F/A!H\=L97T'-SM2BH(6VSP)$K@Y1?>D M6W07S"2.,91H/;Z3IU(DWTM]!VU73('^4!J M(TX[:*D2H'T$@0%%9MZON0@C.$OA?2O3MF90->HJ&'0;8Y5_D>.(JM(/@_@I M-Z\4+87!$GPFU@`U-_2PJ`YD]2"H2P[5D">UJQ'@AL\WN]L$ADX[NF)F2KQO M7!/!Z*#8-LCU.VY6M")GG[JOUJG9U5^;D]GUM1*G]ON\K;M)NV-EE4W2BO:: MFGB"!CY3LWVG&]8QWV6E3(M.^NMB8O.=5L$TB>HQ.)++HTEO%C>G07)WOD5? MDLDU>?FR;FTY4Q`M0IA0U"PJ*?3",-"(6Q#$#I'B^'0Q7RXN9F>T.,IRA?_S M<3I?+<'B')Q.EC^!\XO%+SV72%'R,-+Q1(.#`HT*K73`TPM3Z!6[^36-I+9B M^B2GC%RGS1V1CBT2R?MEC4W"II1H);`@XM?RI\G5]*?%Q=GT:OE[,/WO3[/5 MKV`R/P.GBX^7^)OI?#G[>0IF<_SW=#`45$`,BXO*0&N3DJ_*9*<&/#T6&=V? MO*;=*^[.HV=T&UQ0$2V*C`I%S:I%*O3"L,BHN`5!F4B18J54T$UV57MYZ^,` M3D0K.1?I.*%1(U*@4:D1V0]N[%89=0$?\96AV4WV.:K(VZCE[CI9QR'=NIR, MCA1HW'*D]J'F,VU2SI64$R1G69'K5*AC_L-/>JK?_1YDWX))FL;A]2XM9JN7 M>.(9I>!SH=;W&H)67J.;S*AD,-[Q8W>IWS:,]DOS#2`=`TRXJ^-V@=)G/"7U MN>3%G;7UN-&6JV>9/)+^.6$2OTT=8O&LC$\GE[/5Y`)/3Q>G_S4T>LGP(&"; M&I2XU..HBYC8,PAME2;RC$`:Z5DI`Y$?9FEQ'SA5'R0<(M7C$+)[>-C2-9Q@ M6ZRPSJ(;%-]GKRTX^;F>5C%\J&J9\5:O;S:&#N46!;15M#%>?KJ\O*#+F7CL M.)LM3R\6RT]7T]JK`S";GR^N/DY(I?6>&:L)%-31BPVNJBE7F#HD9%H;3_S! MDHXE%5%`9`$1!A7IX?^HLSDR2!:7*ZB\GR90,QS._R7]CXS@B3S';,\-@TR4=C M77*<_3D"^0?]XI#M`"1\;G4$UD1*_#GSGM4"11V=2`+*"M%L*?_=V=>'XTM> M/.GDS9YB"6>&*Y1AQ19+08SJ3,!@5(@ZPH#?X'M%QC>WJ5P,WF$<7`+Y[O[:Q@O;L[" M[0Y_2E_K)8M=FJ1!M`FCVP8,.VKG3TQ;VX@L'?MJ1B+]1OGTTK4U+A1`K@$R ME?V!@@14Q$<@-]0O);LB"AFZN4YB32,EO;5;MUE64[-QJ[L*>@0Z&6%:4"^V M@+5P#EX50`GP1)N%8;_,2ZXJ&/I^LB M+(C[Z638XS:I'0LXEG2'/*HU2.Y+4"1COA((Q:QGFY!RGM>RAX&.W;2/88V`6B/TSZ&U2RC(/N4?P(R3C8 M0#WW^_SY,+XWXA>W/;.`SS++ITE;>EP[?_8Y^[3GI6Z^:Y#T:=;1W1(K0>S< MOU;#I*&;2="K.OKP_,N+7T8>]GA4.T8/,$Z?2)G)%$=,$BT?R,:W.>2]HM51 M*8YN*ZF8'<75Z)7A46ZUE@1G!_>!P?Q\.)6KP^]8X<8]_>T><%Y7-2!^RB0_/H./<(MH MW]@7?BG)EFL7(EG32:"\'\8K%,(FA',\@>:X^)I2J"(PC(N[U#R,M!S1FLGQ M56J3MW[@8WO9P`6*\L4!)HZ.!S^"M0#["/*98\,;&,=PPY_TBT3V.31+Q#!M MX;=JFB,S+8OR$8;">/_IH)8!A,Y"*@^WF5VT):O9A!>_6TY/+;@_2S]K`#A4 MO_/S2F//^]Z^W0!4_B:P1")7Z M818?9$WPL2K6'-.O0;%UO_+.:BA+=VI.1EJ^J'-`J%)2HS<$64U\'`&)Q,(J ME(X',[S(Z00U_N+L69ZYG8?1O@!DV<$Y;,9:9?G\*2G(&S%&N3\6.*/2%I\W M1MD/J-)*JE53J'5*VSMPYQA.)Q7M$Y5(9J*H#/'U! M=WPHXX5KISCS>4T1C((X1)^BY`&NPYL0;MA7R,KD]M<(<>4,KP62M&]8P4A@ M7G1M#T]K7'PU`I4OAW*IJ=272/FQ-Z^[X8A7KZ]1!4@/EVPP+]QB?MF\-L/* MU5?,EDQ+/39L*MQX4=PD5?P]D$N@V'YH7T8ANHZI)L.X7F(P%R,5-*E>N=X$ M)$NFB=*\3J^MC-[&"DO>)>MVEGD. MAF0D=Y#D]7N+AY_7#X26FKG&T(C9>ZZAF"Q97<^PNH[1ZV1)*Y<0'W@Q[HBK MJ1$.:M-5=GGAI^7T#$^'F#.B008I74!:F@BYF/[8FO;TRA?'.4'_9%'(`336 M]KYQB@6=@V!5[P.[8F9B=?'`ZJ)!KY.8(4Q='$Y9;$Y4!AFD=`%K:5;B8BYB M:PYBMRR\65^L'A4?+,MH,E#DSB](\OP27%XM?IZ=X33ZY%?F&MPW-G4>\@?& M)Z^7/,71.MIFUX[ MW*6O9J.X?J/"2XNU;(T+!?"B4'F)!VA0U?I]OJD&?"::(%?M>=6P*ZJ0H:M; M-R?K&*G=K#Q<6%M]-=\CNO,KNU7Q_;P`+;@,O!](^]REWNS7)8Q#M&G^@M;> M=3VU_8YV537#?=!ZO3/=&ZWGQC-KF;[LD)7O(DQ6:;#9AE@Y?!B'NY6GP$.*YVR]!'`=1.DN2 M'6RFGYWUBY-N^OIF9ZFZ]M?PL%6'9@7GL;2MC2LJ!)^E$B!:9,S.]48@UP29 M:L\'NSK#"QE[O'$X3-=,Y?S8T#%N-2/M&>KT_K_L@P2$F2>`7_?(LV7U]RF[%;YM4N:FB@;.&FYUW[-M#"C94.\=)C")6%3EG( MM(U]F]D@P[8&TO=98`OE`P.Y`K@5(2V`LN.09RT--/,Y.ZH=GK^5@YB!QSU> M/YS-L"_(ZO+B>AO>"L\<*DH75Q/+I,TNLE7KBQGFY8T(;K>5Z.Y+?EQ,)\LI M6)Q:%R(*U:J7(^KB:)>KNZ^#.)%3*OL;'X.MCMX M">/E71`WD:NAT;[>FZ]AZT)H69\,N:34D-)MT5S]VNW1(X#E`(JSTD@;0$7) MVTI`A0=SN;04"JSKIA7Q4[!-KLB\D+H_S+FZEMP5])I7EX_``P;?(X7)J_TEFCM)V'M& MP"1-X_!ZEQ:5IK&7>U\%%GA-L#%$=0N(:+.'=>?_]@>+Y/-]RMQ! M;??KYO3R^0[+[5ICY@/=8H1#:YRZ=#X>%T^"+;G;XR`]S:VVV:^GW^E[>AIM M7/KYW6'[^9T3/WL]'(+NX2KXFJ\QG<`(WH3-!1R)5'G8@RUENOM=U+;0\^\S M($?PEB2"?!CSVQ#N9F?JC.F!H83L!+K!D\A,#&"YOE&<)5S; M6.X/%7H!CI_`6@0$B7`E"(H5;/`B_[KG^9PI*'@!<&"PL'PDQAHVWAYON!"< M4+&##'^#9/T*=;J>T$"?0"+_]4P)(ZP+VC0+?FS#?'"SY,?[#XMU+?KY:!"[ MOD7>0@J/MPYHAF`)9J85F^]M&0WH1;M'&%\C4;RS`(O7Y'_94F<"@EUZA^+PGU@IB#8@0A$$:);17Y7DT\#F3Z?N&,24G(RU?-`_;"%2J!VMZ M0I#E0V).@$2OIFM`:;:'TO$@B']@RP&&_$7=*Y@&800WTR".[+=TL=09OPG78\RMY,R3P@I\E+'A,,DN_T'-C)/N-X1V,DO`19JML M[(135Z](/M7US-((W?X9)J4:S0GR"F4K-3YE)Q]KPL4:\8L+E"0O!Q)\]3&# M.KNSD9.HJE?RDZ$!U6[NZQ>OY?E<%DJ/'Y7<7-DG+GU?P[I?2#E#]WC0:Z!? M*%.[E+4E8^%N5DZ[9H,`S[3LIM:FQKBY8`<^9]_T'+_%+D-*3YAUE6M#M'FC MJ\S_?59)O8))&H=K3$92!O8N4FE0RR:LW62IG5=')F_KR4&)IH/@Z_T&_:;W\U M=*JG7N0ZYENE5?MEX6R,0E.27=12"]D)FGR_#<@$\YJK^\TX6#H3Z'GDTH,% MZN0UQ@9MF6ICS_80,&AUI<`3%,D`L@RV^'FBFV)GSWVP@>!A%R>[(*MO%40` MWMR0$HJ/$.=;MR$YITWK*>[?X0/\!XZ"]V#YZAUX49.9H^_!NW?O7KWYXQ_? MO?[32Q"D(``13,$##J"0M/N[M]^_?U,>HSQ>O`N/GKA&_#!&'WI>[`2/H1LR MOX110D&B,12)#2B,2SP#S@*$N,?N1BQNN]UB!L>WY7!(G/J['[]_\[KR$5GD M2.\@>()!#&"TH6]WU]F2];LW(X`#\^OG2*0N`ZP'*O4^]-)^)IHS/XZ2>(AM M*;F(*IR>.1E*VVUIAXVF">&0F0D/?O['`X>,O&)0B>G:T)52M`\L^AC5[$-R MB--`6F,GZ\L0;IUQ1@'-,THC MW<'/#I7PIQ85+,P/1884H\50B.!O,/7#!YU)XH$,?PY1WVE@]('[H0R9Y,OE MPS9,M29T##6EP;&JYC`0M'OGE1R3)$Z981M*.'],$F.\=>`>2A##LVL-EM@+&*SH$,)9?*M_1V MLZ`RP/`LN..SN,\.AQUNPQWIS;&G-!A=#OFJWXYH4XL$2I!5"0EL0XK101'V M/BLJH9LP)0>8&HQJ?[&OGU1^85@PI]F"A6*W-:.BTCA[L3%9=R#_ZKN(3>MY M(_Z3:A:L*;ZOUJDI=>R6.2KLZA4IY@=/;9>1>L3$:;7C=R/RYW9'$YU+%--Y M8+-*-;FI#T4I[L^6B,TBG*K!I.([ MK]E"\QRFL:>8]?R/\&7R(X3JDBUOXWUM(_C&)-I-[$B7_ MR7KSHJ.2/Q0U%2,(Z_3*0EA2;(X/>24#XZH4K:U7_;I??FC!`'5Q4YU1*IHE MUP:".%NW\WF!&QDYJW(CL)=\-MCCC<8>T.?U:K/F@74\YBYN5L'7?9J<9\G5 M)'F%ZBERD2'SKA-TVTIYA9J;5DROP'+YV\V"B;O.">_8K@F%/*&W=768B\9JUXT]GPAA^V*]8PD40RY_<^B\%EP*>!S,/MC, MS&U&YC83&U9\M?@2PG[/O$73XJ:_>@SM?Z75%;!=14XO\=)9G+2[]FRY<[96 M7`Z8I?EEQ8ZG1=\8WPV6Q\GY/N]GMKAFY<8X]U[H'N>?;GZIA8U2-OND<\6I MV3)4U5YQ]_$QK#DY(H3@KE;[*TQVVQ#=$'LT?+:_I_D0:4V/PA[`I>9#IJ3Z M%=L'0`IWUO.48(J.KB.@R#MJ.?W:7>.ST23,G M$2_"'@Q%20Z2+;H>3^[ABF%N<>4B8%2#GPFDH"*]KRVZ0)FO!3$*=!\7HC]MUV2 MDO)NR0I=0?)PPRUYL92]82+O%U>(7(-P&:/'<`,W)T^?$KB918P[$3CYALLF M]M=ONVC"\,YE=[_:PK#CJ'NB^YT=-#@NK1*Z[LWULV"[K?3@**B>W0"_M]MF>VU'#/F:4KYH`5P_ M@1;BS@WUY_\-'`7T(V#T@MS,5-WCL4-2MU\`7RI\X2,`IN M_!8M)"),X_S8PA`?+ZX^3.:S_YFL9HLYF,S/P,5L/@6+QY\BMP M&)(_XCJ5VG(E$3SXW=:09.QT6A."?DKFI)6G,9S):#>W\V*HH>,]3BC7:[3# ML?@R>")KY:>[.,:AN3DE%`J5U]HSA4RO!A>T;)AH\6P+;_MFJ8R+ST'^Q0CD M7_5^K[?(;TCM*;?NZV;(UB[G]@4#V]?!VT$#37T;>#AD&`@N;K!ME'5P_K>(@2O"L.RNI0O_:TCRVG-H7)UV8NS$N`T;0[:7MW&N>VS9B?R_/ MR6S`\=UE?GCRVQ-!O8/]2<"\95`T#2IMTYI/E=8K"W/U(X2\/:)9/_H-L_WP M&O5*E_I@X+4+Y0#C^9?;W*[JM>MZ!3-51O\6D8<HJB!&W#39#_NDL;-QIZ>G92,9]M]UP/'R=7OY*-#QTUO=F_][XB/K& M>&,0\MR+RCCT+22)NFMK%\NSCD>T_FJES1&HM4K7&JOMTKN>BY;+2^63ZDD2 MHE-I'93-@Z+]`6WP>7YQCIMN/]](YR_++K>SGF/XX1^+.[C#?2QW?9U`,BO- MY/#<`2;3KWA6BN(-_NGQTPS_ZD2IIHB'EG+\.&W):$SR\`S,!A^W'>2/,R[; M'=AUVU&H!E2,,*/3D,CD%F%G(3@,E8;9\6PL>W\*!73P^KX#@\_Y>^!"$ MFWS'&TY;Z9+S)$E@RME\JJ&QO_%70Q=U0$"ZN"IYG694L7J/9H#0)SE2VZ=`X\,;@WH)17L%0\YTSE. MZ/%OVG4,/I^S_D?<`10_7L(7;[L<&+/U-P!C"/A9X#[#:RN$R/JUW!=!=' M";DL=KM%7P+\E),/"&V:Y_HUM8I2S:I:9O5>]?IF6&Q9N3%!J59%&V,J"/:2 M(Y#+9OG:(D;>8RZ@K[-4>Y@N$"D&J/K*S^*#0F6OR1JH\+F>PEZ04*HK)42'Z4 MCWY(Q?M>_5$&`])W5W/E1Z977?CI'7.V=J(Y!URVV%B%')';0ZV0/5ZX\9<: MG0+.8]TYF+**Y+'>HS7`WD&SJ%2GHVE6RDR_CQ9>J>NU*JA_IF%G/)^NP&Q^ M>D7*OH,79]/L7R_Q9^!TLORIYZ)H';""#)S8***F;J!274VG59L;1S0:ME:7 MSS]@:26_HD(SNUPKU?=K&% M#%]$B%JV\O*!TX#HE0-39;S?,U.^)CP\ MK'0-BYT6GD?9`?Y%*2ZHD$LAP.-V>[F)R^I=NY?@ZV M.T@3\>:&*57YZJWV8GGS2[%5^F.X/4JA&1MH,8ETV+U!KW2/<),:LYJF.DD>ST#&VW00P>R8?D16)R%^`' M`$*J=GP`$]YG[@IBO4?P)76J1@AG*(AC>$W!!<,8/7(2Q>OM:).KJBZ,XYG@ MD`,Y"P,RHO%Q(^9914]*-)]0\Q'-[2&.OLG;W5_CAW@0D=P089JQW!;&?!>< M605?*W5RV,L%"I*U@B\<20ME%H1]L%%PA=>`K+X!6V\\FY\N/D[!:O+7OI?D MY!Y$&H^:=?Z?J=`\OZ\\IS>XZ@?_8X2GRE)PWXA8AE.*5H<`W,&R] MB+:,"GJ^8/\ER+X=4-4_&R#AI@XV8>(O1I*]K-(<02R4/P>>D!$#Q"V;@9]K MFX]\CLKX8C&9+\'EY-?)R<6T7XQ+?(74GFP=VVS9$M@\6T-YS5:[9GRRV819 MCRZ#D&RA"Q["--C2O/TD2."&%(&'44+7VVF2OZ"_(+G"W`V3,(5+&#^&Z_S$ M,KFU_#:B%AL(]MQJ<1&EKU;-[BWT^VS,`H6_S@HN4_34AW&E(4+PLBE`V@)A M!/+6\H6H5]>D05!M<93-HT'>*#EBF#<+\G:+^AN5EGN^`-(S5U%/1&A<3>FG M\T/I\81689564`\^)M,=R2H]8$;@D-0%GJ`1YP?[^%%S]0 M?J8!QE\N>Y6!_#*(T^IE1+S=8*KBN=_DXD:15;4W9OF:0BO\("95'E]-+R:K MZ1F>[EVM?@6K*SSUFYRN9HMYSTM@RJY&NNZHDUJF5;)1&TW]K0USZ",3XZP, M6Z*+K'6[BW]*].`J#7U!F,\"11]SUOG:J%<&@S^T3X,X"J/;!`]DQ>@7KB?1 MYBS<[C!!&^!3E,Z?BU3:B`**?;&00#5X!*T6-; MN1QX@:?7&[JM*@$/6)*^B'_9+Y%4T8`T75:GE42I9)?4NLVC)9+&;+V&<0@] M,EDJ1$KPC=K8.RZ0\28DOF#F_T1A?M2EM;N#^6WCG.#^6ROGL!IM62F2UK8M M/UU5R+:.4?6]78/MDM9A*;;/]MLR:D+M`U!.?&K[`'0'=[+.Q1V60V4'W51= M6OW5%_A?^,/B(_Q_9%D>?_+_`5!+`P04````"`"3@*]`,\QD[2,C```11`(` M%0`<`&-E`L``00E M#@``!#D!``#M75ESY#:2?M^(_0_:GN>^[!VOVV'OA$ZO8M1="DFV9YX<+!:J M!)M%E$%2+?G7+\"CB@>.!`D60;1?W'(QD1B=/B":8Q#^\ M>O_FW:L3%(=DA>/-#Z^RY'60A!B_^L?__N=_?/]?KU^?G%,4I&AULGPY^8@H MQ5%T_?UVWTI*07_O]<5V6O^T^OW7[W^^OV;YV3UZH39(4[R MN@&55.1,P@;UYZ\KVO=O__7QYCX7_C6.F"C%>&)%+1WZCE1E/>\_?/CP M-O_ZBEGOY*2P'R41ND/K$_[O3W?7THH^O.44;V.TX>UT$RQ1Q&K,6:0O._3# MJP1O=Q&J?GND:"WF%5':8,5M^X';]OTWW+9_:];P=K"H#R0-HO'EK5<#%3I$ M%.VB($G?A&1;5')!PFR+XO0T7EW&*4Y?KN,UH=L!1%'W?TC0FD?P9KE+0ER&U"FZR-*<1@`FELM58O9`!'O4X80W@J+ M]34+EUO41S0!DP$BG0?)XU5$/B=]1*D5MB'"X%:3<;+39/J$5S-J*^/?9=AO0%V8MO(GQFAF&!=\P)!F+OO'FED0XQ&B@'M`ZK"AT'NPP MZ]KRQA\F=I.3%>%N2!`SKW\)EE&OH"KC9$9TG* M>@^:,`^X(A0Q"-T'T5`Y-:RMB%]T>P_!\S!1:VPL>?PR07]D+!!>/K'_#/;M M-C<[7DRV6Q+GKO=+0&DP6$XA0RNB7J`UFRRR$77P?,;FA6O<:WRIYF)-W+$/M*F-J1>0[%/')"NNWTY<'UFA)$%J06<[5$G;C)T13S"+S/8HQ MH9](.C1>R7C6!=Y1E#`7S!N`C15^;U2(GE,4K]"JJI++/&AREU=<51V1L%%; MQ%,:A.KTX[_\JJKE=)FDE+5.Q2CB$]8?7ID489^YIK`B;\VU*DV8S[\3%+[9 MD*>W*X39Q/[]>_X'U_C]ZW?ORUS,W]A/OQ82W*$-YA7'Z:?@,,[?`C].GS$T1Y+:TJVAHU"0!K6I?_N M!%+!24I.Q(RSA#$D.T[,Q_Z$LFG!#Z_>O^-)P:,V^SE3@0;1-?/&YW^B%V&[ M2V@:#=^AF5G+JW4`#1-@;K4MK9(,-$YR&# M=VD-8HQ\>WR,_$RBC"E'7ZYPA&@BQ(:$IH&)#LW,L*#6<0@&.IS%;?]A@LE[ M$<+NT(Y0OGC%EQLS,034I,VIO(1T9H``:3QH8B^I0);;.3X^LSYM0Z@X MM2.D:*"A13$S$*CT&]+V+;Z2)I\@GW>;+2,<7D4D:*>II=\;S=WX/K/&ENLV MI*D;7"4-?=3D71E]#DN(]X_,D,DB2_E>1KZ=5-P#``HT^P%E@9EAPT#[07V" MLAH)>B;)%1[F/5?LE_:@04/5RA=VJ&8##IB>PW*&'=X2&!PU;=@4KDAKZH$@ MH!-"H4$W4S#(=;4!AP9W"2#J.!@JUT&RS%LN2UYO M@F!70!-%:5+]TL9H^?.OM1V45SAF\F!F.Y)@Q7J\29&R16%%!KJF!2,\U+?J MM=5M?&PK]E#?FC>!+QHU"M%HU71`"&ON@&V6(Z[!6VCJ^Q#%`8L1I\^X'9.5 M-.V&;]),W_[-]B0P;20-GO-J-&V3AYLM7(KX4YSL4(C7&*TNR#;`[14>+5W5 MTG*ZZ5M;V*8$KIRDX>ML\_:7LW,3`Y4BK*-&U^Q/J8MW"-K^72.8OKGESBW3 M`^S9-0:J#32,7[%A]:8PI%2K7"5^1A(USIU-`(;3)$%I(AG,B#]6*[RMC],# MH-O,1*.#!`![1OF*;8N!RJ=G"X`RG:S$@82F`8<.S62HD+0[@6G3!$:3UP$4 M'1Z>88.?SF,S2_X//S7V%$1,V^0T/0\H?<'QYN<@RCH;!$S*5+L%8&4FQI(, M,:2?TB*(M:K(=PK`6'N&O/),7'*'0L1T9OWQ)Y26UFD')P!I%:.4I.["RT!% M(*K4'#T;XUS'_#P6H2^?4!L\HD^E)9N?W`6'0@4@&)H<5%N*9]CXMQ3M`KRZ M?-ZA.$$LDB[21T0;MFAAPJ!$:6=0"7<19*XP$%@@QJIMS#/$FPI9*I/.!BT6 M<`%"P-_[(*!SEN@51)/!BHCZ*B@)M*Z"3)(54KHE57X-R_+ MMEE^9OP",?E#G-N+_1VA'`#QZG3+=R065[5(K=.=PUEE>YCO66([&\B/9,E^ MSF%/&`NQ6W@-GGO1NSM'A9`"!@4S`K&!QI:CMNT9L`OCT=JDZQ.)0V6F'T1; MFEY#Z^#0TT0[W9A3P\NS+,H=8HKAD`5.<3[Z8((6H,P+EO8W*3@9U&"`(@/, MT(2ALCZ.2I-Z/!N:5I=%%=NPT#E)ZNIVNU4P?;7)5$_O/@Y-E3:$'X"]9[/P M:V:<>,,OHRKM@M++YS#*^)[['PE9?<91U`*>29']6@2DB/OPZZ&Z(0)A-7C6 M.[,)%=]RFK0-TXEX:K)]H).1N0\PH(K&84W&U;/%"Z$E(%,$R-1@#OB!*&<( M'@E+SQ8]"@6%ZUW"A2XGYX=">6%;P:R&`A<:]`8'2QSA%"-^)W#W`G%)`L&T M6&ED>#%'MYGVU!NR`17.VK.Q=4UQ]?Y4/6$79N[L5#6&#C'0N`DP:%4MV/F^ MS[7:#5=>(J_>9R@F:NTP;!.Y`"[`!D.E;E(H*?87MAGZ!QR:,8$[MNAB1TUW M@(^,SGT$@30T!)&,IV<]G>3J>#&88,3[K?5J8L=A9:2K";9TC#W+$-7?2!&C M2D%1#9Y$%([C1Z^5"6B$W#Q+`6G[,FV(GV'O9;7;@O=7L\WVU%34;BD`T7:A MX]26@H%3-,/-!CUG:?!M"+,=)]V0>/.`Z%;T>-B^'Y.3[#LR$8D+X%(GIP&J M28$DSDV+.7HV2:L_&)0MF38X+G8D+E/I(H=1F6JH#2OC/L[Z*&\(/&`5GH4O MR:1#CD(HO7JR-S/T&2IMBCP]>]_F?B*30`9ID,'9'!`%4$=!<;BFH$LQ MX7Z*47!(()9H;[NP*4EY\4%7`GO3:C9U6I+I,5F[;UQX$Y3D\WZZW/[L(10U M-A@;A]WJ[TT-I@A M`GDV=;]#:8!CM+H,:,RLDC0.5*]QB+O'[:`%]L?L]`4\!+>QG<8&-T0@SX:T M-17S/?+,D9D6CRA.\!-B]B1;=$,2?H)GL7X(GKM;JOJ4[MX,`2OMH0\,L^#H MT=Y4.HM+["YX1]>BV@R)-LOA)8RU=A@;J2(!5`_ZSC#5]Q''A.:F*M1O05'V MN6R`[FDC8BWC8QV2C9)E'R2Y[Z22CV/OX\;V?T*I7FV?8 M)[1?&[S/EOQ%^R5:G67I3S'F;U6ORA]SI9/#9=/R3&%O5MVL8@]6'KJ<1=L> M,5O90U29>[WSI\<#KY6"UST=6,,\9F\#/(4[?@^B6Z?\]MULMUOJ%GWE.TF4 MY,"#XC-;C#?4WLI&%$E%8QY1F/@!T=N\S1Y1BD.FVN3OKGW)KXDV5\99PRQH M+O$J7Y^\133O^95;&W2%A+L=Y(6FOU`"^"II+RM(+IC0O%8*KS[0#M[(^\ MYP502K*!\^QSX?H.1ANTMYWMLGI'U^L\JZA#6)-*AJZ*:K[($NII"545;XMK MXTXB2CYX@Y#*L#7/89N!QI90!ABPV5D#GR"G53-*L0-J^ES6@V`Y3_RQG9]Z M$"VY3:'"?8CB@&)R^HS;QQR5-&V%FC33NVC3^@2FC<0+ML\_:7LW,3`]); M>]LNWB%H^W>-8/KFECNW3`^P9]<8>)9JNP\BE-RA)Q1GB#\&D8B>RE035:"0 M$$T/C&[S$Z!.$H#.+ MCOQ=K<4Z5^^>1-WDE?#K/K'0^NHH'M1:0*#0X>!9PCSO>F\I67=.@0J^E'9K M?'&TY>720UJ]4=JS:U<7.T29\O'F\GF'X@1U'K&IGFC2T57/-,GI',4&5#,( M4A2\/$M1WS%C,,OS]T`O6-<8D?RMXU+M%G9`M(+@V0(:/+D4;(74*UP=)4FV, MAD=U+A875%U`QOZP3EQ<,E&NJC;!H28ZO-`L)'(4(B"=("B1,;)XV-6%#J92 MLU"OC)2?2$PJ)^DFZ$R*M$"D+N(XI`ST-0&8FJT,;K,=T1R"[A6S_3F)F:H9 MT[:,RB1.SM":T/(FG(?@&267SZQ/+Z[2IR^Y_4!W(!RAICV\1ZS)6:\XEG5A MSC2B-+*I[7P'!Z41RJ!SQB95W5RKAJH!?0&5T[#5:06'G("3!"ZS3844.6?! MY*+[87\ZY_#!41Q(987S"\*;1Z;9Z1,;UV[0IVR[1'2Q[IP0R`W1`EFOLF5C&)9U%(!# M+`"!HR%_"3AGNQHK4;]T1MT9HIZEU0"5EYX71(%6&`!2>0T2F,[VPLUZCJV1 M?)-L.@'3EXT`H'<4?*::0N`&X.G=!7=W;$A+LS#-*%/ZG'G4IK-PJR(Y;$(1 MD$P&'3@X"$B])GBTW,LM*`*NWL%':@MH8((&I+F@":IH#T@I6%NYP+"Y_?[! MA:FIY;F[I-<H$&2"/[PVM5!0'<9E9-BC MH6JLF@NH)L.R3N[Z07S1[2=-Q$FX-4[C/ZANMZ]?KC#!?33G0?)X%9'/R5_W MT/QU#\U?]]#\=0^-K$W_NH?FKWMH_KJ'YI"Y1"GO.F\I><*LRSU[^2E!J^MX M?^+BE(TCG_*W&D1;-&7K+U:95CE12TRG!ZIP\C&*S4#+/98J]NPXZ4SW4%J& M$7S?I9V*@7LUYPJJPPP\>2!W*"1QB".>A3WLAG\@0#-*8N^8550O5H]2A4]+-9TBC$$Y"X"$\RSGBNW4<*4N2+T@F3+=)U%IV%Q'5YW@*0E/0R9%*3> M0MO`0L>!M%H@9Z)WB&@.T*_>?5W"D_]2O_:^N-B?:7&/Z!,.47(?1`$M7AK\ M)>ANZNI3M'LM/J"HMU@>8,'C8-M,0`OWC;BUI%WOE1;K"[1,JVM,;RG:XFS; MGC]`Z:O)@)[>6^R;VNHX@`=(Y=GUD]?;78!I]1I%&L0;O(S0:9*@-+E\+K-1%"3H`A7_ULQU'NQP M&D3RO1&&!0_;)<`%_76+OM8[DD\8B.?9+:1=U:O9#K,OPD^"'1PF1:1.("HR MY08B4W@*0:VU0V>G$;!:,4A%U5E(MK@U:N^J?5%J(3ZT"LEV5A=F^ZV"L!LVWP8O1W*9%KYW8[.EGCT>U!<:9TNSK^A*FVS1C M*N!@B:,\,P&!I*2("I6=(CX`4VT'Z]CL5#?F6]9.P+.=(BZ.UNFSHYIRBBF/ MI-SLT0JSB.VID*1.*_>.N-[5YU>NX)#)EI^)(U20!M8"V82)%-4P)K.'>`]; MV<4[3(`1+D>9'OQ%SN/EYOIJP:R`Z!.Z1123,@_7@3F,?`]H';G'*U=&ECK6 M>I5.*._NE?HQP#&WUR*^P$F>1C5"1:K=AWKK,I0(>?^F)Q$?]Y/)K;/[O9DJO8L8Z;S.KL[ MS&8#SNX:5^S,#G]+AU6"E[*G/@W_R#!%S$"KC-L""8=.8/KJV(J>WK6^H"\6 MB;EU0.'>4)[\D(I>#N_V`3$50X16^1M9]T&$%FOV"[-.^G(;!3%_ZO"2F2)_ MU[F-:?.2AT-9\)(^X;RWQ49#O(E$GL7P85:T.JBQ.ICQRF6LVG4L+QHJI&=/ M4$O,<87C(`XMSQIZ,E4[FC'3>#.:C&>(#^'@*\"'6//:4`""? MS"7Z+.:RVI9D^LA^N5ZCD$WN+Y_#QR#>H#NF]2+FICZ-\V,+?"7[*8AX0@LP M8;#%KL3`<':.KC%9MA-D=6EXE5_&3+G_M+C_''A6V.VO_8!%T"]BBBEVQE-F M$$I?F.H_!U'6/CQE5*:Z(AE6QE'\]=$8@CP@7WMW`.SR0U),&)IZB[Q?O_KR ML-?1>73T]3GB7Z#O,IY\&?$^V^VBW"!!5#T7>AVO"=T6[2W>V618JGHA#UK* M4?SUTQJ"/S!GV23(E:Q`/GH(\.HBH\QM'A[1OU%`KPB5X`A*7@M?:O+ID&.( M#6*L?`M'L/JJX*:NQ[-G6:YC)@9*4JYT"W"B3_N3[?5/DP$)C`JBU*:)%AW3 MXB1YG9EWD.`'DA^"9Y0(42'\VGCEO/9U)MA0Z=0''BU^SARMD'1%A_1BOM<@ MSZ\G/\5,REO*1G@INHV",(^@G9M?S$M64#$IZ>@HI[_VD)&.$7>OE_(.EFAK M#EHAD152+H=T"SD*PEXZ0_`'9>S0`IREB5YECL6Z&B_*SJU`2-N/G@M)IP>7 M2@,B?29="2<4L;BYU[QC--8+ MHET4).D;UG,72-Q+?IN;[A&E.&32?;F8/*:RX2-:9?R\:M[IG04)6IV3+;]N MMW0)RE>&\J[O[.5`4Y[P/OTV]MH(D4OR#;`[7?`QZRB\M-1JIB#@_;V)7*4ANGMJZ9ZY=X[BCZ6 MW5:2S[K`%(6,F%]PLMU%Y`6AZL7>CVB[1+3E5&#ZLB$`]-/!?4P<$G-;M4`[ M@G0Z8OA#\"4G%,&R1 M?BEH5%EH$E"V!')H\4&"SGN4IL7VD],-1?D?0FAJZ:KIF9S.6U!";7,<1"JD M<7VE_S*@T0L_*,2/#3$AKY"DH]835D-*!:&W>`1;YT@#2(4X-L^"C8/),\)T M*\15CAVU=*7-%73>`A)JF^/@42&-#(ZSO8^G=_+MIKV9`YKA!3.$YG,!#.>0 MO3587K%MXC%742S(ZLRHQ-9>"!+^SG07@AG\K>C@C@_/F6`X2Z]&L)U>K\1++7,$0%< ME\''(+S(U>$#0/$S]6JB.E(%1#[!4V>#T3`IJ-B9=*[=QWH6:W[YB?):5SUE MZX$>(:4GN(1;8PQP*FMW:*W+-D;W'84>I'+2#DI%I-[!5&N/<7$JJG[/H7+H$V62M%I)>)6O$ZP-T#YN;2:(.X!NI>AO)/Z'/^I3LO-R@# M"-BU,K[%:)DY1@W+M4J'7*OK,#P+GS3$IZ00)-ZZ@%`SF.FB*@R8H#JUL;.+ MQWFD!Q*^:?0T24B(^8,"O^#T,=]6FK\:4]M;:A`>35D"HB>$:[=`VA=INBALBE)#.;3!5073 M>012P>E"DTBJ*@[))PN+^Q9+`48:-Y.-67!Z6%W4)J;[AI M4\*F6#651)\.5J%U'D'U9Q2O2)^!J;@@()"V"_H60I6&&35XMFLN@?C!=2`6 MSM0'B:J2D%#I#!9[`$H7'@UP"*]=&Q(E&)Q',*RNEN+W3B5,?H-P*"L*"(C= MHKZ%1(UQ1@V*W;KWD'0=DX5']0.ENBPD-CH$RU[8TL5'(U":2*"-D0I(SG2! M]G3U6Y:D^?CW@9RN5K@X^,$?^;F.SX,=3H-(O'>B=A8ON4/,N1.<5C=4%C:[ M0R'9Q%BPKG#D6DM@'*W6.?8"TS3)X`[D:&)7CCY;3U?/A_G'^UV$#1,>W6*@ M/$>]V!R=I:=1QAHN">JMX#K;\T40QRZ[X\(@/;H887F#SJ)5?HY('FJFHP3P ME@`5MF=[OK]KE,*/V^83A6*#8O50#"HV1P#W-(J=4`RJMX+KMQ._Y*$\XP+& M7S\.H!-,KJ'2&%K:,TSFR(3*H#_%I$'GU.`L3Z\6.O)Q.HEYGR!ZW@E"VSYA M+J:=_ERP_+`Y0#OPN7,Q+S>:OB6;\(D@)4UU:Z^89OHF5C8D@2DG:6D1Z_SV M7#%+-QK\MAJPY?%*=J>]E.1PE[V`9++65C`&GN2*2&:`0DB`:/?3>26MNU`Q41((&PW+N=^> M=X=2IBA:708T9H-@\)P8UJN"CWP5F7Y^!-*)2.?,FK>VY;P;,^22IV"&Y-J5A;>Y11]1BL,@FO[^0A=1/,*. MGO8E0.S7/*\&2Y'J2JO3H_+2(8;I[=V&E!YD1+LH-Q7%N8?=!NKU?WCS:!W\+:9VT+]G^L7`7VS& M:?"_E\6]>R:#J/F`,NNX\KUIPI$'B+@"K(9X1D`T4;LOP#1U6$V(3##=N,!) M&)$DHVA!-T&,_RQ:.LZOC5^LS[*$_9LD/>8:$F`KJSE(\\"4D4PE!G`HL="+ MPV1)@T]!RIMGO=@AFHO<7A27$Y3ZB@@F<_,AS4<`RC8=O4=MW.U%M8SY8M>D MGG^?;;G84BR..4]*HEPB%&?$&`'__4F/&195>UY M6[/*8GV%XR`.<1#MPWL"B"&#>0JBR@">D\690?(?T,2HE3CBKG;&U/C=9I,, MJ-Y&Z_6JWHD(/!S\9/*FDT?\WMKQ/N#X6GG;PU2'K)^1)F?5B:B+62< MQ]H\_HFDJ#F,$<56XW+2[>/2>O0-">+D-GC) ME\ZF<@?^UEXMT(H]6TU4-KF,:#)/;PHD\VL-E5`Y%WQ6TR8$JEG34\5*/Y9-VOXXF0<6@BS6-RA)$*"/!=,W%%723^:?DA8B MYEHV/;3)EWLF@)^W/OHQ^(W0\RQ)R98)QN8)5X0B-E7@.6>+&=<[](3B#)V] M=.K[$9$-#7:/.+Q#&XXJL;_V9[#?2VG.P-Y2"KQVO9-;X65L%;>"PP`X$+L6 M;`87<[F*G:Z#Y/$V.!4;+Q^"Y\G&$'L)M$-\`.7A]5`YY93OJ;:ED@4@"*E< M5Q?"!Z2QB)&BG?/<,O[EJZ@*OMZZ\WVV3-`?&3\W^,3SD]-M'FT)(MLOJB&K M$E12LNER="V1I#DY'9U$11=\6-LZ!*Y?:V.&A'.>=Y-S]-9O:SM/J@OH[,T, M!,RU?:U1F>[Y3%49>T-^984RAS0K!%'-!5^ M*&5GXY$S%*,U3B=,IA>B[`=(E\]\TR0JY9)FUXU*[3/2P%+V0D+7TI#TND&9 MEFJ:,A.FWLT:C/0S0SLS#ZJT2-6#*A-'A&_?V;D>V(7%\CPSNEA&>%-N0)OL M=@:Q/++Q`8RZZCYUU!;'!.*J`.,"XX)JY=R*!]#V(@,,T1H=J&O,QP4&-7D< M">Y0?BKZ-J#IRP,;'27,/).&`IE`TH4#&/D^(:XCG_!>";%HD!4#XY(:<[@5 M/\!M3(;8HIWI5]=9Y/4-ZO(XAIR3^`G1%"\C=(]B3"C?JV0UAR#B#T@CF!7; M3[>AQ6PF$]1URO,)AN6`.KK@]<;-1_K;HYU;@-5G=*`D```M0```1`!P`8V5R<"TR,#$R,#,S M,2YXPPQB5O`U";);E_V"'L`W6M+K"PGH7]]1S8./VR$2;)= MTD->`M*,/-]\&FDD#Y]^?8Q"XQY$3#F[J#5/3FL&,)\'E$TN:DE<)[%/:>W7 MSW_\PZ<_U>M&6P"1$!BCN=$#(6@8&FTN9EP0B0,8]7HN>`4,1"[:27ZC,DX, MFTE\DB03,+[<$188K=/FAP_?>J?-A>9C')S'_A0B8D@B)B#[)()X1GRXJ$VE MG)TW&@\/#R<^")B%))8G/H\:[TZ;[T[/SIHU@T@IZ"B1T.$BNH0Q24*)*-CW MA(1T3"%`<"%$P.2:P$HW>H/%YVC&VO,>SDZXF."#3IN-+[VNEUJ8"Z,QLTK6 M9>(A9;^OB3^.1)@/?]90W2,20RXN8+Q5^D,#>W/!2L!8$I6/%DC1D/,9-%`" M!/6?%#BKH,-9?4-/"07R26_5ZO>-K#,7Q4DV(63IPC&)1ZGLHD-YL%D_;=:7 M/F0P45-KJV,^-@0/T:Y,[,FF4./W+UUT_))_NIO_.F4XE9D/JYBIYA&;\A5F M:R88`%WW9`S^R83?-["CQ#N/A2FVL+_Y\>/'1MI;PV`SC#3<"&-+_HA;3:!8J7&G;-)VS*BSJ^>3_-A-P@M;E M(HH>C:=2]E`EQ@F=FM9=/C@?@@B_,$H!)P["9R`DA7@ELAJO!LLGX;ZP4,5/ MPH-&%T+"E4@_+%XU#A#1&"H#S>NK=E(4I,NN9^H9=YD M@<4DE7,;HU1$Z72J&1271*W$T]/SYR]Y^WR*?T;=R/57/ZJM.AO,6!GM4V-S MB,W1DQ@"AWU./V^&\T)[(:+3W(B8ZHKKD[)<;]&:\_!">EHD5"N\-P60&1UK M+7KW-Y7[/?00+/S?=OJ>T[4OS:%U:;3,KMEO6X9W;5E#[^A[K>\'1"#>*4B* M`(I$K'?O8.5]=5:,OZR-_-;01@'#[%\:SO#:68??QNW6DJT!7F\333L@? MXHRFY5<]/6=[T-,VO6NCTW7NCHN:QO\E*]J6OAW,:)>S;K7;K8 M=>V^I:ALW7CXR3N&F(XX+XDB(N;.V*,3AB=PGV`:[?L\P=27308\I#YF\YL, M5M324_FN0*5WT^N9[E=%GF=?]>V.W3;[0\-LMYV;_M#N7QD##-NV;1TYU7': M)C,J2>A)[O^^R=Q:GYZ?LP(_;7-@#\TN+IE.^Y]'"C04=#EAN$?-R2B$30K6 M^O04_*U`0=8O&DI`!(75ZY%J][M[XMNMTSON.IH_=TCOW'1 M3F*))QD1X[[>X0)P>_!(6*1!+ZQGYT.!G9[Y#P>/-S>X+O4L-SOR=!S7PCW$ M\,SND3@M<=GA-TE:=N@)^7N!D.QL:0S-+T?/ZS9J'D6YL;IKFW$RGGA"JU$1$?*+]G-?\5;`>_: M=*UKIWN)N\N?#23.'GY-=YGCE=K+J2RYYME#7D^R_OW""T@^W@[MM<^Q>_5: M$`\\'C#*19_+8DZX14I/<#%51X9O+7=HX_G(\*R^C9EAWQD>[UQ:'XP+S1:5M_JV,,C*[LOV_]]Y^M38+-%:M*R7ZGHZT7GY4J-B"4<=Y27PYU@C;D52]Z>W:4(VZQ2*M55Z6`]>:[>O/# MB^U8+7'6(,^6($C,6];2I'?JJ*G,42X$+6+;(J:JS;]7$L]*UM&ST'-LHF]B8 MFZM`1T!XJD;%1&E<"9[,P,IQT/ANEC M@D0LJL2V@E0OE`>$!I>)LF4XA:]`1(>+$H"[10\-G!W'B>)\<8KRIGADB6\8 M'J4&@MYC6`Q"G&S1\H8CQ;F7UAKD5/(9D,3VT5-:J!)&+^VKA'6?$6VH=9M\K'G^6.@>`^0!!W!(^6 MQ*X>M9(1%P%E:I'LMO0?.@Z<9BYV[H*S(79PJ#R0,FLP)P+2#P5(&IF#PV,1$<[5PJ:6 M.13M0,F4TPD='*(6)R+(K-L:0QJ9@\.SLGEG*=H@U;\E80*Q8L*,8^Y3M4G= M43E-N4KO3%8(6YV+GJVZ3\>6[0Z1XRZ;?``KYO@&\JO4VB]X5>KG7( MY.9'&G7>B:D/%>DMJKU-@O>'OTWOD$G>O*2J2')1[6V2O#_\;7H'2O*FH=B: M(M@-=+OFXBR#!YG9HNT@H&:YA#*GA9ERT.;1#%B<#I;;[A(V@2Y_L%A0-3>I M/MX;=\LUG4Q?U2]/`_YTQY!P_;(.I[8/99&P0_!G`]'^%&SYUGL(C[+DCL4]H*GW[?M*?O_-AR*159ZR!7E#P':EB(E/;Y]E`X"9&D)X]+B'>Q6DC\\:C5FE_-:3>%GDYH5C665,_CUOU!+`0(>`Q0` M```(`).`KT"M&H'WE%D``.;$!``1`!@```````$```"D@0````!C97)P+3(P M,3(P,S,Q+GAM;%54!0`#UK:R3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`).`KT"\AZT76P\``/W?```5`!@```````$```"D@=]9``!C97)P+3(P,3(P M,S,Q7V-A;"YX;6Q55`4``]:VLD]U>`L``00E#@``!#D!``!02P$"'@,4```` M"`"3@*]`*/X'Z9P9```]G`$`%0`8```````!````I(&):0``8V5R<"TR,#$R M,#,S,5]D968N>&UL550%``/6MK)/=7@+``$$)0X```0Y`0``4$L!`AX#%``` M``@`DX"O0%0?,\QG50``\BD%`!4`&````````0```*2!=(,``&-E`Q0` M```(`).`KT`SS&3M(R,``!%$`@`5`!@```````$```"D@2K9``!C97)P+3(P M,3(P,S,Q7W!R92YX;6Q55`4``]:VLD]U>`L``00E#@``!#D!``!02P$"'@,4 M````"`"3@*]`587IW2@)```+4```$0`8```````!````I(&<_```8V5R<"TR M,#$R,#,S,2YX`L``00E#@``!#D!``!02P4&``````8` ,!@`:`@``#P8!```` ` end XML 22 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Mar. 31, 2012
May 10, 2012
Document and Entity Information    
Entity Registrant Name Cereplast Inc  
Entity Central Index Key 0001324759  
Document Type 10-Q  
Document Period End Date Mar. 31, 2012  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Current Reporting Status Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   20,027,204
Document Fiscal Year Focus 2012  
Document Fiscal Period Focus Q1  
XML 23 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Gross Product Sales $ 114 $ 7,285
Sales Discounts, Returns and Allowances (11) (45)
Net Sales 103 7,240
Cost of Goods Sold 638 6,538
Gross Profit (Loss) (535) 702
Operating Expenses:    
Research and Development 129 250
Selling, General and Administrative 1,216 2,043
Total Operating Expenses 1,345 2,293
Operating Loss (1,880) (1,591)
Interest and Other Income 18  
Interest Expense (524) (159)
Loss Before Provision for Income Taxes (2,386) (1,750)
Net Loss (2,386) (1,750)
Gain (Loss) on Foreign Currency Translation 2 (47)
Total Comprehensive Loss $ (2,384) $ (1,797)
Net Loss Per Share - Basic and Diluted (in dollars per share) $ (0.13) $ (0.12)
Weighted Average Common Shares Outstanding - Basic (in shares) 18,948,644 14,873,018
Weighted Average Common Shares Outstanding - Diluted (in shares) 18,948,644 14,873,018
XML 24 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
MAJOR CUSTOMERS AND FOREIGN SALES
3 Months Ended
Mar. 31, 2012
MAJOR CUSTOMERS AND FOREIGN SALES  
MAJOR CUSTOMERS AND FOREIGN SALES

6.              MAJOR CUSTOMERS AND FOREIGN SALES

 

The following customers accounted for 10% or more of net revenue in the periods presented:

 

 

 

Three Months Ended March 31,

 

 

 

2012

 

2011

 

 

 

 

 

 

 

Customer A

 

 

64.8

%

Customer B

 

 

17.0

%

Customer C

 

 

10.2

%

Customer D

 

34.2

%

 

Customer E

 

24.2

%

 

 

Our net sales were made up of sales to customers in the following geographic regions (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2012

 

2011

 

North America

 

$

84

 

81.7

%

$

238

 

3.3

%

International

 

 

 

 

 

 

 

 

 

Germany

 

3

 

3.1

%

4,687

 

64.7

%

Italy

 

6

 

6.2

%

1,533

 

21.2

%

Other

 

10

 

9.0

%

782

 

10.8

%

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

103

 

100.0

%

$

7,240

 

100.0

%

XML 25 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
LEASES
3 Months Ended
Mar. 31, 2012
LEASES  
LEASES

5.              LEASES

 

We currently operate out of El Segundo, CA, Seymour, IN, and Bönen, Germany.  The leases underlying these three facilities are summarized below:

 

·                  California Facility — The El Segundo facility consists of approximately 5,475 square feet of corporate office space. The lease commenced on March 1, 2010 and has a term of five years. The lease was subsequently amended on April 1, 2011 to add additional office space. The lease term relating to the additional office space expires on May 31, 2013. Our current monthly rent is $13,389, with 3% annual escalation.

 

·                  Indiana Facility — The Seymour facility consists of approximately 105,000 square feet used as a manufacturing and distribution facility for our products. The lease commenced in January 2008, with a ten year term expiring in January 2018. Our current monthly rent is $25,000.

 

·                  Bönen Facility— The Bönen facility consists of approximately 1,000 square feet of corporate office space. The facility is subject to a lease with monthly rents of approximately $2,000 expiring in December 2018.

XML 26 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2012
SUBSEQUENT EVENTS  
SUBSEQUENT EVENTS

9.              SUBSEQUENT EVENTS

 

On April 30, 2012, we entered into a Subscription Agreement for the sale of 1,000,000 shares of our common stock at a price of $.50 per share (the “Shares”) in a registered direct offering.  The net offering proceeds from the sale of the Shares will be used for general corporate purposes. The closing of the sale and issuance of the Shares was completed on May 7, 2012.

 

On May 1, 2012, we received notice from NASDAQ that our securities do not meet NASDAQ’s Listing Rule 5550(a)(2) minimum bid price requirement. Under the Listing Rules we have a period of 180 days to regain compliance.

XML 27 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
INCOME TAX
3 Months Ended
Mar. 31, 2012
INCOME TAX  
INCOME TAX

7.              INCOME TAX

 

We are subject to U.S. and California income tax.  Subject to limited statutory exceptions, we are no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for years before 2006.  We are not presently liable for any income taxes nor are we undergoing any tax examinations by the Internal Revenue Service.   No Deferred Tax Assets or Deferred Tax Liabilities are included in our balance sheets at March 31, 2012 or December 31, 2010.

 

Our policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses.

XML 28 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMMON STOCK WARRANTS
3 Months Ended
Mar. 31, 2012
COMMON STOCK WARRANTS  
COMMON STOCK WARRANTS

8.              COMMON STOCK WARRANTS

 

In connection with the registered direct offering of 3,125,000 Units effective November 2011, we issued warrants to purchase 2,343,750 of our common stock. The per share exercise price of the warrants is $2.20. The warrants are exercisable at any time on or after the date that is 180 days after the initial issuance on the date of closing and will expire on a date that is five years from the date of closing.

 

In connection with the issue of 2,596,500 shares of common stock to accredited investors pursuant to the Securities Purchase Agreement entered into on January 26, 2011, we issued warrants to purchase 649,128 shares of the Company’s common stock. The warrants have an exercise price of $6.35 per share and are exercisable for a period of five years commencing August 1, 2011.

 

A summary of warrant activity for the period ending March 31 is as follows (in thousands except per share data):

 

 

 

2012

 

2011

 

 

 

Number of
Warrants

 

Weighted
Average
Exercise Price

 

Number of
Warrants

 

Weighted
Average
Exercise Price

 

Outstanding— January 1,

 

4,219

 

$

5.09

 

1,273

 

$

4.44

 

Issued

 

 

 

649

 

6.35

 

Exercised

 

 

 

 

 

Outstanding—March 31

 

4,219

 

5.09

 

1,922

 

5.08

 

Warrants exercisable at end of period ,

 

4,219

 

$

5.09

 

1,922

 

$

5.08

XML 29 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Loss $ (2,386) $ (1,750)
Adjustment to Reconcile Net Loss to Net Cash Used in Operating Activities    
Depreciation and Amortization 176 216
Allowance for Doubtful Accounts   42
Common Stock Issued for Services, Salaries and Wages 121 584
Amortization of Loan Discount 19 19
Impairment of Intangible Assets   64
Changes in Operating Assets and Liabilities    
Accounts Receivable (43) (6,417)
Deferred Loan Costs 138 28
Inventory 121 (403)
Deposits   (10)
Prepaid Expenses 147 (76)
Accounts Payable (315) (1,337)
Accrued Expenses (289) 97
NET CASH USED IN OPERATING ACTIVITIES (2,311) (8,943)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of Property and Equipment, and Intangibles (115) (89)
Proceeds from Sale of Equipment 15  
NET CASH USED IN INVESTING ACTIVITIES (100) (89)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments on Capital Leases (18) (1)
Payments made on Notes Payable (454)  
Proceeds from Loan Payable, Net of Loan Costs   2,502
Proceeds from Issuance of Common Stock and Subscriptions, Net of Issuance Costs   11,372
NET CASH (USED) PROVIDED BY FINANCING ACTIVITIES (472) 13,873
FOREIGN CURRENCY TRANSLATION 2 (47)
NET INCREASE (DECREASE) IN CASH (2,881) 4,794
CASH, BEGINNING OF PERIOD 3,940 2,391
CASH, END OF PERIOD 1,059 7,185
Cash Paid During the Year For:    
Interest $ 151 $ 119
XML 30 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
LOANS PAYABLE
3 Months Ended
Mar. 31, 2012
LOANS PAYABLE  
LOANS PAYABLE

4.              LOANS PAYABLE

 

Venture Loan Payable

 

On December 21, 2010, we entered into a Venture Loan and Security Agreement (the “Loan Agreement”) with Compass Horizon Funding Company, LLC (the “Lender”). The Loan Agreement provides for a total loan commitment of $5.0 million comprising of Loan A and Loan B, each in the amount of $2.5 million. Loan A was funded at closing on December 21, 2010 and matures 39 months after the date of advance.  Loan B was funded on February 17, 2011 and also matures 39 months after the date of advance. We are obligated to pay interest per annum equal to the greater of (a) 12% or (b) 12% plus the difference between (i) the one month LIBOR Rate, on the date which is five business days before the funding of such loan and (ii) .30%. We are required to make interest only payments for the first nine months of each loan and equal payments of principal over the final thirty months of each loan.  Any payments received after five days of written notice from the Lender will be assessed a 4% late payment fee.  We granted a security interest to the Lender in all of our property.

 

In connection with loan, we issued a seven year warrant to the Lender to purchase 140,000 shares of common stock of the Company at an exercise price of $4.40. The relative fair value of the warrants was $0.2 million and will be recorded as interest expense over the term of the loan. We estimated the fair value of the warrants using the Black-Scholes option pricing model using the following assumptions:

 

Assumptions:

 

December 22, 2010

 

Expected Life

 

7 years

 

Expected volatility

 

39.9

%

Dividends

 

None

 

Risk-free interest rate

 

2.74

%

 

Also in connection with the Loan Agreement, we incurred $0.4 million of debt issue costs which were deferred and are being amortized to interest expense over the term of the loan.

 

Convertible Subordinated Notes

 

On May 24, 2011, we issued $12.5 million in aggregate principal amount of 7% Senior Subordinated Convertible Notes due June 1, 2016 (the “Notes”). The Notes were issued pursuant to an indenture (the “Indenture”), entered into between us and Wells Fargo Bank, National Association, as trustee, on May 24, 2011. In connection with the issuance of the Notes, we entered into a Waiver to our Venture Loan and Security Agreement with Horizon, dated May 18, 2011 pursuant to which Horizon provided its consent to the offering of the Notes and waived any restrictions in the Loan Agreement.

 

The Notes are senior subordinated unsecured obligations which will rank subordinate in right to payment to all of our existing and future senior secured indebtedness and bear interest at a rate of 7% per annum payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2011. The Notes mature on June 1, 2016, with an early repurchase date of June 15, 2014 at the option of the purchaser. The Notes are convertible into shares of our common stock in accordance with the terms of the Notes and the Indenture, at the initial conversion rate of 172.4138 shares of our common stock per $1,000 principal amount of Notes, equivalent to a conversion price of approximately $5.80 per share, subject to adjustment. If the Notes are converted into shares of our common stock prior to June 2, 2014, an interest make-whole payment will be due based on the conversion date up until June 2, 2014. Upon a non-stock change in control, additional shares of our common stock may need to be issued upon conversion, with a maximum additional shares of 25.606 per $1,000 in principal amount of Notes being issuable thereunder, for a total maximum of 198.0198 shares per $1,000 Note. Certain customary anti-dilution provisions included in the Indenture and/or the Notes could adjust the conversion rate. At March 31, 2012, the Notes are convertible into 2,155,173 shares of our common stock.

 

The conversion feature within the Notes is not considered to be a beneficial conversion feature within the meaning of Accounting Standards Codification (“ASC”) 470, Debt, and therefore all of the gross proceeds from the Notes have been classified as long term debt. In connection with the issue of the Notes, we incurred approximately $1.3 million of debt issue costs which were deferred and are being amortized to interest expense over the term to the early repurchase date of June 15, 2014.

 

Also in connection with the issuance of the Notes, we entered into a Securities Purchase Agreement dated May 18, 2011 pursuant to which we agreed to prepare and file a registration statement with the Securities and Exchange Commission (the “SEC”) registering the resale of the Notes and the shares of common stock underlying the Notes. The registration statement was declared effective on August 10, 2011.

 

Mortgage Payable

 

Effective October 24, 2011, Cereplast Italia S.p.A (“Cereplast Italia”), our wholly owned subsidiary, completed its acquisition of an industrial plant and the real estate on which the industrial plant is located in Cannara, Italy. The Deed of Sale between Cereplast Italia and Societa Regionale Per Lo Sviluppo Economico Dell’Umbria — Sviluppumbria S.p.A, provided for an aggregate purchase price of approximately $6.4 million.  In connection with the acquisition, Cereplast Italia entered into the following financing transactions:

 

·                  Mortgage loan with Banca Monte Dei Paschi Di Sienna S.p.A for the principal of $4.5 million. The loan bears interest of Euribor (6-month) plus 5.7%. The loan is for a term of 15 years with interest only payments for the first two years, payable January 1 and July 1 each year and principal and interest payments thereafter according to an amortization schedule. 20% of the principal is guaranteed for 10 years by Gepafin, a local government agency; $0.5 million of the principal is guaranteed by Eurofidi through December 31, 2016.

 

·                  Credit facility with Intesa Sanpaolo for up $0.7 million. The facility is for a term of eight months with a floating interest rate based on Euribor (3 month), currently 5.85%. Interest is deferred for the first two months of the term. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.

 

·                  Credit facility with Unicredit Bank for up to $0.8 million. The facility is for a term of 18 months with a floating interest rate based on Euribor (3 month), currently 5.93%. Cereplast Italia obtained a guarantee of 60% of the amount drawn on the facility from Eurofidi.

XML 31 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 12 105 1 false 3 0 false 3 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.cereplast.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0010 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.cereplast.com/role/BalanceSheet CONSOLIDATED BALANCE SHEETS false false R3.htm 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.cereplast.com/role/BalanceSheetParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME Sheet http://www.cereplast.com/role/StatementOfIncome CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME false false R5.htm 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.cereplast.com/role/CashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R6.htm 0035 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://www.cereplast.com/role/CashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) false false R7.htm 1010 - Disclosure - ORGANIZATION AND LINE OF BUSINESS Sheet http://www.cereplast.com/role/DisclosureOrganizationAndLineOfBusiness ORGANIZATION AND LINE OF BUSINESS false false R8.htm 1020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.cereplast.com/role/DisclosureSummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R9.htm 1030 - Disclosure - CAPITAL STOCK Sheet http://www.cereplast.com/role/DisclosureCapitalStock CAPITAL STOCK false false R10.htm 1040 - Disclosure - LOANS PAYABLE Sheet http://www.cereplast.com/role/DisclosureLoansPayable LOANS PAYABLE false false R11.htm 1050 - Disclosure - LEASES Sheet http://www.cereplast.com/role/DisclosureLeases LEASES false false R12.htm 1060 - Disclosure - MAJOR CUSTOMERS AND FOREIGN SALES Sheet http://www.cereplast.com/role/DisclosureMajorCustomersAndForeignSales MAJOR CUSTOMERS AND FOREIGN SALES false false R13.htm 1070 - Disclosure - INCOME TAX Sheet http://www.cereplast.com/role/DisclosureIncomeTax INCOME TAX false false R14.htm 1080 - Disclosure - COMMON STOCK WARRANTS Sheet http://www.cereplast.com/role/DisclosureCommonStockWarrants COMMON STOCK WARRANTS false false R15.htm 1090 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.cereplast.com/role/DisclosureSubsequentEvents SUBSEQUENT EVENTS false false All Reports Book All Reports Process Flow-Through: 0010 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 0015 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 0020 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME Process Flow-Through: 0030 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: 0035 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) cerp-20120331.xml cerp-20120331.xsd cerp-20120331_cal.xml cerp-20120331_def.xml cerp-20120331_lab.xml cerp-20120331_pre.xml true true